Sonera becomes Telia

“Rebranding our Finnish operations is another step in our journey towards becoming one New Generation Telco under one brand in all our countries, and I am delighted to welcome my Finnish colleagues and customers to the Telia family. The change will enable us to better serve our Finnish customers by combining the international strength of Telia Company with the local expertise and position of Sonera”, says Johan Dennelind, president and CEO of Telia Company. The history of the company now known as Telia in Finland dates back to 1855, and since 1998 the company has been operating under the Sonera name. Each year, the company invests about EUR 200 million in Finland and employs about 3,300 people directly and thousands more indirectly. Today’s announcement means that all fully-owned subsidiaries of Telia Company now operate under the Telia brand. In Latvia, Telia Company offers mobile services through the mobile operator LMT which the company owns 60.3 percent of. Telia Company also owns 49 percent of the fixed network company Lattelecom.  For more information, please contact our press office +46 771 77 58 30, visit our Newsroom  or follow us on Twitter @Teliacompany .  We’re Telia Company, the New Generation Telco. Our 21,000 talented colleagues serve millions of customers every day in one of the world’s most connected regions. With a strong connectivity base, we’re the hub in the digital ecosystem, empowering people, companies and societies to stay in touch with everything that matters 24/7/365 - on their terms. Headquartered in Stockholm, the heart of innovation and technology, we’re set to change the industry and bring the world even closer for our customers. Read more at www.teliacompany.com.

Notice of Annual General Meeting of Mr Green & Co AB (publ)

The shareholders of Mr Green & Co AB (publ), Corporate Registration Number 556883-1449 (“the Company”) are hereby invited to the Annual General Meeting on Monday, 24 April 2017 at 5.00 p.m. at Wallenbergsalen, IVA, Grev Turegatan 16 in Stockholm, Sweden. A. Right to participate in the MeetingShareholders who wish to participate in the Meeting must be included in the share register maintained by Euroclear Sweden AB as of Tuesday, 18 April 2017, and notify the Company of their participation not later than 18 April 2017 at the following address: Annual General Meeting, Mr Green & Co AB, Sibyllegatan 17, SE-114 42 Stockholm, or by e-mail: information@mrg.se. In their notification of attendance, shareholders must state their name, personal identification number or Corporate Registration Number, address, telephone number, e-mail address, any assistants and shareholdings. Proxy forms for shareholders wishing to participate in the Meeting via proxy will be available from the Company’s website mrg.se. Shareholders represented by proxy are to issue a dated power of attorney for the proxy. If the power of attorney is issued on behalf of a legal entity, a certified copy of a registration certificate or corresponding document for the legal entity is to be appended to the notification of attendance. The power of attorney and registration certificate should be sent to the Company at the aforementioned address well in advance of the Meeting. The power of attorney document may not be more than five years old. Shareholders whose shares are registered with a bank’s custody services department or another nominee must temporarily re-register their shares in their own name with Euroclear Sweden AB to be able participate in the Meeting. Such re-registration must be completed by 18 April 2017, and the nominee must thus be informed well in advance of this date. B. Items of business at the MeetingProposed agenda1) Opening of the Meeting 2) Election of Chairman of the Meeting 3) Preparation and approval of the voting list 4) Approval of the agenda 5) Election of two officers to verify the minutes 6) Determination of whether the Meeting has been duly convened 7) CEO’s presentation 8) Presentation of the submitted Annual Report and the Auditor’s Report, and the Consolidated Financial Statements and the Group Auditor’s Report 9) Resolutions regarding: a) adoption of the Income Statement and the Balance Sheet, and the Consolidated Income Statement and Consolidated Balance Sheet b) appropriation of the Company’s profits according to the adopted Balance Sheet c) discharge from liability of the Board of Directors and the CEO 10) Determination of the number of Board members 11) Determination of remuneration of the Board of Directors 12) Determination of remuneration of the auditor 13) Election of Board members and auditor 14) Resolution concerning the Nominating Committee 15) Board of Directors’ motion for resolution concerning approval of guidelines for remuneration of senior executives 16) Board of Directors’ motion for resolution regarding authorisation for the Board to make minor adjustments to resolutions made at the Meeting in conjunction with registration with the Swedish Companies Registration Office and Euroclear Sweden AB 17) Closing of the meeting Motions for resolution, etc. The Nominating Committee’s proposals relating to Items 2, 10-14 on the agendaThe Nominating Committee was appointed by the 2016 Annual General Meeting. The current Nominating Committee comprises Dimitrij Titov, Mikael Pawlo and Board Chairman Kent Sander. Item 2 – Election of Chairman of the MeetingThe Nominating Committee proposes that attorney-at-law Dimitrij Titov be appointed Chairman of the Meeting. Item 10 – Determination of the number of Board membersThe Nominating Committee proposes that the Board of Directors comprise six (6) regular members with no alternate members. Item 11 – Determination of remuneration of the Board of DirectorsThe Nominating Committee proposes that the Board of Directors be paid fees totalling SEK 2,305,000, of which SEK 730,000 to the Chairman of the Board and SEK 315,000 to each of the other Board members. Fees of SEK 385,000 are to be paid for Committee work, distributed as follows: Audit Committee: SEK 125,000 to the Chairman and SEK 75,000 to other Committee members. Remuneration Committee: SEK 50,000 to the Chairman and SEK 30,000 to other Committee members. Provided that all fiscal prerequisites are met for invoicing and it is cost-neutral for the Company, it is possible for Board fees to be invoiced through the Board member’s own company. Should a Board member choose to invoice his/her Board fees through a company, the fees are to be increased by an amount corresponding to the statutory social security contributions and VAT. Item 12 – Determination of remuneration of the auditorsRemuneration of auditors is to be paid in accordance with approved invoices. Item 13 – Election of Board members and Chairman of the Board, and auditorsThe Nominating Committee proposes the re-election of Kent Sander, Tommy Trollborg, Andrea Gisle Joosen, Henrik Bergquist, Eva Lindqvist and Danko Maras. Kent Sander is proposed for re-election as Chairman of the Board. A detailed description of the proposed members is available at the Company’s website mrg.se. The Nominating Committee proposes, in accordance with the recommendation of the Audit Committee, that accounting firm Öhrlings PricewaterhouseCoopers AB be elected auditor for the period until the end of the 2018 Annual General Meeting. On the condition that the Nominating Committee’s proposal is adopted by the Annual General Meeting, the accounting firm has stated that Bo Åsell will be appointed Auditor in Charge. Information about Öhrlings PricewaterhouseCoopers AB and Bo Åsell is available from the Company’s website mrg.se. Item 14 – Resolution concerning the Nominating CommitteeThe Company is to have a Nominating Committee comprising four (4) members. During the year, the Chairman of the Board is to convene the three (3) largest shareholders in the Company in terms of the number of votes to each appoint one representative to serve as a member of the Nominating Committee, in addition to the Chairman of the Board. If one of the three largest shareholders decides to waiver its right to appoint a representative to the Nominating Committee, the next largest shareholder is to be given the opportunity to appoint a member to the Nominating Committee. The Nominating Committee can also decide, if deemed appropriate, to appoint an additional representative for a group of major shareholders who will be co-opted to the Nominating Committee. The Chairman of the Board is to convene the first meeting of the Nominating Committee but is not to serve as the Chairman of the Nominating Committee. The Chairman of the Nominating Committee is to be the member who represents the largest shareholder in terms of the number of votes, unless the members agree otherwise. The appointed Nominating Committee’s period in office extends until such time as a new Nominating Committee is appointed. The composition of the Nominating Committee is normally to be announced not later than six months before the Annual General Meeting. The Nominating Committee elects its members based on Euroclear Sweden AB’s list of registered shareholders on the final banking day of August. If one or more shareholders who appointed a Nominating Committee member are no longer one of the three largest shareholders in terms of the number of votes, this representative is to make their place available after which the shareholder(s) who is(are) now one of the three largest shareholders will be entitled to appoint a new representative. However, marginal changes to the number of votes are not taken into account, unless there are special reasons for this. If a member leaves the Nominating Committee before its work has been completed, the Nominating Committee is to encourage the shareholder who appointed this member to appoint a new representative to the Nominating Committee within a reasonable time. If the shareholder refrains from appointing a new representative, the right to appoint a new Nominating Committee member goes to the next largest shareholder in terms of the number of votes who is not already a member of the Nominating Committee. Any changes to the composition of the Nominating Committee are to be published as soon as they occur. The Company does not pay any fees for Nominating Committee work. However, the members of the Nominating Committee are entitled to remuneration for reasonable outlay and expenses deemed necessary for the Committee’s work. The Nominating Committee is to draft proposals on the following issues for resolution by the 2018 Annual General Meeting: · proposing a candidate for Chairman of the Meeting · proposing candidates for the Board of Directors · proposing a candidate for Chairman of the Board · proposing auditors · proposing directors’ fees · proposing auditors’ fees · proposing principles for the appointment of the next Nominating Committee The Board of Directors’ motions for resolution concerning Items 9b, 15-16 on the agenda  Item 9 b – Appropriation of the Company’s profitsThe Board of Directors proposes that no dividend be paid for the 2016 financial year. Item 15 – The Board of Directors’ motion for resolution concerning approval of guidelines for remuneration of senior executivesA Remuneration Committee elected from within the Board’s ranks is assigned the task of preparing guidelines for salaries and other employment conditions for the CEO and other senior executives and presenting proposals to the Board for a decision on such matters. The Board is to determine the salary and other remuneration paid to the CEO. The CEO is to determine the salary and other remuneration paid to other senior executives in accordance with the Board’s guidelines. The term “other senior executives” refers to individuals who, in addition to the CEO, constitute Group Management. Basic remuneration levels are to be consistent with market terms. Remuneration consists of a fixed basic salary, any variable remuneration calculated on the basis of predetermined targets, other benefits, pension and financial instruments in the form of warrants. The division between fixed salary and variable remuneration is to be proportionate to the executive’s responsibilities and authorities. The variable remuneration for the CEO and other senior executives may not exceed 50% of their fixed salary. Pension terms are to be based on defined-contribution pension solutions. The period of notice in case of termination by the Company may not exceed six months. During the period of notice of up to six months, the employee receives a full salary and employee benefits. Decisions regarding share-based and share price-based incentive schemes are made by the general shareholders’ meeting. In individual cases and where specific reasons exist, the Board may deviate from the above guidelines. Item 16 – Minor adjustmentsIt is proposed that the AGM authorise the Board or the party appointed by the Board to make minor adjustments to the resolutions passed at the Annual General Meeting should they be required in conjunction with registration with the Swedish Companies Registration Office or Euroclear Sweden AB. C. Disclosures, documentation and number of shares and votes If requested by a shareholder and if the Board believes that such action can take place without any material harm to the Company, the Board and CEO are to provide disclosures about circumstances that may influence the assessment of an item of business on the agenda, circumstances that may affect the Company’s financial position, the Company’s relationship with another Group company and the consolidated financial statements. The financial statements, auditor’s report and the Board of Directors’ complete motions for resolution as specified above, along with the statements in accordance with the Swedish Companies Act, will be available at the Company and its website, mrg.se, not later than three weeks prior to the Meeting. These documents will also be sent to shareholders requesting such documentation and who have provided their postal address. The total number of shares and votes in the Company on the publication date of this notice was 35,849,413. The company holds no treasury shares. ____________________ Stockholm, March 2017 Mr Green & Co AB (publ) Board of Directors For further information, please contact:Per Norman, CEO of Mr Green & Co AB, tel. +46 (0) 722 30 9191 per.norman@mrg.se Mr Green is a leading online gaming company with operations in 13 countries. The business concept is to offer entertainment and a first-class gaming experience in a responsible environment. The business was founded in 2007 and has developed into a well-established online gaming company with a broad customer offer and a strong globally viable brand. In 2016, Mr Green generated sales of SEK 924.5 million and the company has over 200 employees. The headquarters and technical development are based in Stockholm, and operations in Malta. Mr Green has gaming licences in Malta, UK and Italy. The company is listed on Nasdaq Stockholm’s main market. 

Annual general meeting in Magnolia Bostad 2017

The Magnolia Bostad AB board of directors has resolved to convene an annual general meeting of shareholders to be held Wednesday April 26, 2017. Further details on the proposals are found in the notice convening the meeting which is found below. The notice is expected to be published in the Swedish Official Gazette (Post- och Inrikes Tidningar) and on the company’s website within the next few days. NOTICE OF ANNUAL GENERAL MEETING MAGNOLIA BOSTAD AB The Annual General Meeting of Magnolia Bostad AB will be held on Wednesday, 26 April 2017 at 2.00pm at Berns, Berzelii Park, Stockholm. Registration begins at 1.00pm. Light refreshments will be served at the meeting. RIGHT TO ATTEND AND NOTIFICATION TO THE COMPANY Anyone wishing to attend the meeting must (i)         be entered as a shareholder in the share register kept by Euroclear Sweden AB as of Thursday, 20 April 2017, (ii)        give notice of their intention to attend no later than Thursday, 20 April 2017. Notification of attendance may be given in writing to the Company at the address Magnolia Bostad AB, PO Box 5853, 102 40 Stockholm,Sweden, or by telephone on +46 70-288 80 49 weekdays between 9.00am and 4.00pm or on the Company’s website: www.magnoliabostad.se. When giving notification please state your name or company name, personal ID or company registration number, address and daytime telephone number. The registration procedure described above also applies to registration for any advisors. NOMINEE REGISTERED SHARES To be entitled to attend the meeting, holders of nominee registered shares must instruct the nominee to have the shares registered in the holder’s own name, so that the holder is entered in the share register kept by Euroclear Sweden AB as of Thursday, 20 April 2017. Registration in this way may be temporary. PROXY AND PROXY FORM Anyone who does not attend the meeting in person may exercise their right at the meeting via a proxy in possession of a signed and dated form of proxy. Forms of proxy are available on the Company’s website: www.magnoliabostad.se. The form of proxy may also be obtained from the Company or be ordered over the telephone using the number above. If the proxy is issued by a legal person, a copy of their registration certificate or equivalent documentary authority must be attached. The proxy must have been issued within the past year unless a longer period of validity is specified on the form of proxy, subject to a maximum of five years. To facilitate entry to the meeting, forms of proxy, registration certificates and other documentary authority must be received by the Company in good time before the meeting. Proposed Agenda  1. Opening of the meeting 2. Election of Chair of the meeting  3. Preparation and approval of voting list 4. Approval of the agenda 5. Election of one or two persons to approve the minutes 6. Examination of whether the meeting has been duly convened 7. Presentation of the annual report and auditor’s report, and also the group accounts and auditor’s report for the group 8. CEO’s address 9. Resolutions on a)    Adoption of the profit and loss account and balance sheet, and also the consolidated profit and loss account and consolidated balance sheet; b)    Allocation of the Company’s result in accordance with the adopted balance sheet and determination of the record day for dividends; and  c)    Discharge from liability towards the Company of the directors and the CEO for the financial year 2016      10.  Resolution on the number of directors and the number of auditors    11.  Resolution on remuneration payable to the directors and auditor     12.  Election of directors, Chairman of the Board and auditor     13.  Resolution on instruction for the Nomination Committee     14.  Resolution on guidelines for remuneration payable to senior executives     15.  Resolution on alteration of the articles of association     16.  Resolution on warrant program and on approval of transfer of warrants    17.  Closure of the meeting PROPOSED RESOLUTIONS Election of Chair of the meeting (Item 2) Shareholders representing a majority of the shares in the Company propose that Fredrik Holmström be elected to chair the meeting. Resolution on allocation of the Company’s result in accordance with the adopted balance sheet and determination of the record day for dividends (Item 9b)) The Board proposes that the distributable funds of roughly SEK 89 825 545 be allocated as follows. A dividend of SEK roughly 66 188 995 will be paid to the shareholders, equal to SEK 1.75 per share. The remaining sum of roughly SEK 23 636 550 will be carried forward. The proposed record day for dividends is Friday, 28 April 2017. If the resolution is passed at the AGM, it is expected that dividends will be distributed by Euroclear Sweden AB on Thursday, 4 May 2017.   Resolution on the number of directors and the number of auditors (Item 10) Shareholders representing a majority of the shares in the Company propose that the Board should be composed of 6 directors elected at the AGM, with no alternates, for the period until the next AGM. It is further proposed that the Company have one auditor, with no alternate. Resolution on remuneration payable to the directors and auditor (Item 11) Shareholders representing a majority of the shares in the Company propose that a total fee of SEK 1,700,000 be paid for the period until the end of the next AGM, comprising SEK 450,000 for the Chairman of the Board, and SEK 250,000 each for other directors elected at the AGM. Further total fee of SEK 200,000 be paid for the audit committee, comprising SEK 80,000 for the Chairman of the audit committee, and SEK 60,000 each for other members of the audit committee. It is further proposed that fees will be payable to the auditor in accordance with approved invoices. Election of directors, Chairman of the Board and auditor (Item 12) Shareholders representing a majority of the shares in the Company propose re-election of Viveka Ekberg, Fredrik Holmström, Jan Roxendal, Andreas Rutili, Risto Silander and Fredrik Tibell as directors. It is proposed that Fredrik Holmström be re-elected Chairman of the Board. It is further proposed that the registered audit company Ernst & Young AB be reappointed auditor. Ernst & Young AB has given notice that if the proposal is adopted at the AGM, Ingemar Rindstig, Authorised Public Accountant, will be the person appointed to have main responsibility for the audit. Resolution on instruction for the Nomination Committee (Item 13) The Board proposes that the meeting resolves on instruction for the Nomination Committee, essentially as follows. The following instructions should apply to a future Nomination Committee until new instructions are decided. Before the next AGM the Nomination Committee will be composed of representatives of the three shareholders holding the highest percentage of voting rights as shown in the share register kept by Euroclear Sweden* on 30 September each year, together with the Chair of the Board, who will also convene the first meeting of the Nomination Committee. The member representing the shareholder holding the highest percentage of voting rights will be appointed Chair of the Nomination Committee. If, more than three months before the AGM, any shareholder that has appointed a member of the Nomination Committee is no longer one of the three shareholders holding the highest percentage of voting rights, the member appointed by that shareholders must stand down, and any shareholder that has then become one of the three shareholders holding the highest percentage of voting rights will then be entitled to appoint a member. If a member leaves the Nomination Committee before its work is completed, and the Nomination Committee finds it desirable that a replacement be appointed, that replacement will represent the same shareholder or, if the shareholder is no longer one of the three shareholders holding the highest percentage of voting rights, the shareholder holding the next highest percentage of voting rights. Changes in membership of the Nomination Committee must be made public immediately. The identity of Nomination Committee members before each AGM must be made public no later than six months before the AGM. No remuneration is payable to members of the Nomination Committee. The Company will pay necessary overheads incurred by the Nomination Committee in its work. The Nomination Committee’s term of office runs until the identity of the next Nomination Committee members has been made public. The Nomination Committee will draw up proposals on the following matters to be decided at the AGM: a)    Proposed Chair of the AGM; b)    Proposed number of directors; c)     Proposed directors and Chair of the Board; d)    Proposed fees for directors elected at the AGM who are not employed by the Company, divided between the Chair and other directors. Remuneration for committee work, per member; e)    Proposed auditor(s) and auditor’s fee; and f)      Where considered necessary, proposed amendments to these instructions for the Nomination Committee. In performing other aspects of its work the Nomination Committee must perform the duties incumbent on it under the Swedish Code of Corporate Governance (including accompanying instructions). * The shareholder data to be used must be sorted according to percentage of voting rights per shareholder, and include the largest shareholders registered as such in Sweden, i.e. shareholders having an account at Euroclear Sweden AB in their own name or shareholders with a custody account with a custodian that has notified Euroclear Sweden AB of the shareholder’s identity. Resolution on guidelines for remuneration payable to senior executives (Item 14) The Board proposes essentially the following guidelines for determining terms of employment and remuneration payable to senior executives. The Company has chosen, considering the size and the scope of its business, not to establish a Remuneration Committee and has concluded that remuneration matters are more appropriately handled by the Board as a whole. In order to attract and retain competent employees and executives the remuneration should be at market level, competitive and comprise a fixed salary. The fixed salary is revised at the beginning of the calendar year. The fixed salary should be based on factors such as position, competence, experience and performance. In this assessment should be taken into account that the Company is in a highly expansive phase rather than in an administrative phase. The Company may engage a consultant in the management team for a salary at market level. Senior executives may receive variable remuneration in the form of a bonus that may total at most 12 months’ fixed base salary. The bonus should be based on defined targets, related to the Company’s financial result as well as to individual performance. Variable remuneration is paid as non-pensionable salary. Conditions governing pension should accord with market practice and be based on defined contribution pension agreements. There are conditions for the CEO, governing non-compete obligations and remuneration after served employment. Remuneration due to the non-compete obligation should not exceed a total amount of 60 per cent of one years fixed salary. All senior executives should, in addition to salary, variable remuneration and pension, receive company car and health care insurance. These benefits should comprise a minor portion of total remuneration and should be in line with market practice. For 2017, the Board has proposed the general meeting to resolve on a share-based incentive programme for inter alia the senior executives. The conditions is set out in item 16 in the notice to the AGM. The Board may depart from the guidelines adopted by the general meeting in individual cases where particular reasons or needs exist. The Board should propose to every annual general meeting, guidelines for remuneration payable to senior executives. The Board should take into account changes in the Company’s size, business, management and ownership structure that may motive alterations of the guidelines. Estimated cost for variable payments The total cost for the variable payments to senior executives in accordance with the Board’s proposal, is estimated to an amount of maximum total MSEK 9.4 (including costs for social security contribution). Costs are based on existing remuneration levels and maximum utilization, and that defined targets required for remuneration are achieved. Resolution on alteration of the articles of association (Item 15)  The Board proposes that the meeting resolves to alter the articles of association, essentially as follows. (i)            Section 3 is altered to have the wording as follows: “The Company shall - directly or indirectly through subsidiaries - acquire, own, manage, develop and sell properties, carry out project activities regarding properties and own and manage securities as well as any related operations.”   (ii)           Section 5 is altered to have the wording as follows: “The Board of Directors shall consist of three to seven members.” (iii)          Section 10, second paragraph, item 8 is altered to have the wording as follows: “Determination of the number of members for the Board of Directors, auditors and deputy auditors, who shall be appointed by the Meeting;” (iv)          New item 11 in Section 10, second paragraph, given the wording as follows: “Resolution on guidelines for remuneration payable to senior executives;” (v)           Section 12 is altered to have the wording as follows: “The Company’s shares shall be registered in a securities register according to the Central Securities Depositories and Financial Instruments Accounts Act (1998:1479).” A resolution under this item regarding resolution on amendment of the article of association, will not be valid unless supported by shareholders representing at least two-thirds of the votes cast and shares represented at the meeting. Resolution on warrant program and on approval of transfer of warrants (Item 16) The Board proposes that the meeting resolves to issue and to transfer the warrants, essentially as follows. A. The Board proposes that the Company shall issue not more than 350,000 warrants. The right to subscribe for the warrants shall, with deviation from the shareholders' pre-emption rights, be vested in Magnolia Utveckling AB (the “Subsidiary”), a fully owned subsidiary of the Company. Subscription shall take place no later than 30 June 2017, such date which may be extended. The warrants shall be issued without any consideration. The Subsidiary shall transfer the warrants in accordance with paragraph B below. Each warrant gives a right to subscribe for one (1) new share in the Company. Subscription for shares in accordance with the terms and conditions may occur during the period from 2 November 2020 up until to 26 April 2022. The Subscription Price per Share shall correspond to either (i) an amount corresponding to 160% of the weighted average of all transactions in the Company’s Shares during December 1, 2017 up and until December 31, 2017 or (ii) an amount corresponding to 160% of the weighted average of all transactions in the Company’s Shares during first 10 trading days after the Company has been listed on Nasdaq OMX, whichever occurs first however, not lower than the quota value of the Share. The increase of the share capital of the Company, if all warrants are subscribed for, will amount to SEK 1,400,000 at the highest, which would represent a dilution of 0.9 percent of the total number of shares and votes in the Company. The reason for deviating from the shareholders' pre-emption rights is so each employee, by implementing this incentive programme, through their own investment, will be able to take part and work for a continuous growth of the share value of the Company. B. The Board propose that the general meeting approves the transfer of warrants from the Subsidiary on the following terms and conditions. The right to acquire warrants from the Subsidiary shall be vested in three categories of employees (including new employees). Adjustments between categories can occur with +/- 10 percent deviation in order to adjust to actual conditions when the allocation is carried out, but the basis for allocation shall be as set out below. +----------+----------------------------------+---------------------------+|Category |Maximum number of options / person|Maximum number per category|+----------+----------------------------------+---------------------------+|Executive |87.500 |175.000 ||management| | |+----------+----------------------------------+---------------------------+|Specialist|30.000 |87.500 |+----------+----------------------------------+---------------------------+|Other |10.000 |87.500 ||employees | | |+----------+----------------------------------+---------------------------+ Any allocation presumes, that an acquisition is legal and that an acquisition, according to the Board, is possible to execute without unreasonable high administrative as well as financial costs. A notification to acquire warrants shall be submitted during the period between 1 May 2017 and 31 December 2017 and in sets either corresponding to the highest number of warrants which are offered or reduced by sets of 1.000 warrants. Allocation shall be made in complete sets of 1.000 warrants. The warrants shall be transferred on market terms at a price (premium) that has been based on the basis of an estimated market value for the warrants by applying the Black-Scholes model. When estimating such market value, the value of a share in the Company, shall be considered to be the average stock-exchange rate of the shares in the Company according to an official stock-exchange list during a period of 10 trading days prior to the transfer. Other than costs for administration, implementation and evaluation of the programme, no other costs are expected to arise in connection to the program. In addition, the warrants shall be subject to competitive and standard market terms and conditions including a right for the Company or the Subsidiary to repurchase the warrants at the then current market value at the time of the repurchase, if the employment of the participant in the Company or the Subsidiary would terminate. The Board of the Company may cancel the warrants that have not been transferred to or that have been repurchased from employees. Cancelation are to be reported to the Swedish Companies Registration Office. The Subsidiary shall be able to transfer repurchased warrants to employees at the current market value and in accordance with the terms and conditions of the incentive program.  C. The Board proposes that the general meeting resolve to authorize the Board of the Company to execute the decision in paragraph A above and to see to that the Board in the Subsidiary execute the transfers of warrants in accordance with paragraph B above. A resolution according to this paragraph is valid, only if it is supported by shareholders holding at least nine-tenths (9/10) of votes casted as well as shares represented at the general meeting.  The general meeting of the Subsidiary shall also approve the resolution regarding the transfer as described above. DOCUMENTS  The complete proposals, along with financial statements and the auditor’s report for 2016 will be available at the Company and on the Company’s website www.magnoliabostad.se as from 5 April 2017 at the latest, and will be sent immediately without charge to any shareholders who so request and state their postal address. The documents will also be available at the AGM. INFORMATION AT THE MEETING If any shareholder so requests and the Board considers it possible without material harm to the Company, the Board and the CEO must provide information at the AGM on any circumstances that may influence determination of an item on the agenda, circumstances that may influence determination of the financial position of the Company or any of its subsidiaries, the group accounts and the Company’s relationship to another group company. Any shareholder wishing to submit questions in advance may do so by post to the Company’s address above or by e-mail to the address bolagsstamma@magnoliabostad.se. __________ Stockholm, March 2017 Magnolia Bostad AB (publ) Board of Directors English translation for information purposes only. If there are differences between the English translation and the Swedish original, the Swedish text will take precedence  For more information, please contact: Fredrik Lidjan, CEO +46 702 23 43 47, fredrik.lidjan@magnoliabostad.se  Mikaela Senator, IR Manager  +46 707 75 57 57, mikaela.senator@magnoliabostad.se                          The information in this press release is such information that Magnolia Bostad is required to reveal according to the European Union’s market abuse regulation, (EU) No 596/2014. The information was published through the above mentioned contact person on March 23, 2017 at 08:00 am.  Magnolia Bostad develops efficient, attractive and functional residential properties, including rental apartments, tenant-owned apartments and hotels, in attractive locations primarily in Sweden’s growth areas. Our work is based on a holistic approach where the operations are conducted in a manner that promotes long-term, sustainable urban development. Magnolia Bostad's share (MAG) is listed on Nasdaq First North. Erik Penser Bank is the Certified Adviser for the Company. More information is available at www.magnoliabostad.se

Alligator announces completion of first phase I study with CD40 agonistic immuno-oncology antibody ADC-1013

The phase I trial, which began in April 2015, is a dose-escalation study involving intratumoral and intravenous administration of ADC-1013 at five clinical sites in Sweden, Denmark and the UK (ClinicalTrials.gov: NCT02379741). The study is sponsored by Alligator and includes 24 patients and ten different tumor types. The data will now be analyzed, focusing on safety and tolerability, pharmacokinetics, immunogenicity, biomarker response and clinical response evaluation. The aim is to present the results during the fourth quarter of 2017 at a scientific meeting, followed by a publication in a scientific journal. “The study has progressed very well and we look forward to evaluating the data,” said Per Norlén, CEO at Alligator Bioscience. “I would like to extend my warmest gratitude to all the patients and their families, as well as the investigators and clinical study staff who enabled this study to be successfully completed ahead of time.” In August 2015, Alligator entered a collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, which has the global development rights to ADC-1013.             In October 2016, Janssen Biotech Inc. started a second phase I clinical study (ClinicalTrials: NCT02829099). This study is an intravenous dose escalation study with ADC-1013 (JNJ-64457107). WebcastThe webcast can be accessed live on the link below and will be available on the company website 30 minutes after the broadcast. https://wonderland.videosync.fi/2017-03-23-alligator-bioscience-press-conference Phone numbers for participants from:UK: +44  2030089806SE: +46856642669US: +18558315944 For further information, please contact:Per Norlén, CEOTelephone: + 46 46 286 42 80 (switchboard)E-mail: per.norlen@alligatorbioscience.com Rein Piir, VP Investor RelationsTelephone: +46 708 537292E-mail: rein.piir@alligatorbioscience.com Per-Olof Schrewelius, CFOTelephone: +46 46 286 42 85E-mail: per-olof.schrewelius@alligatorbioscience.com The information in the press release is such that Alligator Bioscience AB is required to disclose pursuant to the Swedish Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact persons set out above, at 08.00 CET on 23 March, 2017. About Alligator BioscienceAlligator is a biotechnology company that develops innovative immune activating antibody drugs for tumor-directed immunotherapy. The Company has a pipeline of lead clinical and preclinical product candidates: ADC-1013, ATOR-1015 and ATOR-1016 as well as various research candidates. In August 2015, ADC-1013 was out-licensed to Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, for further development and commercialization. The Company’s shares are listed on Nasdaq Stockholm under the ticker “ATORX”. The Company is headquartered in Lund, Sweden, and has approximately 40 employees. For more information, please visit www.alligatorbioscience.com. About ADC-1013ADC-1013 is a human, monospecific, agonistic, IgG1 antibody intended for immunotherapy of cancer. The drug candidate targets the co-stimulatory receptor CD40, which is expressed on, for example, antigen-presenting dendritic cells. The dendritic cells reside in blood vessels and various tissues where they discover and digest proteins from viruses, bacteria or cancer cells. Next, the digested proteins are presented to so-called T-cells which are activated and kill the infected cells or the cancer cells. ADC-1013 activates CD40 on dendritic cells, enabling them to activate T-cells more effectively and thereby increasing the immune system's attack of the cancer.

Concentric AB secures order for new electric oil pump technology with leading global OEM

This exciting new product reinforces the company’s reputation for reducing fuel consumption, increasing system efficiency, providing high power density and reducing noise. Concentric's electric oil pump offers system power savings through its variable pressure and speed control capability with the additional benefits of low noise. It also offers on-demand flow and variable speed capability. The new electric oil pump product allows CAN Bus communication between the motor and the vehicle's main control system so as to control pressure and flow on demand. This significantly reduces system losses compared to traditional mechanical drive systems, ensuring optimum performance. David Woolley, President and CEO of Concentric AB, commented: “This first major nomination for Concentric’s new electric oil pump technology is another significant breakthrough in a market driven by increased electrification and control.  Our modular design strategy is ideally suited for a wide range of applications for emerging hybrid electric vehicles and demonstrates our ongoing commitment to innovation that enables our customers to achieve sustainable solutions.” The Concentric electric oil pump has been developed in collaboration with a leading supplier of electric motors, resulting in a permanent magnet, brushless DC motor with integrated motor drive electronics. The elimination of brush wear contributes to the unit's ability to operate continuously and trouble-free. Concentric AB is an innovator in flow control and fluid power, supplying proprietary systems and components to the world’s truck, agricultural machinery, construction equipment and industrial applications end-markets.  The company has manufacturing facilities in the UK, USA, Germany, Sweden, India, China and Argentina. In addition to supplying oil, fuel transfer and water pumps for diesel engines, the group also manufactures lubrication pumps for transmissions and compressors within its range of engine products.

Notice of Annual General Meeting of Shareholders in NeuroVive Pharmaceutical AB

Please see the attached notification, which is being announced within short in Svenska Dagbladet and Post- och Inrikes Tidningar. Lund, March 23, 2017NeuroVive Pharmaceutical AB (PUBL)THE BOARD OF DIRECTORS About NeuroVive NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine. The company is committed to the discovery and development of medicines that preserve mitochondrial integrity and function in areas of unmet medical need. The company’s strategy is to take drugs for rare diseases through clinical development and into the market. The strategy for projects within larger indications outside the core focus area is out-licensing in the preclinical phase. NeuroVive enhances the value of its projects in an organization that includes strong international partnerships and a network of mitochondrial research institutions, as well as expertise with capacities within drug development and production. NeuroVive has a project in early clinical phase II development for the prevention of moderate to severe traumatic brain injury (NeuroSTAT®). NeuroSTAT has orphan drug designation in Europe and in the US. The R&D portfolio consists of several late stage research programs in areas ranging from genetic mitochondrial disorders to cancer and metabolic diseases such as NASH. NeuroVive is listed on Nasdaq Stockholm, Sweden (ticker: NVP). The share is also traded on the OTCQX Best Market in the US (OTC: NEVPF). NeuroVive Pharmaceutical AB (publ)Medicon Village, SE-223 81 Lund, SwedenTel: +46 (0)46 275 62 20 (switchboard)www.neurovive.com This information is information that NeuroVive Pharmaceutical AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:30 a.m. CET on March 23, 2017. Notice of Annual General Meeting of NeuroVive Pharmaceutical AB (publ) The shareholders of NeuroVive Pharmaceutical AB (publ), corporate identity number 556595-6538, are hereby convened to the Annual General Meeting, held at 4 p.m. on Thursday, 27 April 2017 at Medicon Village, Scheelevägen 2, in Lund, Sweden, with admission for registration from 3:30 p.m. Entitlement to participate and notificationShareholders that wish to participate at the Annual General Meeting should · be included in the share register maintained by Euroclear Sweden AB on Friday 21 April 2017, and · notify the Company by email to anmalan@neurovive.com or, in writing to NeuroVive Pharmaceutical AB, Medicon Village, Scheelevägen 2, 223 81 Lund, Sweden, no later than Friday, 21 April 2017. Notifications must state full names, personal or corporate identity numbers, shareholdings, address, daytime telephone number, and where applicable, information on deputies or assistants (maximum of two). Where applicable, notifications should also enclose powers of attorney, certificates of registration and other legitimacy papers. Nominee-registered shares For entitlement to participate at the Annual General Meeting, shareholders with nominee-registered holdings with banks or other administrators must temporarily re-register their shares in their own name with Euroclear Sweden AB. Such re-registration must be complete by no later than Friday 21 April 2017, which means that shareholders that wish to conduct such re-registration must inform their administrator thereof in good time prior to the aforementioned date. Proxies etc.   If shareholders attend by proxy, such proxy must bring a written power of attorney, dated and signed by the shareholder to the Meeting. This power of attorney may not be older than one year, unless a longer term of validity (although subject to a maximum of five years) is stated in the power of attorney. If the power of attorney has been issued by a legal entity, the proxy should also bring the relevant certificate of registration or corresponding legitimacy papers for the legal entity. To facilitate entry, a copy of the power of attorney and other legitimacy papers should be attached to the notification of attendance of the Meeting. Power of attorney forms are available from the Company’s website www.neurovive.se and can be sent by mail to shareholders that contact the Company stating their mail address. Number of shares and votes   At the time of publication of this Notice, the total number of shares and votes of the Company is 49,458,645. The Company does not hold any treasury shares. Proposed agenda:    0.     Opening the Meeting.  1.     Election of a Chair of the Meeting.  2.     Preparation and approval of the voting list.  3.     Approval of the agenda.  4.     Election or two persons to verify the minutes.  5.     Consideration of whether the Meeting has been duly convened.  6.     Chief Executive Officer's address.  7.     Submission of the Annual Accounts and Audit Report and the Consolidated Accounts and Consolidated Audit Report.  8.     Resolutions         a)     On adopting the Income Statement and Balance Sheet and the Consolidated Income Statement and Consolidated Balance Sheet.         b)     On appropriation of the Company's earnings in accordance with the adopted Balance Sheet.         c)      On discharging the Board members and Chief Executive Officer from liability.  9.    Determination of the number of Board members and Auditors.  10.   Determination of Directors' and audit fees.  11.   Election of a Board of Directors and Auditors.  12.   Resolution on guidelines for remuneration to senior executives.  13.   Resolution on guidelines for the Nomination Committee.  14.   Resolution on authorizing the Board of Directors to decide on the new issue of shares, warrants and/or convertibles.  15.   Closing the Meeting. Proposed resolutions in brief: Election of a Chairman of the Meeting (point 1)   The Nomination Committee proposes that the Annual General Meeting appoints Lawyer Annika Andersson, Law firm Lindahls, as Chair of the Meeting. Appropriation of profits (point 8 b)   The Board of Directors proposes that the Annual General Meeting disposes over the Company’s earnings in accordance with the Board of Directors’ proposal in the Annual Accounts. Additionally, the Board of Directors proposes that no dividend is paid for the financial year 2016. Determination of the number of Board members and determination of Directors’ and audit fees (point 9 and 10) The Nomination Committee proposes that the Annual General Meeting resolves that the number of Board members shall be five. The Nomination Committee also proposes that fees to Board members elected by the Annual General Meeting not employed by the Company and members of the Board of Directors’ various Committees not employed by the Company shall be payable as follows: · SEK 300,000 to the Chairman of the Board; · SEK 150,000 each to other Board members; · SEK 100,000 to the Chairman of the Audit Committee; · SEK 50,000 each to other members of the Audit Committee; · SEK 40,000 to the Chairman of the Remuneration Committee; · SEK 20,000 each to other members of the Remuneration Committee. Having considered the Company’s and the Board of Directors’ appraisal of the auditors’ work, the Nomination Committee proposes that as in the previous year, audit fees should be in accordance with approved account pursuant to customary billing terms. No fees shall be payable to members of the Nomination Committee. Election of the Board of Directors and Auditors (point 11)   The Nomination Committee proposes that the Annual General Meeting approves re-election of the following Board members: Gregory Batcheller, Marcus Keep, and David Laskow-Pooley. The Nomination Committee also proposes the election of Jan Törnell and David Bejker as Board members. The Nomination Committee proposes that Gregory Batcheller is re-elected as Chairman of the Board. Jan Törnell, born 1960, is Associate Professor and Medical doctor with 20 years’ experience from different senior positions within the pharmaceutical industry, both in Sweden and internationally. Jan has held the position as Vice President in AstraZeneca Oncology & Infection 2009-2011 and Vice President Translational Science 2006-2008. He was Director at AstraZeneca Discovery 1999-2005 and Astra 1996-1999. Jan is Editor-in-Chief for Drug Discovery Today –Disease Models published by Elsevier. Principal supervisor of several students resulting in PhD theses. Author of 80 scientific publications and innovator on 6 patents. Currently, Jan is adjunct Professor at the Institute of Neuroscience and Physiology, Sahlgrenska Academy, Gothenburg University. Chairman of the Board at LIDDS AB, Glactone Pharma AB and Glactone Pharma Development AB. Director of the Board at Stayble AB and Diaprost AB. CEO at Oncorena AB and Innoext AB. Partner of P.U.L.S. AB.  David Bejker, born 1975, has an MSc from Stockholm School of Economics. David Bejker is the CEO of Affibody Medical AB, a company that develops innovative biopharmaceuticals, since 2008. He has many years of industry experience both from an investor perspective, through employment in HealthCap, and also operating as a business developer of Affibody AB during 2003 to 2005. David Bejker has been CEO of Affibody in a period when the company successfully focused its strategy to become a financially strong biopharmaceutical company with projects in clinical development and a large number of global licensing and collaboration deals. Affibody has under his leadership also secured major grants from the EU, the NCI and Vinnova. Resolution on guidelines for remuneration to senior executives (point 12) The Board of Directors proposes that the Annual General Meeting approves the following guidelines for remuneration to senior executives:   Guidelines for remuneration and other employment terms for management primarily imply that the Company should offer its senior executives market remuneration, that the remuneration shall be subject to consultation by a dedicated Remuneration Committee within the Board of Directors, that the associated criteria shall constitute the senior executive’s responsibilities, role, competence and position. Remuneration to senior executives is decided by the Board of Directors excluding any Board members affiliated to the Company and management. The guidelines shall be applied to new agreements, or amendments to existing agreements reached between senior executives after the guidelines have been adopted, and until new or revised guidelines are determined. What is stipulated for NeuroVive also applies to the Group, where applicable. This proposal is basically identical to the guidelines approved for remuneration to senior executives in the previous year.   1.     Basic principleSalary and other remuneration, as well as any share-related incentive programs, shall be on market terms and shall be structured so that NeuroVive can attract and retain competent senior executives.  2.     Fixed remunerationSenior executives shall be offered fixed remuneration that is on market terms and based on the senior executive's responsibilities, roll, competence and position. Fixed remuneration shall be subject to annual review.  3.     Variable remuneration 3.1. Short-Term Incentive (STI Bonus) From time to time, senior executives and other key individuals may be offered variable remuneration. Such variable remuneration shall be on market terms and shall be based on the outcome of predetermined financial and individual targets. The terms and conditions and basis of computation of variable remuneration shall be determined for each financial year. Variable compensation is settled in the year after vesting and may either be paid as salary or as a lump-sum pension premium. Payment as a lump-sum pension premium is subject to indexation so the total cost for NeuroVive is neutral. The board shall decide on the amount of STI Bonus. The basic principle is that the yearly STI Bonus is capped at an amount corresponding to a portion of the fixed annual compensation for the current year: +---+----------+-----------------+|CEO|Management|Other key persons|+---+----------+-----------------+|30%|20% |10% |+---+----------+-----------------+ The total of the variable remuneration for senior executives (CEO and Management) may amount to a total maximum of SEK 2,000,000. The amount could increase in the event the company hires additional employees. 3.2 Long-Term Incentive (LTI Bonus) In order to incentivize senior executives and other key individuals on a longer term and to encourage investment in NeuroVive shares, a cash bonus share savings opportunity should be implemented (the “LTI Bonus”). The LTI Bonus is a cash program in which the participants commit to use the cash paid out by the Company to acquire shares in the Company. The shares are acquired by the participants on the stock market. This shall apply in addition to the STI Bonus. The decision regarding the annual amount available as LTI Bonus will be built into the yearly bonus appraisal process to link yearly achievements to long term goals, to build employee shareholding in NeuroVive, and to retain employees. The amount of possible LTI Bonus will depend on the employee’s position and the ability to influence the performance of NeuroVive. The participants should use the full amount of the LTI Bonus, net after income tax to acquire NeuroVive shares on the stock market. The company will pay the social security costs. The shares acquired for the LTI Bonus will be locked in for a period of 3 years after the acquisition. An employee who resigns, is terminated or otherwise leaves the Company will be obliged to hold the shares acquired within the LTI Bonus for the full period of 3 years after acquisition notwithstanding the termination of their employment.  In the event an employee or former employee breaches the terms of the LTI Bonus program, such as for example by failing to provide information on the status of their shareholding or prematurely disposing of their shareholding they will be subject to contractual sanctions including a penalty equal to the full amount of the LTI Bonus (including income tax, but excluding social security contributions thereon). The board shall decide on the amount of LTI Bonus. The maximum amount in the LTI Bonus is capped at an amount corresponding to a portion of the fixed annual compensation for the current year: +---+----------+-----------------+|CEO|Management|Other key persons|+---+----------+-----------------+|15%|10% |5% |+---+----------+-----------------+ The total maximum cost for the above LTI Bonus is SEK 1,000,000. The amount could increase in the event the company hires additional employees. 3.3 General principles for STI and LTI When structuring variable remuneration that is payable to management in cash, the Board of Directors should consider introducing provisions such as: · disqualification from future LTI Bonus in relation to an individual who sells his/her shares during the 3 year qualification period, · making payment of a predetermined portion of such remuneration conditional so the performance on which vesting is based is demonstrably sustainable over time, and · offers the Company the opportunity to reclaim such remuneration paid on the basis of information that subsequently proves manifestly erroneous. 4.     Non-monetary benefitsWhere the Board of Directors considers it appropriate and/or after individual consideration of an overall salary and remuneration structure, a senior executive may be entitled to additional healthcare insurance  5.     PensionSenior executives are entitled to market-based pension solutions in accordance with collective bargaining agreements and/or agreements with NeuroVive. All pension obligations should be defined contribution. Salary waivers may be utilized to increase pension provisions through lump-sum pension premiums, providing the total cost for NeuroVive is neutral.  6.     Notice periodFrom NeuroVive’s side, the maximum notice period shall be six months for the Chief Executive Officer and a maximum of six months for other senior executives. The notice period from the Chief Executive Officer’s side shall be a minimum of six months, and from other senior executives’ side, shall be a minimum of three months. In addition to this notice period, severance pay subject to a maximum of six months’ salary plus fringe benefits may be payable to the CEO.  7.     The consultative and decision-making process of the Board of DirectorsThe Board of Directors' Remuneration Committee consults on proposals for decision regarding salary and other employment terms for senior executives. Remuneration to senior executives is then decided by the Board of Directors, excluding any Board members who are affiliated to the Company and its management.  8.     Share-related incentive programs approved by shareholders’ meetings Through its Nomination Committee, the Board of Directors shall consider the need for share-related incentive programs yearly, and where necessary, submit a proposal for resolution to the Annual General Meeting regarding a well-considered share-related incentive program for senior executives and/or other employees. Resolutions regarding any share and share price-related incentive programs targeted at senior executives shall be made by shareholders’ meetings  9.     Information on previously approved remuneration that is not due for paymentThere is no remuneration decided that is not due for payment.  10.   Information on departure from the guidelines resolved by the Annual General MeetingThere has been no departure from the guidelines.   11.   Other The Board of Directors shall be entitled to depart from the above guidelines if the Board of Directors judges that there are special circumstances justifying this in an individual case. Resolution on the guidelines for the Nomination Committee (point 13)  The Nomination Committee proposes that the work of the Nomination Committee for the Annual General Meeting 2018 should be conducted as follows: · The Company shall have a Nomination Committee that shall consist of a member for each of the three largest shareholders in terms of votes, based on the shareholder statistics as of 30 September 2017, which the Company obtains from Euroclear Sweden AB. If such shareholder does not exercise its right to appoint a member, the right to appoint a member of the Nomination Committee shall transfer to the next largest shareholder in terms of votes. Coincident with the appointment of a new Nomination Committee, in an appropriate manner, the Chairman of the Board shall contact the three largest shareholders identified and request them to nominate the person said shareholder intends to appoint as a member of the Nomination Committee in writing within a reasonable period in the circumstances, although not exceeding 30 days.The majority of the Nomination Committee's members should be non-affiliated to the Company and its management. The Chief Executive Officer or other member of management should not be a member of the Nomination Committee. At least one of the members of the Nomination Committee should be non-affiliated to the largest shareholder of the Company in terms of votes, or group of shareholders that cooperate on the Company’s administration. Board members may be members of the Nomination Committee, but should not constitute a majority of Nomination Committee members. The Chairman of the Board or other Board members should not be the Chairman of the Nomination Committee. If more than one member is a member of the Nomination Committee, a maximum of one of these people should be affiliated to the Company’s largest shareholder.Information on the definitively appointed Nomination Committee shall include the name of the three appointed members, as well as the name of those shareholders that appointed them, and shall be published by no later than six months prior to the scheduled Annual General Meeting. The Nomination Committee’s term of office extends until a new Nomination Committee has been appointed. Unless the members agree otherwise, the chairman of the Nomination Committee should be that member appointed by the largest shareholder in terms of votes. · If one or more of the shareholders that have appointed members of the Nomination Committee are no longer one of the three largest shareholders in terms of votes, members appointed by such shareholders shall put their places on the Nomination Committee at the Committee’s disposal, and that, or those, shareholders that have become one of the three largest shareholders in terms of the vote shall be entitled to appoint members. However, unless there are special circumstances, there shall be no changes to the composition of the Nomination Committee if only marginal changes to the number of votes have occurred, or any such change occurs later than two months prior to the Annual General Meeting. Shareholders that have appointed members of the Nomination Committee are entitled to dismiss such member, and appoint a new member of the Nomination Committee if the member appointed by said shareholder decides to leave the Nomination Committee. Changes to the composition of the Nomination Committee shall be published as soon as they have occurred. · The Nomination Committee shall prepare proposals on the following issues to be submitted to the Annual General Meeting for resolution:            a)     a proposal regarding a Chairman of the Meeting;            b)     a proposal regarding the number of Board members elected by the Annual General Meeting, and where applicable, the number of auditors;            c)      a proposal regarding fees to Board members not employed by the Company, and members of the Board’s various Committees not employed by the Company;            d)     a proposal regarding audit fees;            e)     a proposal regarding election of the Chairman of the Board and other Board members, and where applicable, election of auditors;            f)      a proposal regarding guidelines for appointing members of the Nomination Committee, and for the duties of the Nomination Committee;           g)     a proposal regarding fees to members of the Nomination Committee. · The Company’s Chairman convenes the first meeting and shall ensure that the Nomination Committee receives relevant information regarding the results of the Board of Directors’ review of its work without delay. Such information shall be presented by January at the latest and shall contain information about the Board of Directors working methods and how effective its work is. Furthermore, the Chairman shall be co-opted to the Nomination Committee’s meetings when required. · On request from the Nomination Committee, the Company shall provide personnel, e.g. secretarial services in order to facilitate the work of the Nomination Committee. When required, the Company shall reimburse the Nomination Committee’s reasonable expenses, such as the cost of recruitment, and for any external consultants the Nomination Committee deems necessary in order to complete its assignment. Resolution on authorization for the Board of Directors to decide on the new issue of shares, warrants and/or convertibles (point 14) The Board of Directors proposes that the Annual General Meeting resolves to authorize the Board of Directors to decide on the new issue of shares, warrants and/or convertibles, with or without waiving the preferential rights of shareholders on one or more occasions in the period until the next Annual General Meeting. The number of shares issued through this authorization may correspond to an increase of share capital of a maximum of fifteen per cent (15%) based on the total share capital of the Company at the time the Boards of Directors at first exploits the authorization. Share issues should be at market subscription price, subject to reservation for a market discount where applicable, and apart from cash, payment may be as assets contributed in kind or through offset or subject to other terms and conditions. The purpose of this authorization and the rationale for eventual waiving of shareholders' preferential rights, should be to raise working capital for the Company and/or to add new owners of strategic importance to the Company and/or acquisitions of other companies or operations. In order for such a resolution to be valid, the proposal must have the support of shareholders representing at least two-thirds of the votes cast and shares represented at the Meeting. Other   The Annual Accounts and Audit Report of the Company and Group, as well as complete proposals for resolution and the auditor's statement pursuant to chap. 8, § 54 of the Swedish Companies Act, will be available at the Company's offices, Medicon Village, Scheelevägen 2, Lund, Sweden, and at the Company’s website www.neurovive.se by no later than three weeks prior to the Annual General Meeting, and will be sent to those shareholders that so request and state their mail address. Shareholders attending the Annual General Meeting are entitled to request disclosures regarding matters on the agenda or the Company’s or Group’s financial position in accordance with chap. 7 § 32 of the Swedish Companies Act (2005:551) THE BOARD OF DIRECTORSNeuroVive Pharmaceutical AB (publ)Lund, Sweden, March 2017

Capio’s Nomination Committee proposes Board members for the Annual General Meeting 2017

Anders Narvinger and Gun Nilsson have declined re-election. ”I am satisfied with Capio now being established on Nasdaq Stockholm. At the same time, after six years as Chairman, it is now time for Capio to take the next step and I have consequently declared that I am not available for re-election.” says Anders Narvinger. During Anders Narvinger’s time as chairman, the company’s strategy has been defined and deepened around Modern Medicine and Modern Management. With this strategy, Capio provides healthcare with higher quality at a lower cost across the five countries where the company operates, in a Europe with aging population and increased healthcare demand. Anders Narvinger has also led Capio from being a privately owned company into becoming a public one through the IPO in Stockholm during the summer of 2015. The IPO adds to Capio’s increased legitimacy, as well as the potential to use the stock exchange as source of future funding. With this suggested change of chairman, the next phase of Capio’s development starts – with the starting point in the decided strategy, Capio should increase the speed of expansion, both organically and through acquisitions, in existing and new markets. In short, a new phase of increased growth. “The Nomination Committee proposes that the work in the board in this new phase should be chaired by Michael Wolf. He has a comprehensive and successful career managing international service companies in the financial sector. His task will be to focus the work of the board on the growth agenda and together with the company’s management drive and support that future development of Capio”, concludes Robert Furuhjelm, Nordic Capital VI Limited, the Chairman of the Nomination Committee. The complete proposals from the Nomination Committee will be presented in the notice of the AGM. The Nomination Committee, in anticipation of the 2017 AGM, consists of Robert Furuhjelm (Nordic Capital VI Limited), Joakim Rubin (Zeres Capital), Per Hesselmark (R12 Kapital), Per Colleen (Fjärde AP-fonden), Bo Lundgren (Swedbank Robur fonder) and the Chairman of the Board Anders Narvinger. Robert Furuhjelm is the Chairman of the Nomination Committee. Summary of biographies, new Board members Michael Wolf (born 1963) most recent position was as President & CEO of the Swedish/Baltic banking group Swedbank AB (publ). Prior to joining Swedbank, Michael was President & CEO of Intrum Justitia AB and before that he held several different leading positions at the insurance company Skandia, including CEO Skandia Group Germany, CIO Skandia Group and Executive Vice President, Head of Division Europe & Latin America. Michael is currently Chairman of the Stockholm Chamber of Commerce and the Anna Lindh Academy. He holds a Degree in Business and Administration from Stockholm University.  Gunilla Rudebjer (born 1959) is currently partner at Blomqvist & Rudebjer HB. Gunilla has extensive experience from the service industry and has held several positions as Chief Financial Officer in both public and private companies, such as Scandic Hotels, Cision, Parks & Resorts Scandinavia, Mandator and TUI Nordic. Gunilla serves as Board member and Chairman of the Audit Committee in Ambea AB. She holds a M.Sc. of Business and Economics from Stockholm School of Economics. Karl Åberg (born 1979) is currently Partner at Zeres Capital, based in Stockholm. Prior to establishing Zeres Capital, Karl was a Partner at CapMan and before that he worked in the Investment Banking department of Handelsbanken Capital Markets. Karl is currently a board member of Eltel. He holds a M.Sc. in Economics and Business Administration from Stockholm School of Economics.  For further information, please contact:Robert Furuhjelm, Chairman of the Nomination CommitteeTelephone: +46 76 111 34 14 This information is information that Capio AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.15 CET on 23 March 2017.

ChromoGenics share and warrant TO1 start trading today on Nasdaq First North, Stockholm

In the recently completed rights issue (the "Offering"), a total of 13,800,000 shares and 13,921,312 TO1 were issued. The number of shares may be increased by a maximum of 121 312 for the event that it decided allotment option would be fully utilized. The price per "Unit" in the Offering consisting of one share and one TO1 amounted to SEK 8.50, corresponding to issue proceeds of SEK 117.3 million before issue costs. After completion of the Offer, the number of outstanding shares in ChromoGenics is 23,214,326 shares, prior to exercise of the over-allotment option. Shares in the Offer thus comprises approximately 59.4 percent of the total shares of the Company and the market value of the Company's shares is approximately 197.3 MSEK. The share's ticker name is CHRO, ISIN code: SE0009496268The warrant’s ticker name is CHRO TO1, ISIN code: SE0009554470 Conditions for CHRO TO1 is that possession of four (4) TO1 entitles the holder to subscribe for one (1) new share in ChromoGenics at the rate of SEK 10.20 during the period 1 to 31 May 2018. The last trading day with TO1 is May 29, 2018. The main shareholders K-Svets Venture AB and New Energy Solutions II K/S will after completion of the Offer remain as the major shareholders of ChromoGenics. K-Svets Venture AB will hold approximately 22 percent and New Energy Solutions II K/S around 19 percent of the shares in the company. Within the framework of the Offer, the main owners converted the bridge loan of approximately 23.2 MSEK corresponding to 2,725,443 Units G&W Fondkommission is the financial advisor to ChromoGenics in connection with the transaction and appointed as Certified Adviser for the planned listing on Nasdaq First North Stockholm. This information is such that ChromoGenics AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and according to the Act (1991: 980) regarding trading with financial instruments. The information was submitted for publication, through the agency of the contact person set out below, at 08:30 CET on March 23, 2017.  Every care has been taken in the translation of this interim report. In the event of discrepancies, the Swedish original will supersede the English translation. Contact:Thomas Almesjö, CEOSusanne Andersson, CFO & Head of CommunicationsTel: +46 18 430 0430E-mail: info@chromogenics.com  About ChromoGenicsChromoGenics is a leader in dynamic glass with controllable heat- and light transmission. The company’s unique electrochromic technology ConverLight™, provides sustainable solar control with increased indoor comfort and energy efficiency. In 2016 the company started commercial sales to real estate projects in Scandinavia. ChromoGenics is located in Uppsala and has about 20 employees. The technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) will be listed on Nasdaq First North Stockholm from March 23rd 2017. G&W Fondkommission is appointed Certified Adviser. www.chromogenics.com  Important information StabilizationIn connection with the Offering, Erik Penser can implement measures that stabilize or maintain the share price. The warrants will not in any case be subject to any stabilization measures. These stabilization measures will not be implemented at higher prices than the offer price, 8.50 SEK. Such stabilization is intended to support the market price of the shares in order to balance any sales pressure that may be present and may be implemented in a period from the first day of trading in the Company's shares on Nasdaq First North to the date that falls 30 calendar days thereafter. Stabilization Measures include transactions that stabilize, maintain or otherwise affect the market price of the shares. Stabilization transactions consist of certain bids or purchases made for the purpose of preventing or retarding a decline in the shares' market price. Erik Penser is not obliged to take stabilization measures. Thus, there is no guarantee that the stabilization measures will be taken. If stabilization measures, the measures can at any time be terminated by Erik Penser Bank decision without notice. Erik Penser Bank's acquisition of shares in connection with the stabilization measures, at Erik Penser Bank's request neutralized by a reduced allotment. Stabilization Measures should not mean that Erik Penser in total acquire more than 121,312 shares. Neutralization by reducing the allotment may result in the number of warrants issued can not exceed the number of shares issued under the Offer up to 121,312. Within one week after the end of the period during which stabilization measures can be taken, it will be published by Erik Penser whether stabilization measures were carried out or not, the date on which stabilization started, the date of the last stabilization operation was performed and the price range within which stabilization was carried out (for each of the dates during which stabilization measures were carried out).

Welcome to the Annual General Meeting of Studsvik AB

Registration and notification of attendance Shareholders who wish to participate in the Annual General Meeting must ·  be registered in the share register kept by Euroclear Sweden AB by Friday, April 21, 2017, and ·  give notification to the company by Friday, April 21, 2017 at the latest. Notification of attendance can be given on the company’s website, www.studsvik.se; by telephone, +46 155 22 10 25; by fax, +46 155 26 30 70 or by email, studsvik@studsvik.se. Notification can also be given in writing to Studsvik AB, Annual General Meeting, SE 611 82 Nyköping. The notification must state name or business name, personal identity number or corporate identity number, address, telephone number and the number of advisors where relevant. Nominee-registered holdings Apart from giving notification of attendance, to be entitled to participate in the Annual General Meeting shareholders with nominee-registered holdings must apply to the bank or broker managing their shares for temporary re-registration in their own name in the share register by Friday, April 21, 2017. The shareholder must inform the nominee in good time before that date. Power of attorney Shareholders who have appointed a proxy must issue a power of attorney to the proxy. If the issuer of the power of attorney is a legal person, a copy of the certificate of registration (or equivalent document of authorization if there is no certificate of registration) must be enclosed. To facilitate registration for the Annual General Meeting the original power of attorney and, where relevant, documents of authorization, should be received by the company under the address given above by Friday, April 21, 2017. A proxy form is available on the company’s website, www.studsvik.se. The form is also sent to shareholders who request it from the company by telephone, +46 155 22 10 25. Agenda 1                       Election of chairman of the meeting. 2                       Drawing up and approval of the voting list. 3                       Approval of the agenda. 4                       Election of one or two persons to verify the minutes. 5                       Consideration whether the annual general meeting has been properly convened. 6                       Presentation of the annual accounts and auditor’s report and the consolidated accounts and auditor’s report for the Group. 7                       Report on the work of the Board and the work of the Remuneration Committee and Audit Committee. 8                       Address by the President. 9                       Report on the audit work in 2016. 10                    Resolution on adoption of the income statement and balance sheet as well as the consolidated income statement and consolidated balance sheet. 11                    Resolution on appropriation of the company’s profit according to the adopted balance sheet. 12                    Resolution on discharge from liability of the members of the Board of Directors and the President. 13                    Report on the work and proposals of the Nomination Committee. 14                    Determination of the number of members of the Board of Directors. 15                    Determination of fees to the Board of Directors and auditors. 16                    Election of the Board of Directors. 17                    Election of auditors and any alternate auditors. 18                    Resolution on the Nomination Committee for the next Annual General Meeting. 19                    Resolution on guidelines on remuneration to senior management. 20                    Close of the Annual General Meeting. Proposed resolutions A Nomination Committee consisting of Stina Barchan (Briban Invest AB), Sven Ericsson (representative of the Karinen family), the Chair of the Nomination Committee, Carina Heilborn (Peter Gyllenhammar AB) and Anders Ullberg (Chairman of the Board of Studsvik) prepared the proposals for points 1, 14, 15, 16, 17 and 18. The Board of Directors prepared the proposals for points 11 and 19. Item 1 The Nomination Committee proposes that the Chairman of the Board of Studsvik, Anders Ullberg, be elected as chairman of the meeting. Item 11 – Distribution of profits The Board of Directors proposes to the Annual General Meeting that dividend be distributed of SEK 1.00 (0) per share, or a total of SEK 8.2 million (0), equivalent to 13 per cent of the consolidated profit after tax for 2016. The Board of Directors further proposes that the record date for the dividend be Tuesday, May 2, 2017. If Annual General Meeting resolves in accordance with the proposal, the dividend will be distributed via Euroclear Sweden AB on Friday, May 5, 2017. Item 14 The Nomination Committee proposes that the number of Board members elected by the general meeting of shareholders shall be six. Item 15 The Nomination Committee proposes that the fees to the Board members elected by the General Meeting of Shareholders remain unchanged and be paid in the following amounts:  · SEK 650,000 to the Chairman of the Board · SEK 225,000 each to the other members of the Board The Nomination Committee further proposes that the fees to members of the Audit Committee shall remain unchanged and be paid in the following amounts: · SEK 150,000 to the chair of the Committee · SEK 75,000 each for other members of the Committee In connection with the board fee proposals of the Nomination Committee, the Board proposes, provided that it is cost-neutral to the company, and after written agreement between the company and a Swedish limited liability company wholly owned by a member of the Board, that the board fee may be invoiced through the company owned by the member. If this is done, the invoiced fee will be increased in an amount equivalent to statutory social security contributions and value added tax. The Nomination Committee further proposes that auditors’ fees shall be payable in accordance with an approved invoice. Item 16 The Nomination Committee proposes re-election of Jan Barchan, Peter Gossas, Anna Karinen, Alf Lindfors, Agneta Nestenborg and Anders Ullberg, and re-election of Anders Ullberg as Chairman of the Board. Item 17 The Nomination Committee proposes re-election of the registered public accounting firm Price­water­houseCoopers AB as auditor of the company until the close of the Annual General Meeting in 2018. Item 18 The Nomination Committee proposes that the Meeting resolves to appoint a new Nomination Committee ahead of the Annual General Meeting in 2017, consisting of the members Stina Barchan (Briban Invest AB), Sven Ericsson (representative of the Karinen family), Carina Heilborn (Peter Gyllenhammar AB) and Anders Ullberg (Chairman of the Board of Studsvik). The proposal is based on the instruction approved by the 2010 Annual General Meeting for appointing members of the Nomination Committee. The Nomination Committee has not found any reason to propose any change to the instruction applicable to the Nomination Committee, which consequently will continue to apply until otherwise resolved by a general meeting of shareholders. Item 19 - Guidelines on remuneration to senior management The Board of Directors proposes that the Annual General Meeting adopts a resolution on the guidelines below on remuneration to senior management. The proposal is substantially in agreement with the guidelines adopted at the 2016 Annual General Meeting. Fixed salary – Senior executives will be offered a commercially competitive fixed salary based on the individual executive’s responsibilities and powers. Salary will be fixed for a calendar year. Variable remuneration – Senior management may be offered variable remuneration. Variable remuneration may not exceed 50 per cent of fixed salary. Variable remuneration shall primarily be based on the Group’s financial targets. A model for variable remuneration shall be determined for the financial year. Pension – Pension provisions must be defined contribution based and be a maximum of 35 % of fixed salary. Salary may be used to increase pension provisions, given that the cost to Studsvik remains unchanged over time. Notice of termination and severance pay – A maximum period of notice of 12 months from either senior executives or Studsvik is applicable. Severance payments, apart from salary during the period of notice, may be made up to the equivalent of 6 months’ salary. Documents The annual accounts and auditor’s report as well as the auditor’s opinion concerning compliance with the guidelines of the Annual General Meeting on remuneration to senior management will be available at the company’s head office in Studsvik, Nyköping and on the company’s website, www.studsvik.se no later than on April 6, 2017. Copies of these documents will be sent to shareholders who request them from the company and who supply their postal address. The documents will also be available at the Annual General Meeting. Shares and votes There are 8,218,611 shares in the company with one vote each. The company has no holding of own shares. Information at the Annual General Meeting The Board of Directors and the President shall, if any shareholder so requests and the Board of Directors considers that it can be done without material harm to the company, provide information regarding circumstances that may affect the assessment of an item on the agenda, circumstances that can affect the assessment of the company’s or its subsidiaries’ financial situation and the company’s relation to other group companies. Questions Shareholders are welcome to put questions during the Annual General Meeting. To facilitate responses to questions intended to be put at the Annual General Meeting the questions should preferably be submitted in advance to the company and addressed to Studsvik AB, Annual General Meeting, SE 611 82 Nyköping or by email to studsvik@studsvik.se. Nyköping, March 2017 STUDSVIK AB Board of Directors ……………………………………………………….............................................. For further information please contact: Pål Jarness, CFO, +46 155 22 10 09 Facts about Studsvik Studsvik offers a range of advanced technical services to the global nuclear power industry. Studsvik’s business focus areas are fuel and materials technology, reactor analysis software and consultancy services within waste treatment technology, decommissioning, NORM and solutions for final disposal. The company has 70 years nuclear technology and radiological service experience. Studsvik has 700 employees in 7 countries and the company’s shares are listed on the Nasdaq Stockholm. This information is information that Studsvik AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation. The information was released for public disclosure, through the agency of the contact person above, on March 23, 2017, at 08:30 am (CEST).  www.studsvik.com

Badger Explorer ASA – Final results of Subsequent Offering II

Reference is made to the stock exchange releases from Badger Explorer ASA ("BXPL" or the "Company") published 15th February 2017 and 20th March 2017 regarding the subsequent offering (the “Subsequent Offering II”) of up to 80,000,000 new shares in the Company at a subscription price of NOK 0.50 per share (the "Offer II Shares”). The final results show that a total of 61.7 million shares were subscribed for. The Board of Directors resolved the allocation of the Offer II Shares today according to the allocation principles set out in the prospectus dated 14th February 2017. The Company expects that the Offer II Shares will be issued on or about 30th March 2017 and admitted to trading on or about 31st March 2017. ABG Sundal Collier acted as Manager for the Subsequent Offering II. Important information: The release is not for publication or distribution, in whole or in part directly or indirectly, in or into Australia, Canada, Japan or the United States (including its territories and possessions, any state of the United States and the District of Columbia). This release is an announcement issued pursuant to legal information obligations, and is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. It is issued for information purposes only, and does not constitute or form part of any offer or solicitation to purchase or subscribe for securities, in the United States or in any other jurisdiction. The securities mentioned herein have not been, and will not be registered under the United States Act of 1933, as amended (the "Securities Act"). The Securities may not be offered or sold in United States except pursuant to an exemption from the registration requirements of the Securities Act. The Company does not intend to register any portion of the offering of the securities in the United States or to conduct a public offering of the securities in United States. Copies of this announcement are not being made and may not be distributed or sent into Australia, Canada, Japan or the United States. The subscription or purchase of shares in the Company is subject to specific legal or regulatory restrictions in certain jurisdictions. Neither the Company nor the Managers assumes any responsibility in the event there is a violation by any person of such restrictions. The distribution of this release may in certain jurisdictions be restricted by law. Persons into whose possession this release comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute violation of the securities laws of any such jurisdiction. The Managers are acting for the Company and no one else in connection with the Subsequent Offering and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients or for providing advice in relation to any other matter referred to in this release. Forward-looking statements: This release and any materials distributed in connection with this release may contain certain forward-looking statements. By their nature, forward-looking statements involve risk and uncertainty because they reflect the Company's current expectations and assumptions as to future events and circumstances that may not prove accurate. A number of material factors could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. Stavanger, 23rd March 2017

European patent granted for Idogen’s vaccine technology

The European Patent Office issued in January 2017 a “Notice of intention to grant” and will now formally grant Idogen’s Patent Application relating to induction of IDO for treatment of autoimmune diseases and rejection of transplanted organs. The patent, with patent No. EP2654758, belongs to Idogen’s second patent family and covers Idogen’s technology until 2031 in Europe. The granted patent will be validated in a number of strategically interesting countries in Europe. Idogen already has an issued patent in this patent family for Japan and has received a “Notice of Allowance” in the USA. A related patent application is pending in Canada. Idogen’s first patent family covers additional aspects of using zebularine for the treatment of autoimmune diseases and rejection of transplanted organs, which together with the second patent family creates broader protection for the company’s product to potential competitors. The first patent family is previously granted in Europe and is pending in the USA.  CEO Lars Hedbys commented that ”The granted patent in Europe is a significant endorsement. Idogen develops tolerogenic vaccines with high medical and commercial potential, and we have now secured patent protection for these methodologies in two major markets – Europe and Japan. We also have a Notice of Allowance issued in the USA”. For additional information about Idogen, please contact: Lars Hedbys, CEO Tel: +46 (0)46-275 63 30 E-mail: lars.hedbys@idogen.com This is an English version of an original Swedish press release communicated by Idogen AB. In case of interpretation issues or possible differences between the different versions, the Swedish version shall apply. This constitutes information that Idogen AB is required to publish under the EU’s Market Abuse Regulation. The information was submitted for publication through the above contact person on the 23th of March 2017.

NeuroVive Pharmaceutical AB publishes 2016 Annual report

About NeuroVive NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine. The company is committed to the discovery and development of medicines that preserve mitochondrial integrity and function in areas of unmet medical need. The company’s strategy is to take drugs for rare diseases through clinical development and into the market. The strategy for projects within larger indications outside the core focus area is out-licensing in the preclinical phase. NeuroVive enhances the value of its projects in an organization that includes strong international partnerships and a network of mitochondrial research institutions, as well as expertise with capacities within drug development and production. NeuroVive has a project in early clinical phase II development for the prevention of moderate to severe traumatic brain injury (NeuroSTAT®). NeuroSTAT has orphan drug designation in Europe and in the US. The R&D portfolio consists of several late stage research programs in areas ranging from genetic mitochondrial disorders to cancer and metabolic diseases such as NASH. NeuroVive is listed on Nasdaq Stockholm, Sweden (ticker: NVP). The share is also traded on the OTCQX Best Market in the US (OTC: NEVPF). For investor relations and media questions, please contact: Cecilia Hofvander, NeuroVive, Tel: +46 (0)46 275 62 21 or ir@neurovive.com NeuroVive Pharmaceutical AB (publ)Medicon Village, SE-223 81 Lund, SwedenTel: +46 (0)46 275 62 20 (switchboard)www.neurovive.com This information is information that NeuroVive Pharmaceutical AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:35 a.m. CET on March 23, 2017.

Coor signs agreement with Novozymes in Denmark

Coor has won a five-year contract with Novozymes, a global leader in biology, on development and delivery of operating and maintenance for Novozymes 275,000 sqm. buildings in Bagsværd, Kalundborg and Fuglebakken in Copenhagen. Previously, Novozymes outsourced all property services to a variety of suppliers, but the choice of Coor as strategic partner fulfils the company´s new strategy for the operation and maintenance of their properties. -       Several parameters made Coor the top choice. With Coor´s Energy Management solution we expect to be able to optimize energy in our buildings and lower the energy usage, not least by a behavioral change among our 2,600 employees in Denmark. But the most important aspect was a partnership where we can benefit from mutual learning in close cooperation. In addition to this, we also see a great strength in the overall data picture we now will get as basis for strategic decisions, René Jacobsen, Facility Manager, EMEA & Global Security Officer at Novozymes. The delivery to Novozymes starts on May, 1. Coor in Denmark will hire 15 – 20 new employees to the assignment. -       We’re so pleased about this assignment. Coor is the Nordic market leader in integrated facility management (IFM), but in the last few years, has also started to focus on property services, cleaning and food & beverage segments. We’ve sharpened our offering in these segments, and this assignment advances our positioning in hard FM, commented Jørgen Utzon, President of Coor Denmark. For more information, press images etc., please visit www.coor.com or contact: Jørgen Utzon, President, Coor in Denmark, +45 2363 7178, jorgen.utzon@coor.com  Åsvor Brynnel, Communications and Sustainability Director, Coor Group, + 46 10 559 54 04, asvor.brynnel@coor.com

Alma Media’s share-based incentive scheme commencing in 2017

Alma Media Corporation         Other information disclosed according to the rules of the Exchange  23 March 2017 at 10:00 a.m. (EET) ALMA MEDIA’S SHARE-BASED INCENTIVE SCHEME COMMENCING IN 2017 (LTI 2015 III) In 2015, the Board of Directors of Alma Media Corporation approved the establishment of a long-term share-based incentive scheme for the key management of Alma Media (hereinafter referred to as “LTI 2015”). The objective of LTI 2015 is to align the interests of the participants with those of Alma Media’s shareholders by creating a long-term equity interest for the participants and, thus, to increase the company value in the long term as well as to drive performance culture, to retain participants and to offer them competitive compensation for excellent performance in the company. LTI 2015 consists of annually commencing individual plans, each subject to separate Board approval. Each of the individual plans consists of three main elements: an investment in Alma Media shares as a precondition for participation in the scheme, matching shares based on the above share investment and the possibility of earning performance-based matching shares. The main terms of the 2017 incentive scheme (LTI 2015 III) correspond to those of LTI I, which began in 2015, and LTI II, which began in 2016. The matching share plan In the matching share plan, the participant receives a fixed amount of matching shares against an investment in Alma Media shares. In the matching share plan commencing in 2017, the participant will receive two matching shares for each invested share free of charge after a two-year vesting period. If all the eligible members participate in the matching share plan by investing the maximum amount of shares, the maximum aggregate amount of the first matching shares is 195,000 shares (gross amount from which taxes are withheld). The performance matching plan The performance matching plan comprises a five-year performance period in total. The potential share rewards will be delivered in tranches after three and five years if the performance targets set by the Board of Directors are attained. The performance measures used in the performance matching plan commencing in 2017 are based on the company’s profitable growth and share value. If the performance targets set by the Board of Directors are attained in full, the participant will receive in total four matching shares for each invested share free of charge. In that case, if all the eligible key management members participate in the performance matching plan by investing the maximum amount of shares, the maximum aggregate amount of the first performance matching shares is 390,000 shares (gross amount from which taxes are withheld). Other information A maximum of 44 people are eligible to participate in the first plan, which commences in 2017. The Board of Directors anticipates that no new shares will be issued in connection with the new share-based incentive plan. Therefore, the plan will have no dilutive effect on the number of the company’s registered shares. The Annual General Meeting of Alma Media Corporation held on 22 March 2017 authorised the Board of Directors to decide on the repurchase of a maximum of 824,000 shares in one or more lots, and further authorised the Board of Directors to decide on a share issue by transferring shares in possession of the company to implement incentive programmes. ALMA MEDIA CORPORATION Board of Directors For more information, please contact: Petri Niemisvirta, Chairman of the Nomination and Compensation Committee, tel. +358 10 516 7200

The Board of Directors of Seamless Distribution AB proposes a divestment of the subsidiary Seamless Distribution System AB

The Board of Directors of Seamless Distribution AB proposes that the annual general meeting on April 20 2017 resolves to authorise the Board of Directors to divest the Company’s wholly owned subsidiary Seamless Distribution Systems AB (“SDS”). The divestment is envisaged to be carried out either (i) through a purchase offer and subsequent listing of the SDS share on Nasdaq First North, whereby the Company’s shareholders are granted purchase rights (Sw. Inköpsrätter) for shares in SDS pro rata in relation to their holdings in the Company; or (ii) to a third-party buyer, subject to the purchase price of all outstanding shares in SDS being higher than what the Board of Directors, with support from its advisors, has estimated as the fair trading value of the SDS shares upon listing. More information and background to the Board’s proposal and financial figures for the Company excluding SDS and for SDS as an independent unit will be held available on the Company’s website, www.seamless.se This information is information that Seamless Distribution AB (publ) is obliged to make public pursuant to the EU Market. Abuse Regulation. This information was submitted for publication, through the agency of the contact person set out above, at 09.50 a.m. CET on March 23, 2017.    Seamless Distribution AB, Box 6234, 102 34 Stockholm | Visiting address: St Eriksgatan 121 D | Org. no: 556610-2660 Phone: 08-564 878 00 | Fax: 08-564 878 23 | www.seamless.se

Notice Convening the AGM of Beijer Electronics (publ)

Notice will be done through advertisement in The Official Swedish Gazette (Post- och Inrikes Tidningar) and by making the notice available on the company website www.beijerelectronics.com/ir. The notice is sent to shareholders who so request and state their address. Such request may be made in the same way as the notification shall be made according to below. Entitlement to participate at the Meeting Shareholders entitled to participate at the Meeting shall · Firstly, be included in the share register maintained by Euroclear Sweden AB (the Swedish Central Securities Depository & Clearing Organization) on Friday, April 21, 2017;   · Secondly, have notified the company of their intention to participate by no later than Friday April 21, 2017.   Notifications can be made via the company’s website, www.beijerelectronics.com/ir, by telephone on +46 (0)40 35 86 44, by e-mail arsstamma@beijerelectronics.com or by mail to Annika Johnsson, Beijer Electronics AB (publ), Box 426, 201 24 Malmö, Sweden (please mark the envelope ‘AGM’). Notifications shall state the shareholders’ name, personal or corporate identity number, address, telephone number, shareholding and potential proxies/assistants. If participation is by power of attorney, a dated original shall be sent to the company. Power of attorney forms are available on the company’s website. Business/proposed agenda 1. Electing a Chairman of the Meeting   2. Preparing and approving the voting list   3. Approval of the agenda 4. Appointment of two people to verify the minutes  5. Consideration of whether the Meeting has been duly convened  6. Review of Board of Directors’ activities  7. Statement by the Chief Executive Officer  8. Submission of the annual accounts and audit report and the consolidated accounts and consolidated audit report   9. Resolutions in the matters of:a)    Adopting the Income Statement and Balance Sheet and the Consolidated Income Statement and Consolidated Balance Sheetb)    Appropriation of the company’s profits pursuant to the adopted Balance Sheetc)    Discharging the Board members and Chief Executive Officer from liability   10. Determining the number of Board members 11. Determining fees to the Board of Directors and Auditors 12. Electing the Board of Directors 13. Electing the Auditors 14. Resolution regarding remuneration guidelines for senior managers 15. Resolution on authorization for the Board of Directors to reach decisions on new share issues 16. Resolution on (A) implementation of a long-term share based incentive program for 2017 (LTI 2017/2020) and (B) hedging including resolution on (1) amendment of the articles of association, (2) authorization for the Board of Directors to resolve decisions on a directed issue of series C shares, (3) authorization for the Board of Directors to repurchase all issued series C shares and (4) transfer of own ordinary shares to participants in LTI 2017/2020 17. Resolution on amendment of the Articles of Association 18. Closing the Meeting Nominee-registered holdings In order to participate at the meeting, shareholders’ with nominee-registered holdings must temporarily register their shares in their own name. This re-registration must be complete by April 21, 2017, and shareholders should notify their nominees in good time before this date. Welcome to the Meeting! The Board of DirectorsBeijer Electronics AB (publ)Registraton No. 556025-1851Malmö, Sweden, March 2017

Construction Simulator 2

Moenchengladbach/Germany, March 23, 2017 – astragon Entertainment GmbH and weltenbauer. Software Entwicklung GmbH are very happy to announce the release of the most recent part of their internationally popular Construction Simulator franchise today. Construction Simulator 2 for iPhone® and iPad® as well as smartphones and tablets using the Android™ operating system is now available in the Apple® App Store® and on Google Play®! Construction Simulator 2 takes the player to the United States of America. As the owner of a small construction company in the fictional state of Westside Plains he will be able to seize his chance to become the biggest real estate tycoon in the whole region. In order to achieve this goal the player will be able to access 36 originally licensed vehicles and construction machines by well-known makers such as Caterpillar®, Liebherr®, Palfinger®, Bell Equipment, ATLAS® and STILL during the course of the game. Thanks to this great variety of vehicles and machines as well as challenging building contracts and missions players will not only be able to excavate building pits, control gigantic cranes and pour concrete to their heart’s content, but also tackle road construction tasks for the first time in the history of the Construction Simulator series – a gameplay element which has been long desired by fans of the popular franchise. After founding his very own company the freshly minted businessman will be able to explore the open, freely accessible game world and gain experience by successfully completing first construction jobs. These will be not only be awarded with experience points, which the player can use to improve selected skills, but of course also with appropriate funds to further expand the company and its vehicle fleet. By branching out his business into new regions bit by bit the player will also be able to tackle larger and more lucrative construction contracts overtime. These challenges include smaller gardening jobs, the construction of residential buildings, apartment blocks and industrial warehouses as well as the transport of materials or machines and the repair of sewage canals. And this is only the beginning: The renovation of crumbling streets, the reconstruction of a railway bridge, unique special missions as well as challenging development tasks to gain new building plots for the growing city await ambitious players in Construction Simulator 2. The simulation game’s huge vehicle fleet includes powerful machines such as the bulldozer D8T, the backhoe loader 430F2 and the dump truck 745C by Caterpillar as well as the PK 27002 SH loading crane by Palfinger, the 81K fast-erecting crane and the LTM 1300 mobile crane by Liebherr, the wheel loader L310 by ATLAS and the articulated B45E dump truck by Bell Equipment. In the event of a budget shortage - or if the player wishes to test a vehicle before its purchase - there is also the possibility to hire equipment from one of the vehicle dealers. All originally licensed vehicles of Construction Simulator 2 at a glance: Caterpillar®: 430F2 backhoe loader, 349F hydraulic excavator, M318F wheeled excavator, AP1055F asphalt paver, 140M3 motor grader, CS56B vibratory soil compactor, CT660 concrete mixer, PM620 cold planer, 950M wheel loader, CB44B tandem vibratory roller, CT660 dumper, CT660 flatbed truck with crane, D8T bulldozer, 745C articulated truck, CT660 truck Liebherr®: 150 EC-B flat-top crane, L1 fast-erecting crane, LTM 1060 mobile crane, LTM 1300 mobile crane, PR 736 crawler tractor, R 936 crawler excavator, R 956 crawler excavator, 81K fast-erecting crane, A 918 wheeled excavator, L 546 wheel loader, 41M5 concrete pump Palfinger®: PK 27002 SH loading crane Bell Equipment: B45E articulated dump truck ATLAS®: 160W wheeled excavator, L310 wheel loader, 340LC hydraulic excavator STILL: R70-50 forklift Miscellaneous: HS7T semitrailer low loader, HS7P semitrailer flatbed, HS7H semitrailer heavy duty, HS7M semitrailer halfpipe Construction Simulator 2 is currently deemed to be the most comprehensive construction simulation game for smartphones and tablets. In addition to many new vehicles as well as road construction and enhanced graphics Construction Simulator 2 offers many brand new features in comparison to its internationally successful predecessor. Examples are the intuitive user menu, a refined economic system or vehicle maintenance options. The huge, freely accessible game world of the idyllic Westside Plains, smooth day and night cycles as well as interesting missions will offer an impressive gameplay experience to all fans of the construction industry. . Construction Simulator 2 for iPhone®, iPad® as well as smartphones and tablets using the Android™ operating system is available now for 4.99 EUR/4.99 USD/4.99 GBP in the Apple® App Store® and on Google Play®. Get Construction Simulator 2 for iPhone®, iPad® in the Apple® App Store®: https://itunes.apple.com/app/construction-simulator-2/id983632334 . Get Construction Simulator 2 for Android™ devices on Google Play®: https://play.google.com/store/apps/details?id=com.astragon.cs2016 . For more information please visit: Homepage:    http://www.bau-simulator.de/index-en.html   Facebook:      https://www.facebook.com/ConstructionSimulator/ Pressroom:    http://news.cision.com/astragon-entertainment-gmbh/?q=Construction%20Simulator%202 . Construction Simulator 2 - PressKit An extensive PressKit including further information and materials is available for download here: http://presskit.astragon.net/presskit-cs2.rar User: presse / PW: presskit . © 2017 astragon Entertainment GmbH. © 2017 weltenbauer. Software Enwicklung GmbH. Published and distributed by astragon Entertainment GmbH. Construction Simulator, astragon, astragon Entertainment and its logos are trademarks or registered trademarks of astragon Entertainment GmbH. weltenbauer., weltenbauer. Software Entwicklung GmbH and its logos are trademarks or registered trademarks of weltenbauer.. Developed with the kind support of Caterpillar, Liebherr, Bell, Palfinger and ATLAS. All intellectual property relating to the construction equipment, associated brands and imagery (including trademarks and/or copyrighted materials) featured in the game are therefore the property of their respective companies. iOS, Game Center, iPhone, iPad are trademarks of Apple Inc., registered in the U.S. and other countries. All other registered trademarks or trademarks are property of their respective owners. .

SMART SYSTEM USES POST OFFICE VEHICLES TO ANALYZE ROADS.

Heavy vehicles tend to cause severe wheel ruts on soft gravel roads during the spring thaw period. In an effort to reduce maintenance costs, some stretches of these roads in Sweden are currently closed to traffic during predetermined periods. This creates problems for e.g., forestry-related transports by often forcing drivers to take long detours that waste time and money and lead to an increased environmental impact. Local residents and municipal services are also affected. With decisions based on better information about these roads’ bearing capacity, they could be kept open longer. This was the starting point for the BiFi (Bearing capacity information through vehicle intelligence) research project. “The BiFi project is an excellent example of how interested parties from diverse areas can act together to solve a concrete problem affecting many people. The smart aspect of this system, aside from its technology, is that it uses vehicles that already travel on these roads to take readings,” says Rickard Farby, project manager at Semcon. BiFi consists of a system that can forecast whether or not a road is useable. This solution has been developed by Semcon and Klimator and utilises vehicle-based vibration readings collected by some 50 post office vehicles, which are then combined with climatological and geological data. The compiled information is presented graphically in real time on a website where haulage contractors, local residents and the Swedish Transport Administration can keep track of the roads’ status. The project has spanned three spring thaw periods between 2014 and 2016 and the final report shows that BiFi can reduce the need to close roads by 50%, thereby making a clear contribution to the transport industry and improving the quality of life in the affected areas. “BiFi is a good example of an objective method that enables us to increase our knowledge of the bearing capacity of gravel roads, particularly during the spring thaw period but also at other times of the year when the roads may not be able to bear the weight of heavy vehicles,” says Thomas Asp, project manager at the Swedish Transport Administration. BiFi facts: · Semcon started the BiFi research project in 2010 together with Klimator. In 2012, it became a demonstration project for the Swedish Transport Administration. · The project spanned three spring thaw periods: 2014, 2015 and 2016. · It was conducted in four operational areas: Nora, Arboga, Örebro and Hallsberg, which cover an area of 8,546 km². · In the spring of 2015, the Finnish Transport Agency also implemented BiFi as a demonstration project. Download images here  or visit Semcon´s homepage . More about BiFi here: http://bifi.se/

MyTona LLC has sent formal response and counterclaim towards G5 Entertainment

G5 has received a formal answer and cross-complaint from developer MyTona, LLC, in response to the complaint filed by G5 against MyTona on January 9, 2017.   As previously announced, G5’s action arises from disputes between the parties concerning a license agreement between the parties entered into on May 2, 2012, with regard to the game "The Secret Society."  The full text of the answer and cross-complaint, as well as G5’s original complaint, are available through the Clerk's Office of the Orange County Superior Court, Case No. 30-2017-00896250-CU-BC-CJC.  In the suit, G5 contends that MyTona has failed to perform certain obligations under the May 2, 2012 license agreement with regard to “The Secret Society”, and has improperly refused to extend the license agreement beyond its initial 5-year term. G5 seeks substantial damages for past and future lost profits, declaratory relief and other remedies against MyTona for these violations.  G5's action also seeks to enforce rights claimed by G5 in relation to MyTona’s game “Seeker’s Notes”, in which G5 claims a contractual right under the license agreement to participate financially, and seeks substantial damages, declaratory relief and other remedies against MyTona.   MyTona, in its answer and cross-complaint, generally denies G5’s claims and asserts cross-claims for breach of contract, breach of the implied warranty of good faith and fair dealing, declaratory relief, and unfair competition.  MyTona contends that G5 has breached its relationship and affiliation with MyTona in its efforts to promote other games within G5’s portfolio, misappropriated game concepts and source code, delayed royalty reports, engaged in “rude and threatening” communications, and committed other acts which MyTona contends justify its refusal to extend the agreement between the parties. MyTona also seeks damages in an unspecified sum, an injunction and other equitable relief, including a ruling that MyTona need not renew the agreement, from G5 based upon these alleged violations. Vlad Suglobov, G5’s CEO, stated that “I can only repeat what I said previously that our actions against MyTona are both necessary and justified and that we look forward to having these disputes decided through the court process”. More information about the Company can be found on www.g5e.se/corporate.

Canada’s Island Garden Inc. Enhances Production with Heliospectra Intelligent Lighting Solution

Canada’s Island Garden Inc. is a family-run business with a deeply rooted agricultural background and generations of floral nursery experience. The company received a license from Health Canada to grow medical marijuana and operates within a new and highly regulated system under the terms of the Access to Cannabis for Medicinal Purposes Regulations (ACMPR ). “We believe our horticultural experience, pristine environment and stringent quality controls will result in a consistent and high-quality medicinal product for our customers here at Canada’s Island Garden,” says Edwin Jewell, president. “We chose Heliospectra because the lighting solution proved to us that it can deliver consistent yields and the pharmaceutical-grade cannabis our customers demand.”   Heliospectra’s intelligent LED lighting solutions provide growers a sole-source lighting solution with high intensity and a fully adjustable spectrum for strain-specific lighting strategies across the plant growth cycle. Proven to accelerate cannabis flowering time and boost trichomes harvest after harvest, Heliospectra lighting technology significantly reduces energy and utility costs as well as HVAC infrastructure needs when compared to traditional high pressure sodium (HPS) lights often used in controlled environment agriculture.  “Our adjustable light combined with Heliospectra’s lighting strategies enable commercial crop producers to achieve consistent medicinal properties, consistently high yields and high-quality products year round,” said Ali Ahmadian, CEO. “Commercial cultivators also recognize sustainable gains with reduced energy consumption and HVAC infrastructure which clearly confirm intelligent LEDs as the most viable option for business.”  Join the Heliospectra conversation: Read more at  www.heliospectra.com/blog  Follow  @Heliospectra  on Twitter Like Heliospectra on Facebook at  facebook.com/heliospectra  

YIT to start the construction of two apartment buildings in Tallinn, Estonia

YIT starts the construction of two apartment building projects in Tallinn, Estonia. The total value of the projects is approximately EUR 12 million, and the start-ups are recorded in the order backlog in the first quarter. The construction work of both projects starts in April. Algi 59 is a new project to be implemented in one phase. The project is located in Kristiine district. Algi 59 will comprise 76 apartments in four buildings of with total area of approximately 4,500 square metres. The project will be completed in summer 2018. Mäepealse 13/1 is the 11th phase of Mäepealse area development project, that will comprise 38 apartments with total area of approximately 2,000 square metres. The project is located in a peaceful area close to good transportation connections and services. The second phase will be completed in spring 2018. The projects are supporting YIT’s strategy to grow in the growth centres in Finland and CEE countries, Tallinn being one of these. For further information, please contact: Hanna Jaakkola, Vice President, Investor Relations, YIT Corporation, tel. +358 40 5666 070, hanna.jaakkola@yit.fi Tom Sandvik, Head of the Baltic countries and Central Eastern Europe business division, YIT Construction Ltd., tel. +358 400 617 807, tom.sandvik@yit.fi   YIT CORPORATION Hanna Jaakkola Vice President, Investor Relations Distribution: Nasdaq Helsinki, major media, www.yitgroup.com YIT creates better living environment by developing and constructing housing, business premises, infrastructure and entire areas. Our vision is to bring more life in sustainable cities. We want to focus on caring for customer, visionary urban development, passionate execution and inspiring leadership. Our growth engine is urban development involving partners. Our operating area covers Finland, Russia, the Baltic countries, the Czech Republic, Slovakia and Poland. In 2016, our revenue amounted to nearly EUR 1.8 billion, and we employ about 5,300 employees. Our share is listed on Nasdaq Helsinki. www.yitgroup.com

Dome Energy acquires oil field in Wyoming

Dome Energy AB.  (herein after “Dome” and/or “the Company”) today announces that the Company acquires oil field in Wyoming. Internal calculations estimates; · Total reserves of 1.4mm barrels, whereof 450,000 barrels are proven · Future discounted cash flow of $ 17mm at current oil price · Potential daily field production of more than 600 BOPD · Potential wells to re-enter for immediate production start Acquisition cost less than $50,000 Paul Morch, CEO: “We are happy to announce this small acquisition with big economic potential that we have been able to finalize. Our team out of Wyoming first examined this opportunity back in 2012, but was unable to close a deal with the previous owner. The acreage became available since it was no longer HBP “held by production” and we proposed the acreage for public auction. Our local presence and previous analysis allowed us to buy this at a very low price. We will aim to restart production in the coming months, and present a development program shortly after.”    For further information, please contact:Paul MorchPhone: +1 713 385 4104E-mail: pm@domeenergy.com  This information is the kind of information that Dome Energy AB (publ) is obliged to publicize according to EU Market Abuse Regulations (MAR). The information was publicized, by the above contact person March 23, 2017 14.45 CET.    About Dome EnergyDome Energy AB. is an independent Oil & Gas Company publicly traded on the Nasdaq First North exchange in Sweden (Ticker: DOME ). Mangold Fondkommission AB, phone: +46 8 503 01 550, is the Company’s Certified Adviser. Headquartered in Houston, Texas, the Company’s focus is on the development and production of existing onshore Oil & Gas reserves in the United States. For more information visit www.domeenergy.com.

SSAB announces Tender Offer regarding notes and considers issuance of new notes

SSAB AB (publ) (the “Issuer”) has mandated Danske Bank, DNB and SEB (the “Joint Bookrunners”) to arrange a series of fixed income investor meetings commencing on March 27, 2017. Subject to, inter alia, the prevailing market conditions and the final decision of the Issuer, a SEK 5-year fixed and/or floating rate senior unsecured bond transaction will follow (the “New Issue”). In addition and subject to the conditions stated below, the Issuer hereby announces a Tender Offer directed to holders of its SEK denominated floating and fixed rate notes with ISIN SE0004950517 and SE0004950525 issued on December 13, 2012 and maturing on December 13, 2017 (the “December 2017 Notes”) and to holders of its SEK denominated floating and fixed rate notes, ISIN SE0005757523 and SE0005757515, issued on February 25, 2014 and maturing on February 25, 2019 (the “February 2019 Notes”). As part of the Issuer’s continuous liability management efforts, the purpose of the Tender Offer is to proactively manage upcoming debt redemptions and to extend the debt maturity profile of the Issuer. The Tender Offer Conditional upon the New Issue, the Issuer is hereby offering to repurchase any and all of the outstanding December 2017 Notes and February 2019 Notes for cash (the “Tender Offer”). The Issuer offers to pay a cash purchase price for the December 2017 Notes and February 2019 Notes tendered equal to the following amounts: December 2017 Notes · for the floating rate notes (ISIN: SE0004950517), 102.20% of the nominal principal amount of each note (plus accrued and unpaid interest from (but excluding) the previous day of interest payment and including the relevant settlement date); and · for the fixed rate notes (ISIN: SE0004950525), 103.50% of the nominal principal amount of each note (plus accrued and unpaid interest from (but excluding) the previous day of interest payment and including the relevant settlement date) February 2019 Notes · for the floating rate notes (ISIN: SE0005757523), 101.90% of the nominal principal amount of each note (plus accrued and unpaid interest from (but excluding) the previous day of interest payment and including the relevant settlement date); and · for the fixed rate notes (ISIN: SE0005757515), 105.70% of the nominal principal amount of each note (plus accrued and unpaid interest from (but excluding) the previous day of interest payment and including the relevant settlement date) Holders who participate in the Tender Offer and express an interest in participating in the New Issue may be given priority allocation in the New Issue. The Issuer reserves the right to not proceed with the New Issue. Preliminary Timeline The Tender Offer is expected to close on March 29, 2017. However, the Issuer reserves the right to extend, withdraw or terminate the period of acceptance for the Tender Offer. The Issuer will announce the results and whether any of the December 2017 Notes and/or February 2019 Notes will be accepted for the offer after the pricing of the New Issue. The anticipated settlement date for the Tender Offer and New Issue is on or about April 5, 2017. Participation We kindly ask you to contact your custody bank or your sales contact at one of the Joint Bookrunners if you wish to tender your notes and/or if you have any questions related to the Tender Offer or the New Issue. Joint Bookrunners Danske BankContact person: Johan HansenEmail: liabilitymanagement@danskebank.seTelephone: +46 8 568 805 54 DNBContact person: Henrik KansmarkEmail: henrik.kansmark@dnb.seTelelphone: +46 8 473 4816 SEBContact person: Peter SwärdEmail:  SEBliabilitymanagement@seb.seTelephone: +46 8 506 232 18 For further information please contact: Henrik G. Welch, Vice President, Head of Group TreasuryTelephone: +46 70 2638399E-mail: henrik.welch@ssab.com Peter Nordquist, Head of Funding and Markets OperationsTelephone: +46 8 454 5745E-mail: peter.nordquist@ssab.com  This announcement does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States or in any other jurisdiction in which, or to or from any person to or from whom, it is unlawful to make such invitation under applicable securities laws. The securities to which this announcement relates have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "Securities Act") or the securities laws of any state or other jurisdiction of the United States and may not be offered or sold in the United States or to US persons (as such term is defined in Regulation S under the Securities Act), except pursuant to registration or an exemption from the registration requirements of the Securities Act. There will be no public offer of securities in the United States. This communication is being distributed outside the United States solely to non-US persons as defined under Regulation S. This announcement is not being made, and this announcement has not been approved, by an authorised person for the purposes of Section 21 of the Financial Services and Markets Act 2000 (the "FSMA"). This announcement is not an invitation nor is it intended to be an inducement to engage in investment activity for the purpose of Section 21 of the FSMA. Accordingly, this announcement is not being distributed to, and must not be passed on to, the general public in the United Kingdom. Rather, this announcement is being distributed on the basis it is only directed at: (i) persons who are outside the United Kingdom; (ii) persons who are investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) of the United Kingdom; or (iii) any other persons to whom this announcement for the purposes of Section 21 of FSMA can otherwise lawfully be made (all such persons together being referred to as "relevant persons"), and must not be acted on or relied upon by persons other than relevant persons. Any invitation or inducement to engage in any investment activity included within the announcement is available only to relevant persons and will be engaged in only with relevant persons.  Anyone other than a relevant person must not rely on this announcement.

Regional Jet OÜ takes over ATR production for SAS

SAS has concluded an agreement with Regional Jet OÜ, which will mainly operate routes to and from Copenhagen with four ATR72-600s. The other Jet Time production will be solved by a reduction in services and by redistributing existing capacity to other types of aircraft. “We have now found the right collaborative partner to take over Jet Time’s flights. We look forward to working with Regional Jet OÜ, which is a competent and reliable partner and a key contribution to our wet lease strategy,” says Mikael Wångdahl, VP External Production at SAS. Since November 2016 when the agreements with Jet Time were wound up, the company has been working to find a new wet lease operator which can operate SAS’s regional services with ATR72s. A number of airlines have been involved in negotiations for the contract but the choice has fallen on Regional Jet OÜ on the basis of a number of parameters. Among other things, audits of SAS’s Quality and Compliance Monitoring have yielded excellent results. The agreement with Regional Jet OÜ spans six years but can be terminated after three. The four ATR72-600s that will be flying for SAS, in SAS’s colors, will be staffed mainly by Copenhagen-based crews on local agreements. Regional Jet OÜ was founded in 2015 as an independent company, supplying wet lease services to other companies. The company is owned by Nordic Aviation Group (Nordica) and LOT Polish Airlines (LOT). Today it operates three aircraft for LOT and five for Nordica and will thereby expand its fleet by four aircraft to operate flights for SAS.

Announcement from Sotkamo Silver AB AGM on 23 March 2017

Sotkamo Silver AB (publ) held its Annual General Meeting (AGM) on Thursday 23 March 2017 in Stockholm.The following main decisions were made at the AGM:The income statement and the balance sheet for both the parent company and the group regarding the financial year 2016 were adopted by the AGM. The AGM decided that no dividend would be paid out for the financial year 2016. The members of the Board and the CEO were granted discharge from liability for the financial year 2016.The AGM decided that the Board would comprise of five ordinary members without deputy directors. Mauri Visuri, Teuvo Jurvansuu and Jarmo Vesanto were re-elected as directors and Ilkka Tuokko and Matti Rusanen were elected as directors. Mauri Visuri was re-elected chairman of the Board.The AGM resolved to re-elect the auditing company PWC until the end of the AGM 2018, with Anna Rosendal as the head auditor for the time being.The guidelines for remuneration for the management and the procedure for appointing the members of the nomination committee were approved in accordance with the proposals from the Board.The AGM approved the nomination committee’s proposal for annual fees to the Board with a total of SEK 850,000.The AGM resolved, for the period until the next AGM, to authorize the Board, at one or several occasions, to issue new shares or other financial instruments. The authorization is limited to a maximum dilution of ten (10) percent of the total number of shares outstanding at the time of the first Board resolution in accordance with the authorization.Stockholm on 23 March 2017SOTKAMO SILVER AB (publ)Timo Lindborg, CEOSotkamo Silver AB discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act.The official Stock Exchange Releases are given in Swedish and there may be differences in the translated versions.About Sotkamo Silver AB:Sotkamo Silver AB´s business concept is to exploit mineral deposits in the Nordic countries with positive social and environmental benefits. Sotkamo Silver owns mineral deposits, which contain silver and gold in Finland as well as zinc and gold in Norway. The Company’s main development project is the Silver Mine project in the municipality of Sotkamo, Finland.Sotkamo Silver applies SveMin’s & FinnMin’s respective rules of reporting for public mining & exploration companies. Sotkamo Silver has chosen to report mineral resources and ore reserves according to the internationally accepted JORC or NI 43-101 code. The company applies International Financial Reporting Standards (IFRS) as approved by the European Union.The number of shares and votes in the company are 105,966,095.The ticker symbol is SOSI in NGM Equity in Stockholm and SOSI1 in NASDAQ OMX Helsinki.ISIN-code for Sotkamo Silver shares is SE0001057910.ISIN- code for share warrants series 2016/2017 are SE0008373880Legal Entity Identifier (LEI): 213800R2TQW1OZGYDX93Read more about Sotkamo Silver on www.sotkamosilver.com or www.silver.fiRead more about Mining Associates on www.miningassociates.com

Decisions by Stockmann’s Annual General Meeting

STOCKMANN plc, Decisions of general meeting 23.3.2017 at 16:45 EET The Annual General Meeting of Stockmann plc, held in Helsinki on 23 March 2017, adopted the financial statements for the financial year 1 January - 31 December 2016, granted discharge from liability to the responsible officers and, in accordance with the proposal of the Board of Directors, resolved not to pay a dividend for the financial year 2016. The General Meeting also decided on the composition and remuneration of the Board of Directors and the selection and remuneration of the auditor in accordance with the proposals presented. A permanent Shareholders' Nomination Board will be appointed to yearly prepare proposals on the composition and remuneration of the Board of Directors to the Annual General Meeting, and if necessary to an Extraordinary General Meeting. CEO’s review At the Annual General Meeting, Stockmann’s CEO Lauri Veijalainen gave an overview of Stockmann’s strategy implementation and financial performance in 2016. During the year, the company withdrew from several non-core businesses, which helped the company to reach a positive operating result after two years of losses. The department store operations in Russia were divested on 1 February 2016 and Hobby Hall on 31 December 2016. The company now focuses on retail operations under the Stockmann and Lindex brands and real estate business. All options are investigated also in the future to improve profitability and value of the company. Stockmann’s efficiency programme had an annual cost savings target of EUR 50 million, which was achieved by the end of 2016. Additional measures launched in summer 2016 will bring more than EUR 20 million of further savings beginning from this year. The Stockmann Group’s positive operating result in 2016 is proof that the chosen direction is right. Stockmann expects the Group’s adjusted operating profit in 2017 to improve, compared with 2016. Composition and remuneration of the Board of Directors In accordance with the proposal of the Shareholders' Nomination Board, the Annual General Meeting resolved that eight members be elected to the Board of Directors. In accordance with the Nomination Board’s proposal, Kaj-Gustaf Bergh, Jukka Hienonen, Susanne Najafi, Leena Niemistö, Michael Rosenlew, Per Sjödell and Dag Wallgren were re-elected as members of the Board of Directors. Following the announcement by Torborg Chetkovich that she will no longer be available as member, Esa Lager was elected as a new Board member. The Board members’ term of office will continue until the end of the next Annual General Meeting. It was resolved to keep the Board members’ fixed annual remuneration unchanged, and the remuneration will continue to be paid mainly in shares. The members of the Board are also paid a meeting remuneration for each Board and committee meeting, as decided by the Annual General Meeting. Auditors Henrik Holmbom, Authorized Public Accountant, and Marcus Tötterman, Authorized Public Accountant, were re-elected as regular auditors. KPMG Oy Ab, a firm of authorised public accountants, will continue as the deputy auditor. The auditors will be paid in accordance with approved invoices. Organisational meeting of the Board of Directors The Board of Directors, which convened after the Annual General Meeting, elected Jukka Hienonen as its Chairman, and Leena Niemistö as its Vice Chairman. The Board has assessed the independence of its members in accordance with Recommendation 10 in the Finnish Corporate Governance Code 2015. According to the assessment six of the members of the Board are independent of the company (Jukka Hienonen, Leena Niemistö, Kaj-Gustaf Bergh, Esa Lager, Michael Rosenlew and Dag Wallgren). Five of the company's board members are independent of major shareholders (Jukka Hienonen, Esa Lager, Susanne Najafi, Leena Niemistö, and Per Sjödell). The Board of Directors decided to establish an Audit Committee and a Compensation Committee among its members. Dag Wallgren was elected as Chairman of the Audit Committee, and Esa Lager and Michael Rosenlew were elected as the other members of the committee. Jukka Hienonen was elected as Chairman of the Compensation Committee and Kaj-Gustaf Bergh and Leena Niemistö as the other members of the committee. Further information:Jukka Naulapää, Director, Legal Affairs, tel. +358 9 121 3850 www.stockmanngroup.com STOCKMANN plc Lauri VeijalainenCEO Distribution:Nasdaq HelsinkiPrincipal media

New tools to study the origin of embryonic stem cells

During the first week of fertilisation, the embryo grows from a single cell into a blastocyst, a hollow cluster of a few hundred cells. The blastocyst then attaches itself to the wall of the uterus (implantation), and for a limited period from fertilisation to a few days after implantation the embryo contains pluripotent stem cells. These cells can develop into all the body’s cell types and are therefore of considerable interest to the field of regenerative and reparative medicine.  A few years ago, it was discovered that there are two stages for human pluripotent stem cells, corresponding to the pre-implanted and post-implanted embryonic cells. Although the classical stem cells used in regenerative medicine are isolated from the pre-implanted embryo, they have adopted a mature stage that is most likely more similar to a post-implantation embryo. A new type of pluripotent cell that genuinely corresponds to the more immature, pre-implantation stage has been identified and can now be cultivated in the laboratory. These immature stem cells are of great scientific interest since they are believed to have the potential to build certain cell types that are difficult to obtain from the classical stem cells, and they may also be easier to cultivate and manipulate in the laboratory.  Fredrik Lanner’s research team at Karolinska Institutet and their colleagues in Peter Rugg-Gunn’s team at Cambridge’s Babraham Institute in the UK have now developed a tool for separating the two stem cell states. They have screened combinations of antibodies that bind to specific proteins on the surface of the immature and mature stem cells and that can be used for flow cytometry, a common laboratory technique for sorting cells.  “We’ve not had cell surface markers for the different stem cell states before, which has made it hard to study them,” says Fredrik Lanner, Assistant Professor at Karolinska Institutet’s Department of Clinical Science, Intervention and Technology. “We now have a simple tool for identifying and sorting the cells, which benefits future stem cell research and basic research on early embryonic development.”  Mature embryonic stem cells cultivated in the laboratory can, under the right conditions, be backed up in their development to the more immature stem cell type. The researchers tested their technique on such cultivated stem cells of both a mature and immature type, and on donated human embryos left over from IVF treatments. As expected, only the immature stem cell type was identified in such pre-implanted embryos, which indicates that the antibodies are highly specific. “It is at the point of implantation that the stem cells go through this change and ‘mature’, which is also a highly critical time for the embryo,” says Dr Lanner. “These cells are therefore also of interest to infertility research.” The study was financed by several bodies, including the Swedish Research Council, the Ragnar Söderberg Foundation, the Swedish Foundation for Strategic Research, the Knut and Alice Wallenberg Foundation, the Centre for Innovative Medicine (CIMED) and the Ming Wai Lau Centre for Reparative Medicine. Publication: ‘Comprehensive Cell Surface Protein Profiling Identifies Specific Markers of Human Naive and Primed Pluripotent States’, Amanda J. Collier, Sarita P. Panula, John Paul Schell, Peter Chovanec, Alvaro Plaza Reyes, Sophie Petropoulos, Anne E. Corcoran, Rachael Walker, Iyadh Douagi, Fredrik Lanner, Peter J. Rugg-Gunn. Cell Stem Cell, online 23 March 2017, doi: 10.1016/j.stem.2017.02.014.

Tieto Corporation Decisions of the Annual General Meeting on 23 March 2017

Tieto Corporation STOCK EXCHANGE RELEASE 23 March 2017, 19.00 EETTieto Corporation's Annual General Meeting of Shareholders approved the financial statements for 2016, decided to distribute a dividend of EUR 1.37 per share (ordinary dividend of EUR 1.15 and additional dividend of EUR 0.22) and discharge the company's officers from liability for the financial year 2016. The dividend settlement date is 27 March 2017 and the dividend will be paid as from 6 April 2017.In addition, the Annual General Meeting made the following decisions:Board composition and remunerationThe meeting decided that the Board of Directors shall consist of eight members and re-elected the Board's current members Kurt Jofs, Johanna Lamminen, Harri-Pekka Kaukonen, Sari Pajari, Endre Rangnes and Jonas Synnergren. Timo Ahopelto and Jonas Wiström were elected as new members. Kurt Jofs was elected as the Chairman of the Board of Directors.In addition to the above, the company's personnel appoints two members, each with a personal deputy, to the Board of Directors. The term of office for the personnel representatives is two years. Esa Koskinen (deputy Ilpo Waljus) and Anders Palklint (deputy Robert Spinelli) have been appointed to the Board until the Annual General Meeting 2018.The meeting approved that the fixed annual remuneration of the Board of Directors will be as follows: EUR 91 000 to the Chairman, EUR 55 000 to the Deputy Chairman and EUR 36 000 to the ordinary members of the Board of Directors. The same fee as to the Board Deputy Chairman will be paid to the Chairman of a Board Committee unless the same individual is also the Chairman or Deputy Chairman of the Board. In addition, a remuneration of EUR 800 is paid for each Board meeting and for each permanent or temporary committee meeting. It is the company's practice not to pay fees to Board members who are also employees of the Tieto Group.The meeting approved that 40% of the fixed annual remuneration be paid in Tieto Corporation’s shares purchased from the market. The shares will be purchased within two weeks from the release of the interim report 1 January–31 March 2017 of Tieto Corporation. The Annual General Meeting resolved to acquire the shares directly on behalf of the members of the Board which is an approved manner to acquire the company’s shares in accordance with the applicable insider rules.AuditorThe meeting re-elected the firm of authorized public accountants PricewaterhouseCoopers Oy as the company's auditor for the financial year 2017. The auditor shall be reimbursed according to the auditor’s invoice and in compliance with the purchase principles approved by the Audit and Risk Committee.Amendment of the company’s Articles of AssociationThe meeting decided that Articles 1 and 6 of the Articles of Association of the company be amended as follows:“1 § Company name and domicileThe company name in Finnish is Tieto Oyj, in Swedish Tieto Abp and in English Tieto Corporation.The domicile of the company is Espoo.”"6 § AuditorThe company has one ordinary auditor who shall be an audit firm with a KHT auditor as the auditor with principal responsibility.The term of office of the auditor expires at the closing of the first Annual General Meeting following his election."Authorizing the Board of Directors to decide on the repurchase of the company's own sharesThe Board of Directors was authorized to decide on the repurchase of the company's own shares as follows:The amount of own shares to be repurchased shall not exceed 7 400 000 shares, which currently corresponds to approximately 10% of all the shares in the company. Only the unrestricted equity of the company can be used to repurchase own shares.Own shares can be repurchased at a price formed in public trading on the date of the repurchase or at a price otherwise formed on the market.The Board of Directors decides how the share repurchase will be carried out. Own shares can be repurchased inter alia by using derivatives. The company’s own shares can be repurchased otherwise than in proportion to the shareholdings of the shareholders (directed repurchase).The authorization cancels previous unused authorizations to decide on the repurchase of the company’s own shares. The authorization is effective until the next Annual General Meeting, however, no longer than until 30 April 2018.Authorizing the Board of Directors to decide on the issuance of shares as well as options and other special rights entitling to sharesThe Board of Directors was authorized to decide on the issuance of shares as well as on the issuance of option rights and other special rights entitling to shares referred to in chapter 10 section 1 of the Companies Act in one or more tranches as follows:The amount of shares to be issued based on the authorization (including shares to be issued based on the special rights) shall not exceed 7 400 000 shares, which currently corresponds to approximately 10% of all the shares in the company. However, out of the above maximum amount of shares to be issued no more than 700 000 shares, currently corresponding to less than 1% of all of the shares in the company, may be issued as part of the company’s share-based incentive programs.The Board of Directors decides on the terms and conditions of the issuance of shares, option rights and other special rights entitling to shares. The authorization concerns both the issuance of new shares as well as the transfer of treasury shares. The issuance of shares and of special rights entitling to shares may be carried out in deviation from the shareholders’ pre-emptive right (directed issue).The authorization cancels previous unused authorizations to decide on the issuance of shares and on the issuance of options and other special rights entitling to shares. The authorization is effective until the next Annual General Meeting, however, no longer than until 30 April 2018.There were 532 shareholders represented at the meeting representing altogether 47 792 617 shares and votes. All decisions were made without voting.For further information, please contact: Deputy General Counsel Esa Hyttinen, tel. +358 40 766 6196, firstname.lastname (at) tieto.comDISTRIBUTIONNASDAQ HelsinkiPrincipal Media

Welcome to Annual General Meeting 2017

Registration and participation Shareholders who wish to participate in the Annual General Meeting shall ·  be included in the shareholders’ register maintained by Euroclear Sweden AB on Wednesday, 19 April 2017, and ·  give notice of attendance no later than Wednesday, 19 April 2017 via ÅF’s website www.afconsult.com , or by telephone +46 (0)10 505 00 00 weekdays 9 am – 4 pm (CET), or by mail to: ÅF ABAnnual General MeetingSE-169 99 Stockholm, Sweden Please state name, personal ID, address, telephone and any attending assistants. The personal information kept in the shareholders’ register maintained by Euroclear Sweden AB will be used for registration and voting list for the annual general meeting. The will be conducted in Swedish. Nominee-registered shares Shareholders whose shares are registered in the name of a bank or other nominee shall, to be eligible to participate in the Annual General Meeting, register their shares in the share register in their own name per Wednesday, 19 April 2017. Shareholders who wish to exercise their right should therefore inform their nominee well before the aforementioned day. Proxies Shareholders who are represented through proxy shall issue a power of attorney, duly signed and dated. If the power of attorney has been issued by a legal entity, a certified copy of the certificate of registration or its equivalent confirming the right to issue the power of attorney shall also be provided. It is desirable that the power of attorney in original and, where appropriate, other documentation, is submitted well before the annual general meeting to ÅF AB, Årsstämman, SE-169 99 Stockholm, Sweden. The documents and any other correspondence concerning the general meeting may also be sent via e-mail to agm@afconsult.com. A proxy template is available on the ÅF website: www.afconsult.com . Annual Report It is anticipated that the Annual Report in will be published on www.afconsult.com  during the week beginning on 3 April 2017. Printed copies may be ordered through the ÅF switchboard, +46 (0)10 505 00 00. Proposed agenda 1          Election of Chairman of the Meeting. 2          Preparation and approval of the voting list. 3          Approval of the agenda. 4          Election of persons to approve the minutes. 5          Determination whether the meeting has been duly convened. 6          The CEO’s address. 7          Report of the work of the Board, the Remuneration- and Audit Committees. 8          Presentation of the Annual Report and the Auditors’ Report together with the consolidated accounts and the auditors’ report for the same. 9          Adoption of the Income Statement and Balance Sheet of ÅF AB and the Income Statement and Balance Sheet of the ÅF Group. 10       Resolution regarding discharge from liability of the Board and of the CEO. 11       Appropriations and allocations of the profit or loss made by the Company according to the approved balance sheet, and the record day for the right to receive a shareholders’ dividend. 12       The Nomination Committee’s proposals, election of board members etc. 12a     Decision concerning the number of board members and deputy members to be elected by the meeting. 12b     Election of Chairman of the Board, other members of the Board and any deputies. 12c     Election of Auditors and any Deputy Auditors. 12d     Resolution regarding the remuneration to the Board and the Auditors. 12e     Resolution regarding the Principles for the Nomination Committee. 13       Resolution regarding the principles relating to salary and other remuneration for the CEO and other members of the senior management team. 14       Resolution regarding long term incentive programme (Convertible Debenture 2017), authority for the Board to repurchase the Company’s own shares and decision to reduce the number of shares in the Company and to decide on the size of the reduction. 15       Resolutions authorising the Board to sell the Company’s own shares on Nasdaq Stockholm and to transfer own shares to participants in Performance Related Share Program (PSP) 2014. 16       Resolution authorising the Board to decide on new issue of shares. 17       Close of the Annual General Meeting. Item 1 –Election of Chairman of the Meeting The Nomination Committee proposes that the Chairman of the Board, Anders Narvinger, chairs the meeting. Item 11 – Shareholders’ dividend The Board proposes a shareholders’ dividend of SEK 4.50 per share. It is proposed that 29 April 2017 be made the record day for the right to receive the dividend. It is anticipated that payment will be made via Euroclear Sweden AB on 4 May 2017. Item 12 – The Nomination Committee’s proposals, election of the Board etc. The Nomination Committee, which was elected in accordance with the Principles for the Nomination Committee adopted by the Annual General Meeting 2016, consists of the Chairman of the Nomination Committee Jonas Abrahamsson (ÅForsk Foundation), Annika Andersson (Swedbank Robur Fonder), Anders Narvinger (Chairman of the Board), Jonathan Schönbäck (Handelsbanken Asset Management), Johan Strandberg (SEB Investment Management) and Karl Åberg (Zeres Public Market Fund). Item 12a – Number of members of the Board and deputies The Nomination Committee proposes that the Board of the Company shall consist of eight (8) members elected by the Annual General Meeting with no deputies. Item 12b – Election of the Board The Nomination Committee proposes re-election of all Board members: Staffan Jufors, Anders Narvinger, Björn O. Nilsson, Maud Olofsson, Joakim Rubin, Kristina Schauman and Anders Snell. Gunilla Berg is proposed to be elected member of the Board. Gunilla Berg Gunilla Berg was born 1960. She holds a degree from Stockholm Business School. As of today, Gunilla Berg is CFO of the PostNord Group and is a director of Atlas Copco and Alfa Laval. Gunilla Berg holds no shares in ÅF.* * Refers to the holding of shares or other stocks as of 3 mars 2017. This also includes holdings by close related natural or legal persons. Marika Fredriksson has declined re-election. The Nomination Committee proposes that Anders Narvinger is elected as Chairman of the board. Item 12c – Election of Auditors The Nomination Committee proposes, in accordance with the recommendation of the Audit Committee, that the auditing company KPMG AB shall be appointed auditor of the Company to serve until the end of the 2018 annual general meeting. Item 12d – Remuneration to the Board and the Auditors The Nomination Committee proposes that remuneration to the Board, including its committees, until the time of the next Annual General Meeting shall total SEK 3 285 000. For the work of the Board, a fee of SEK 725 000 is proposed for the Chairman of the Board and SEK 310 000 for each of the seven other directors. This brings the total fees paid for board work to SEK 2 895 000. This is an increase of SEK 320 000 compared to the decision of the annual general meeting of 2016. The reason for the increase is that the growth of the company brings an increase in the workload of the directors and that competitive remunerations are deemed an important factor when recruiting new directors. For the members of the Audit Committee, it is proposed a remuneration of SEK 125 000 to be paid to the Chair and SEK 50 000 for each of the other two members of the committee. For the members of the Remuneration Committee, it is proposed that remuneration of SEK 75 000 is paid to the Chair and SEK 45 000 for each of the other two members of the committee. This brings the total of fees paid out for committee work to SEK 390 000 which is, with the exception of the remuneration to Chair of the audit committee, unchanged compared to the levels adopted by the annual general meeting of 2016. The Nomination Committee also proposes that, provided that it is not more costly for the Company and if agreed between the Company and a (Swedish) limited company wholly owned by the board member, the remuneration may be invoiced by said company. The invoiced amount shall then be increased with a sum corresponding to statutory employer’s contribution costs and VAT. It is proposed that remuneration to the auditors be paid in accordance with approved invoices. Item 12e – Principles for the Nomination Committee The Nomination Committee proposes that the Principles for the Nomination Committee shall remain the same as those approved by the 2016 Annual General Meeting: The Nomination Committee shall consist of representatives of a minimum of three and a maximum of five of the largest shareholders by voting entitlement, together with the Chairman of the Board. The Chairman of the Board shall invite the five largest shareholders by voting entitlement to participate in the Nomination Committee. The entitlement shall be based on Euroclear Sweden AB’s list of shareholders (by groups of owners) on the last banking day in August, and on other reliable information provided to the Company at this time. The names of the members of the Nomination Committee and the names of the shareholders they represent are to be published at the latest six months before the Annual General Meeting. If any of the five largest shareholders by voting entitlement waives the invitation to appoint a representative to the Nomination Committee, the next largest shareholder in terms of voting rights shall be given the opportunity to appoint a representative. It is however not required to ask more than seven of the largest shareholders by voting entitlement unless the Nomination Committee has fewer than three representatives. The person appointed by the largest shareholder by voting entitlement shall be appointed Chair of the Nomination Committee, unless the Nomination Committee decides otherwise. The Nomination Committee exercises its mandate until the appointment of a new Nomination Committee. Should a significant change takes place in the ownership structure after the Nomination Committee has been constituted and more than two months before the Annual General Meeting and a major new owner expresses a wish to participate in the work of the committee, the composition of the Nomination Committee shall be altered to accord with the principles specified above. This shall be done either by replacing the committee member who has been appointed by the smallest shareholder by voting entitlement, or by expanding the Nomination Committee with an additional member. Shareholders who acquire sufficient shares to qualify as one of the three largest shareholders by voting entitlement within the two months preceding the annual general meeting shall have the right to appoint a co-opted representative on the Nomination Committee. Shareholders who have appointed a member of the Nomination Committee have the right to appoint a new member of the Nomination Committee in his/her place. The Nomination Committee shall submit proposals to the Annual General Meeting on: ·  the election of chairperson of the annual general meeting, ·  the election of a Chairman of the Board and other members of the Board, ·  the allocation of Directors’ fees between the Chairman of the Board and other members, and any remuneration for committee work, ·  election and remuneration of Auditors and Deputy Auditors (if any), and ·  resolution regarding the principles for the appointment of the Nomination Committee. The Nomination Committee shall have the right to charge the Company for expenses such as those incurred in conjunction with the use of recruitment consultants, whose assistance may be required to enable the Nomination Committee to execute its duties properly. No fees are payable to members of the Nomination Committee. Item 13 – Resolutions regarding the principles for salary and other remuneration for the CEO and other members of the senior management team The Board proposes that the Annual General Meeting adopts the following principles relating to remuneration to the senior management team up until the time of the 2018 Annual General Meeting. The Remuneration Committee The Board appoints a Remuneration Committee to prepare proposals relating to the CEO’s employment conditions, pension benefits and bonuses and to make decisions on corresponding conditions for the other senior executives. The Remuneration Committee shall also consider principles relating to terms of employment and other remuneration for all employees in the ÅF Group. Senior executives Senior executives include the CEO, the senior management team and other executives reporting directly to the CEO. Remunerations The ÅF Group bases remunerations on the principle that remuneration shall be adjusted to conditions on the market facilitating that the Group can recruit and retain senior executives. ÅF employs the “grandfather principle”, meaning that the immediate superior of the manager who has negotiated the terms shall approve all employment terms. The remuneration of senior executives consists of the components basic salary, variable remuneration, pensions and long-term incentive programmes. Other remuneration may also be provided, usually in the form of car benefit. The Board shall safeguard an appropriate balance between fixed and variable remuneration. The board may deviate from these guidelines if required by special circumstances. Basic salary and variable remuneration These forms of remuneration are renegotiated annually. Remuneration shall be based on factors such as duties, expertise, experience, position and performance. In addition, the ratio between basic salary and variable remuneration shall be related to the individual’s position and duties. Variable remuneration for the CEO and other senior executives is a maximum of 60% of fixed annual salary. Fixed annual salary is current monthly salary multiplied by 12. The variable component of salary is based on outcomes in relation to targets. The Board sets the goals and salary of the CEO. For other senior executives, these are set by the Remuneration Committee. Long term incentive programmes Key personnel within the ÅF Group may be eligible to participate in various types of incentive programmes on market terms. The emphasis shall be placed on share-related incentive programmes that aim to reward performance, increase and spread share ownership among senior executives, and encourage them to remain with the Company. The assumption is that a personal, long-term ownership commitment among key personnel stimulates greater interest in the business and in profitability, while also strengthening motivation and identification with the Company, thus safeguarding the Company’s needs for key competence. The board has decided on a specific incentive programme for the new CEO, connected to the Company’s growth target until year 2020. The size of the remuneration depends on the development of the stock price between first quarter of 2017 and first quarter of 2021. The form and structure of incentive programmes shall be determined by the Board and shall, as regards share and share related programmes be subject to the final decision of the Annual General Meeting. Pensions Senior executives shall have defined contribution pension plans with premiums that reflect current market terms and conditions. All pension benefits shall be vested and thus not be dependent on future employment. Remuneration resulting from the short term and long-term incentive programmes shall not constitute pensionable salary. Termination of employment and severance pay The notice period for the CEO is 12 months when notice of termination is given by the Company and 6 months if given by the CEO. In the event that the company gives notice the CEO shall receive a severance payment corresponding to up to 12 month’s salary. For other senior executives, the notice period is normally 12 months for the company and 6 months for the employee. Item 14 – Resolution regarding long-term incentive programme (Convertible Debenture 2017), authority for the Board to repurchase the Company’s own shares and decision to reduce the number of shares in the Company The Board proposes that the meeting decides on a convertible debenture programme for ÅF employees on the following terms, which in all material respects conform to those of the convertible programmes adopted by the annual general meetings of 2015 and 2016. The main purpose of the program is to award performance, increase the ownership of shares among key staff and to incentivize them to stay in the company. A personal long-term ownership among key staff is expected to increase the interest in the business and the financial results, increase motivation and identification with the company, thus attracting and retaining talent. Under the program, ÅF AB takes up a debenture loan at a nominal amount not exceeding SEK 200 000 000 by emitting convertible debentures. The subscription price for each debenture shall correspond to its nominal amount. Participants shall, with exception from the shareholders rights, be employees of the ÅF Group who have not at the end of the subscription period given or been given notice of termination of their employment. The board along the following guidelines shall determine the allocation of debentures. The CEO shall be entitled to subscribe to debentures to a nominal amount of SEK 2 000 000 and may as a maximum subscribe to SEK 6 000 000. Senior executives (approximately 10 persons) shall be guaranteed a subscription of SEK 1 000 000 each and may as a maximum subscribe to an amount of SEK 3 000 000 each. Key staff (approximately 300 persons) shall all be guaranteed a subscription of a nominal amount of SEK 300 000 each and may subscribe up to SEK 900 000 each. If the final total amount of the debenture loan is adjusted to avoid exceeding the maximum dilution, the allocated subscribed amounts shall be adjusted in proportion to this. In case of oversubscription employees shall in the first instance be granted the guaranteed allotment and then be allotted additional debentures with the same percentage regardless of category and in relation to their subscriptions in addition to the guaranteed amount (within the specified maximum amount for each category). When determining the number of convertibles in addition to the guaranteed allotment, only the desired subscription up to the specified maximum subscribed amount for each category shall be considered. The convertibles shall be subscribed for in multiples of SEK 50 000, rounded off to the closest whole number of convertible debentures. The lowest nominal amount to be subscribed for shall be SEK 50 000, rounded off to the closest whole number of convertible debentures. Trading of the convertibles shall not be subject to restrictions. Between 15 June 2020 and 15 March 2021 (inclusive), each convertible may be converted by the owner into a class B share at a conversion rate calculated at 120 percent of the average latest price paid for the Company’s class B share on the Nasdaq Stockholm exchange each day during the period 2-12 of May 2017 (inclusive), but not lower than SEK 10. Days without a noted price paid shall not be included in the calculation. The thus calculated conversion price shall be rounded off to the closest whole number of 10 öre (SEK 1/10), where 5 öre (SEK 1/20) shall be rounded off upwards. The conversion price shall be determined by the board immediately after the specified measurement period. The convertibles are due for payment on 10 April 2021 if conversion has not taken place by then. The convertibles shall carry an interest to be determined considering inter alia the conversion price and the estimated market value of the convertibles when issued. The interest is paid in arrears on February 10 each year and on the maturity of the loan. Assuming an average share price of SEK 180 during the measurement period and a conversion price of SEK 215 and the current interest rate situation the interest will be approximately 1 percent per annum. The debentures shall in case of the winding up or liquidation of the Company entitle to payment only after non-subordinated debt and along (pari passu) with other subordinated debt not expressly subordinated to this loan. Subscription for the convertibles shall take place from 26 May 2017 until and including 9 June 2017 and shall be paid in cash no later than 18 August 2017. The convertibles shall be issued at a price of 100 percent of the nominal value. Subscription is made at market price in accordance with valuation by EY, requested by the Board of the Company. For the evaluation, EY has applied methods considered by market professionals as established for comparable securities. The complete terms and conditions are included in Appendix 1. As stated in the terms and conditions in Appendix 1, the conversion price may be adjusted for new issues and other certain situations. The reason for deviating from the shareholders right to subscription is that the convertible debenture program constitutes a personal long-term ownership among the employees, which is expected to promote the interest for the business and its results. It is therefore advantageous for the Company to be able to offer employees an opportunity to share in the development of the Group in a way that is also beneficial for the shareholders. Dilution and influence on important key figures If all convertibles are assigned and the conversion rate is assumed to be SEK 215, which corresponds to 120 percent of SEK 180, on full conversion the share capital will increase by SEK 2 325 280 based on a quota value of SEK 2.50 per share. This corresponds to a dilution effect of approximately 1.2 percent on share capital and 0.9 percent of voting rights after full conversion. In case the conversion rate at the time of issue should be set at a value that would bring a dilution after full conversion of more than 2 percent of the share capital and the votes, the maximum amount of the loan shall be reduced through a lower subscription, bringing the maximum dilution to 2 percent (provided however that the maximum dilution may be larger than 2 percent due to a later recalculation of the conversion price as per Appendix 1). The proposed convertible debentures cause the earnings per share to change in direct opposite proportion to the change in the number of shares a full conversion results in (the dilution). Since the dilution of the share capital under the terms and conditions shall not exceed 2 percent, the earnings per share can never decrease by more than 2 percent at full conversion. Authorisation for the Board to acquire shares in the company and to reduce the share capital through reduction of the number of shares, including authorisation for the Board to decide on the size of the reduction The purpose of the Board’s proposal to acquire the company’s own shares to fulfil its obligations pursuant to the programme and to reduce the number of shares is that the Company shall be able to reduce the share capital corresponding to the number of shares which the debentures subscribed for in 2016 and 2017 can be converted to. The Board proposes that the annual general meeting grant the board a mandate to make decisions before the next annual general meeting about purchases of the Company’s class B shares corresponding to a maximum of 2 percent of the total of shares in the Company. Buy-backs may be made only on the Nasdaq Stockholm exchange and only at a price within the current registered price range on the purchase date. The Board also proposes that the annual general meeting resolves that the Company’s share capital shall be reduced by the number of shares that subscribed convertible debentures, under the 2016 and 2017 Convertible Debenture programmes can be converted into a maximum of 1 762 720 shares. The amount that the share capital hereby shall be reduced by, minimum SEK 0 and maximum SEK 4 411 800, shall be converted to unrestricted equity. According to the Swedish Companies Act, the decision on reduction may only be executed after registration with and the approval of the Swedish Companies Registration Office (Sw: Bolagsverket). Preparation of the proposal The remuneration committee has prepared the convertible debenture program and the Board advises by external experts. The Board has made the proposal. The CEO has not participated in the preparation of the proposal or the Boards decision. Ongoing share related incentive programmes The Company’s ongoing share related incentive programmes – convertible debenture and performance share programmes – are described in the Company’s Annual Report for 2016, note 6. Costs for the convertible debenture programme The programme costs pertaining to fees to external advisors and banks are estimated to amount to less than SEK 1 000 000 during the course of the programme. In the Board’s opinion, the proposed convertible debentures will not entail any future costs except for employer’s contributions at the time of conversion to shares in certain countries (not Sweden). Authority for the Board The Board shall be authorised to make such minor changes to the decisions as may be deemed necessary for registration at the Swedish Companies Registration Office (Sw: Bolagsverket) and Euroclear Sweden AB. Majority rules A resolution by the annual general meeting about issuing convertible debentures as proposed by the Board requires a majority of 9/10 of the vote and of the shares present at the meeting. For a decision by the general meeting to authorise the Board to repurchase the Company’s own shares and for the decision to reduce the share capital of the Company it is necessary that the decision is supported by at least 2/3 of the votes cast as well as of the vote present at the meeting. Financing One or two Swedish commercial banks will offer financing to the employees who subscribe to the convertible debenture programme. The financing will be on market terms. Item 15 – Resolutions authorising the Board to sell the Company’s own shares on Nasdaq Stockholm and to transfer own shares to participants in the Performance related Share Programme (PSP) 2014 The purpose of the proposed mandate is to enable the Company to secure ÅF’s commitments with regard to the Performance Related Share Programme (PSP) 2014, already in place. Transfer of own shares at Nasdaq Stockholm The Board proposes that the general meeting authorises the Board to, on one or more occasions prior to the annual general meeting 2018, decide to transfer a maximum of 50 000 shares of series B for the purpose of covering certain costs for the Performance related Share Programme (PSP) 2014, mainly employer contributions. Transfer may only be made on Nasdaq Stockholm and at a price within the registered price range at the time. The authorisations above also includes the right to purchase or transfer the larger amount of shares resulting from split or free issue of shares or other similar circumstances. The numbers are calculated with a safety margin to account for that variations in the share price will affect the number of shares included in the programmes. The majority required for the decision is least 2/3 of the votes cast as well as of the vote present at the meeting. Transfer of own shares to participants in Performance related Share Programme (PSP) 2014 To fulfil obligations under performance related share programmes 2014 (PSP) the Board proposes that the general meeting decides to authorise the Board to, prior to the annual general meeting 2018, decide to transfer shares of series B as follows. A maximum of 140 000 shares of series B may be transferred to participants in the programmes. The right to receive shares shall belong to the participants in the programmes, with the right of each participant to receive the number of shares set out in each programme. The right to receive shares requires that all the conditions for this in the programmes are met. The transfer will be made without consideration. Split or free issue of shares or other similar circumstances can alter the number of shares, which may be transferred. The reason for the deviation from the shareholders rights when transferring own shares is to be able to transfer the shares to the participants in the programmes. The decision requires a majority of 9/10 of the vote and of the shares present at the meeting. Item 16 – Resolution authorising the Board to make new issue of shares The Board proposes that the Annual General Meeting grants the Board a mandate to issue new class B shares on one or more occasions before the 2018 Annual General Meeting. Payment for new shares may be in capital contributed in kind or, with preferential rights for shareholders, in cash. The purpose of such an issue is to increase share capital by issuing shares on market terms. However, the maximum number of new shares issued must not exceed 7 800 000 shares of series B, which is equivalent to 10 percent of the Company’s share capital and 7,2 percent of the votes. The mandate above also extends to the right to issue a larger number of shares as a consequence of a share split, new issue or similar measures. Item 17 – Close of the Annual General Meeting _______________ Shares and votes ÅF’s share capital totals SEK 197 533 882,5 and comprises a total of 79 013 553 shares, of which 3 217 752 are class A shares and 75 795 801 are class B shares, corresponding to a total of 107 973 321 votes. Class A shares entitle the holder to 10 votes per share. Class B shares entitle the holder to one vote per share. At the time when this invitation to the Annual General Meeting was issued, ÅF AB held 1 186 300 of the Company’s own class B shares, corresponding to 1 186 300 votes for which there can be no representation at the Annual General Meeting. Information to the Annual General Meeting The Board of the Company and the CEO shall, if requested to do so by a shareholder and on condition that the Board considers that such a request can be met without any significant adverse effects on the Company, provide information about circumstances that may affect the assessment of an item on the agenda, or of the financial situation of the Company or one of the Company’s subsidiaries, and/or of the Company’s relationship to another Group company. Shareholders who wish to do so may submit their questions in advance to ÅF AB, Annual General Meeting, SE-169 99 Stockholm, Sweden. Further information The Board’s statement with regard to the proposals concerning shareholders’ dividend and reduction of numbers of shares in the company, the Board’s evaluation of remuneration to members of the senior management team and the Auditor’s report in accordance with Chapter 8, Section 54 of the Swedish Companies Act (2005:551) on whether the guidelines adopted by the annual general meeting regarding remuneration to senior management team have been complied with, will all be available at the Company’s headquarters (visiting address: Frösundaleden 2A, Solna, Sweden) from 4 April 2017. They will also be posted to the Company’s website www.afconsult.com . Shareholders who wish to avail themselves of these documents may apply to the Company to have the material sent to them by post or e-mail. Stockholm, March 2016ÅF AB (publ)Board of Directors This English version is a translation of the Swedish original. The Swedish text is the binding version and shall prevail in the event of any discrepancies.

Nordic Nanovector publishes Annual Report 2016

Oslo, Norway, 24 March 2017 The Board of Directors of Nordic Nanovector ASA (OSE: NANO) has approved the company’s Annual Report 2016 including the complete 2016 Annual Accounts with notes. The report is attached to this announcement and available on Nordic Nanovector’s website in the section Investor Relations/Reports and presentations/Annual Reports. For further information, please contact: IR enquiries:Tone Kvåle, Chief Financial OfficerCell: +47 91 51 95 76Email: ir@nordicnanovector.com Media enquiries:Mark Swallow/David Dible (Citigate Dewe Rogerson)Tel: +44 207 282 2948/+44 207 282 2949Email: nordicnanovector@citigatedr.co.uk About Nordic Nanovector:Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The company aspires to become a leader in the development of targeted therapies for haematological cancers. Nordic Nanovector’s lead clinical-stage candidate is Betalutin®, a novel CD37-targeting Antibody-Radionuclide-Conjugates (ARC) designed to improve upon and complement current options for the treatment of non-Hodgkin Lymphoma (NHL). NHL is an indication with substantial unmet medical need and orphan drug opportunities, representing a growing market forecast to be worth nearly USD 20 billion by 2024. The Company aims to rapidly develop Betalutin®, alone and in combination with other cancer therapies, for the treatment of major types of NHL, targeting first regulatory submission in relapsed/refractory follicular lymphoma in 1H 2019. Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets. The Company is also advancing a pipeline of ARCs and other immunotherapies for multiple cancer indications.Further information about the Company can be found at www.nordicnanovector.com Forward-looking statementsThis announcement may contain certain forward-looking statements and forecasts based on uncertainty, since they relate to events and depend on circumstances that will occur in the future and which, by their nature, will have an impact on Nordic Nanovector’s business, financial condition and results of operations. The terms “anticipates”, “assumes”, “believes”, “can”, “could”, “estimates”, “expects”, “forecasts”, “intends”, “may”, “might”, “plans”, “should”, “projects”, “will”, “would” or, in each case, their negative, or other variations or comparable terminology are used to identify forward-looking statement. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied in a forward-looking statement or affect the extent to which a particular projection is realised. Factors that could cause these differences include, but are not limited to, implementation of Nordic Nanovector’s strategy and its ability to further grow, risks associated with the development and/or approval of Nordic Nanovector’s products candidates, ongoing clinical trials and expected trial results, the ability to commercialise Betalutin®, technology changes and new products in Nordic Nanovector’s potential market and industry, the ability to develop new products and enhance existing products, the impact of competition, changes in general economy and industry conditions and legislative, regulatory and political factors. No assurance can be given that such expectations will prove to have been correct. Nordic Nanovector disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. This information is subject to a duty of disclosure pursuant to Section 5-12 of the Securities Trading Act.

SSM acquires project in the Municipality of Stockholm for approximately 260 cooperative apartments

SSM has acquired another project within the Municipality of Stockholm. The building is attractively located near public transport including the subway, commuter trains and buses. The project is a purely cooperative apartment project covering about 24,000 square meters of BUA that SSM intends to develop into approximately 260 apartments. The project will be managed by SSM in full with construction planned to start in 2018 and occupancy in 2020.The purchase price is a total of 500 MSEK. The acquisition is conditioned and the conditions are expected to be removed during the second quarter of 2017. - SSM targets a customer group looking for functional, space-efficient homes in central locations with access to public transport. Our new project meets all three criteria and will therefore be a valuable addition to our portfolio, says Mattias Roos, President & CEO of SSM. Following the acquisition, SSM will have close to 5,800 building rights in planning or construction phase. The information in this press release is such, which SSM Holding AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out below, at 07:30 CET on March 24, 2017. For more information, please contact:Mattias Roos, President & CEOEmail: mattias.roos@ssmliving.se Ann-Charlotte Johansson, Chief Communications & IR Officer            Phone: + 46 (0)761-65 17 71Email: ann-charlotte.johansson@ssmliving.seTwitter: @AnnCharlotteSSM About SSM Holding AB (publ)SSM produces functionally smart and affordable homes with attractive common areas, close to public transport and the city center for the company’s target group — the urbanites of tomorrow. The company envisions a housing market that is accessible to as many people as possible and aspires to produce 60 percent cooperative apartments, 30 percent rental units and 10 percent student housing. SSM is the leading property developer in its niche within the Greater Stockholms-region and in March 2017, the company had close to 5,800 building permits in its portfolio. www.ssmlivinggroup.se 

Bulletin from AB Electrolux Annual General Meeting 2017

Petra Hedengran, Hasse Johansson, Ronnie Leten, Ulla Litzén, Bert Nordberg, Fredrik Persson, David Porter, Jonas Samuelson and Ulrika Saxon were re-elected to the Board of Directors. Kai Wärn was elected new Board member. Ronnie Leten was re-elected Chairman of the Board. The proposed dividend of SEK 7.50 per share was adopted. The AGM adopted the proposal that the dividend shall be paid in two equal installments of SEK 3.75 per installment and share, the first with the record date Monday, March 27, 2017, and the second with the record date Wednesday September 27, 2017. The first installment of the dividend is expected to be paid by Euroclear Sweden AB on Thursday, March 30, 2017 and the second installment on Monday, October 2, 2017. The parent company’s and the Group’s income statements and balance sheets were adopted. The Board of Directors and the President were discharged from liability for the financial year 2016. The Meeting resolved to adopt the remunerations to the Board that were proposed in the notice convening the AGM. The proposal for remuneration guidelines for Group Management was also approved, as well as the scope of and the principles for Electrolux performance based, long-term share program for 2017. The Meeting authorized the Board of Directors to resolve on acquisitions of Electrolux B shares up to a maximum amount of 10 percent of all shares issued by the company. The Board was also authorized to transfer own shares on account of company acquisitions and to cover costs that may arise as a result of the share program for 2015. These authorizations are effective during the period until next year’s AGM. Full details on the proposals adopted by the AGM can be downloaded at www.electroluxgroup.com/agm2017.

Creating impact through philanthropy – A Nordic perspective

The report demonstrates the very specific flavor of Nordic philanthropy. It does not exist in a vacuum from public funding and institutions, but rather complements it in providing public goods and has the potential to create innovative solutions to address contemporary challenges. Philanthropists themselves are tending to give earlier in their lives and take a more active role in the projects and the organizations they support. There is also an increasing interest in measuring and evaluating philanthropy’s impact. According to the study, philanthropic interests are driven by personal connections to the issues. Family involvement remains important despite a culture of individualism. Of the areas supported, scientific research and the care of children and youth are most prioritized. And for the majority, philanthropy is primarily a domestic affair, although more than half also have some degree of international involvement. Nordic philanthropists are becoming more strategic, focused, professional and collaborative, with two-thirds collaborating with other philanthropists and organizations. They also consider that all actors in society share a responsibility for societal development; hence an increasingly holistic and impact-driven approach could be identified. There is also a growing interest in new and innovative forms of giving. Recent examples are venture philanthropy, social impact investing, and social impact bonds. Silvia Bastante de Unverhau, Head of UBS’s Philanthropy Advisory, explains the rationale behind this report, "Despite the scarcity of literature on the subject, Nordic countries have a long tradition of philanthropy and many philanthropists in the region are at the forefront of innovative ideas and approaches to combat some of the most pressing social challenges. Creating impact through philanthropy provides key insights into the very flavor of Nordic philanthropy while crucially also identifying drivers of future success in the development of philanthropy in the region." Johanna Palmberg, Research Director of the Swedish Entrepreneurship Forum and co-author of the report commented:  "There are a number of ways in which individuals may be incentivized to engage in philanthropy: successful philanthropists being role models, possibilities to deduct taxes for philanthropic initiatives and opportunities for public procurement for social entrepreneurs." Over the past decade, economic growth has led to an increase in private wealth accumulation while the Nordic welfare model has come under increasing pressure. This is translating into an ever-greater need for philanthropy. Against this backdrop, Nordic philanthropy is in a strong position to enhance its impact as it gathers the experience and skill to become an even stronger societal force. Download Creating impact through philanthropy   För interviews and comments:   Pontus Braunerhjelm (pontus.braunerhjelm@entreprenorskapsforum.se), Research Director Swedish Entrepreneurship Forum and Professor Royal Institute of Technology, KTH, + 46 72-965 55 69.Johanna Palmberg (johanna.palmberg@entreprenorskapsforum.se), Research Director Swedish Entrepreneurship Forum and Associate Professor Södertörn University, +46 72-375 79 75.Silvia Bastante de Unverhau (silvia.bastante@ubs.com), Head of Philanthropy Advisory, UBS Switzerland AG, +41-79-583 54 18.Nina Hoas (nina.hoas@ubs.com), Philanthropy Advisor, UBS Switzerland AG, +41-79-464 88 43. Swedish Entrepreneurship Forum is the leading network organization for initiating, conducting and communicating policy relevant research in the field of entrepreneurship, innovation, business dynamics and growth. UBS Philanthropy Advisory's award-winning global team provides individual philanthropists with objective, independent and tailored advice which helps them to create their own solution. Its philanthropy advisors deliver not only expertise but also inspiration, from UBS's global network of philanthropists, social entrepreneurs, and public leaders.

Kindred Group explores AI to detect problem gambling

Kindred Group’s (formerly Unibet Group) innovation arm, Kindred Futures, recently co-hosted a roundtable session in London to explore how artificial intelligence (AI) and machine learning can be used to help recognise patterns in player behaviour. Detecting signs of problem gambling at an early stage, greatly improves the ability to successfully prevent a continued destructive gaming pattern. The discussions between leading academics, industry experts and Kindred’s team of responsible gambling experts, focused on the value AI can have in modelling behaviours and changes in behaviour over time, to assess if a player is developing a problem. Past research in responsible gambling has identified a number of critical factors such as the amount a player stakes, the time s/he plays for, how they deposit money. However, each individual is different, indicating that there is no universal solution to detecting problem gambling. AI and machine learning will potentially serve as a complement to Kindred Group’s award winning proprietary system PS-EDS (Player Safety Early Detection System), adding to the set of tools and systems used by the team of responsible gambling experts at Kindred. Thereby, Kindred hopes to further limit the small number of customers who see gambling as a challenge rather than a form of entertainment. "This was a fascinating discussion, bringing together experts from a number of different fields.  The outcome was very encouraging - we agreed there was significant potential for an AI capability to bring together and analyse many data sources to give a much improved ability to detect signs of a developing problem.  We also agreed there was real value in doing this - both socially and commercially", said Will Mace, Head of Kindred Futures.  

Storytel expanding to four new markets

“Whenever we enter a new country or region, we make long-term investments and build from the ground up,” says Storytel’s CEO Jonas Tellander. “Cooperating with leading publishers is important, and so is our local staff: we hand-pick employees in order to fit Storytel’s entrepreneurial corporate culture. This is a sustainable and goal-oriented strategy which has served us well in our existing markets.” First up will be Russia, where Storytel goes online this spring. The focus will be on lighter fiction, but non-fiction will also be offered among the 1,500 audio books first available. By the end of the year, the Russian catalogue will have grown to 4,000 titles. “We’re breaking new ground and intend to make audio books a major force in Russia. Our local team has a strong set-up, and will work hard to make sure Storytel achieves its goals,” says CEO Tellander. Storytel currently produces about 2,000 audio books in about ten languages per year, which makes the company one of the world’s largest audio-book producers. “Stories written by local authors are often more popular, which is why we’ve been developing and producing Stoytel Original-content through our local teams. However in Russia we’ll be satisfied strictly distributing and producing previously published material. We’re aware of the limitations of freedom of speech in Russia and that’s why we have, for the time being, decided against offering original content there,” says Tellander. With the range of audio books in local languages increasing, in the autumn of 2017 Storytel plans to open shop in the Spanish, Indian and Arabic markets. Storytel’s overseas expansion has already been budgeted for during the current fiscal year, for which the concern accordingly made a secondary stock offering worth 100 million Swedish crowns last autumn. For more information, please contact: Jonas Tellander, CEO and founder: 0046 70 261 6136 The information in this press release is information which Storytel AB (publ) is required to disclose under EU Market Abuse Regulation (EU). The information was provided by the below contact persons for publication on March 24, 2017.

Capio to acquire a German eye specialist clinic in Bremen

Augenklinik Universitätsallee is located centrally in Bremen and performs annually about 6,000 surger­ies and 6,000 other treatments. The clinic serves both publicly remunerated and private pay patients, and to some extent also international patients. Around 70% of sales is publicly remunerated, while the remaining 30% refers to private pay patients. One of the two former owners of Augenklinik Universi­tätsallee will continue his involvement in the company and secure continuity and knowledge transfer. “We are very pleased with the opportunity to acquire Augenklinik Universitätsallee, which is a well-established ophthalmology business focused on Modern Medicine. Capio already today offers ophthalmology treatments in several markets, and is through Capio Medocular one of the largest private companies within ophthalmology treatments in the Nordics. The acquisition of Augenklinik Universitätsallee opens up for further exchange of knowledge and experience between operations in different countries, and improvements of quality and productivity – for the benefit of our patients”, says Thomas Berglund, President and CEO of Capio. The size of the German market for ophthalmology is estimated around EUR 3 billion (2014). The market is relatively fragmented and the market share for single practices is in total around 75% and there are no large players of substantial size. Two types of treatments, of cataracts and age-related macular degenera­tion, account for about 64% of eye surgery expenditures in Germany. Eye diseases are to a large extent age related, and the market is consequently expected to grow with the forecasted demographic development in Germany (with an increasing share of the population being elderly). An ageing population combined with a higher prevalence of eye diseases from lifestyle effects (such as e.g. diabetes), is expected to lead to a general increase in the demand for eye treatments. Enterprise value, i.e. purchase price plus acquired net debt, is approximately MEUR 10, corresponding to about MSEK 95. The acquisition also includes an agreed possible future earn-out of maximum MEUR 3 based on the future financial performance. The acquisition is expected to be closed and included in Capio from April 2017, and is expected to contribute positively to Capio’s earnings during 2017. For information, please contact: Kristina Ekeblad, IR managerTelephone: +46 708 31 19 40  Henrik Brehmer, SVP Group Communication and Public AffairsTelephone: +46 761 11 34 14    This information is information that Capio AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:30 CET on March 24, 2017. 

The Nomination Committee’s proposal to the 2017 Annual General Meeting of Ahlsell AB

Charlotta Sund was born in 1963 and holds a Master of Science in Industrial Engineering & Management from the Institute of Technology, Linköping University, Sweden. Charlotta is Senior Vice President of Ericsson AB (publ) and is a member of Ericsson’s Group management team. Charlotta has been Head of Customer Group Industry & Society since 1 July 2016, prior to which she was Head of Region Northern Europe & Central Asia. Charlotta has previously held various positions at Ericsson, including Head of Customer Unit Industry & Society in Region Northern Europe & Central Asia, and Vice President and Head of Multimedia & Systems Integration in the Market Unit Nordic and Baltics. The Nomination Committee consists of Tomas Ekman appointed by Keravel S.a.r.l., Vegard Söraunet appointed by Odin Fonder, Jan Särlvik appointed by Nordea Fonder and Mikael Wiberg appointed by Alecta. In addition, Kenneth Bengtsson, Chairman of the Board, is a co-opted member of the Nomination Committee. At 31 December 2016, the shareholders represented in the Nomination Committee held approximately 66 percent of the voting rights in Ahlsell. Independence in accordance with the Swedish Code of Corporate GovernanceKenneth Bengtsson, Magdalena Gerger, Satu Huber, Terje Venold and Charlotta Sund are considered to be independent from the company, the company’s management and the company’s major shareholders. Peter Törnquist, Gustaf Martin-Löf and Søren Vestergaard-Poulsen are considered not to be independent from the company’s largest shareholder Keravel S.a.r.l., but independent from the company and the company’s management. Johan Nilsson is considered not to be independent from the company and the company’s management, but independent from its major shareholders. Election of auditorsIn accordance with the recommendation of the Audit Committee, the Nomination Committee proposes the re-election of KPMG AB as auditors until the end of the next Annual General Meeting. Remuneration to Board members and auditorsThe Nomination Committee proposes to the Annual General Meeting that remuneration to Board members shall remain unchanged, so that SEK 1,000,000 is paid to the Chairman of the Board, SEK 600,000 to the Deputy Chairman and SEK 400,000 to each of the other Board members. In addition, a special fee shall be paid for the work of the Audit Committee, with SEK 150,000 to the chairperson and SEK 100,000 to each of the other members. A special fee shall be paid for the work of the Remuneration Committee, with SEK 100,000 to the chairperson and SEK 50,000 to each of the other members. Remuneration is not paid to members who are employees of the Ahlsell Group. It is proposed that payment of fees to the auditors shall be made on the basis of approved invoices. The Nomination Committee's proposal for Chairman of the 2017 Annual General MeetingThe Nomination Committee proposes that the Chairman of the Board, Kenneth Bengtsson, be appointed Chairman of the Annual General Meeting. Instructions to the Nomination CommitteeThe Nomination Committee proposes that no changes be made to the instructions to the Nomination Committee that were approved in 2016. For further information, please contact:Tomas Ekman, Chairman of the Nomination Committee, phone number +46 8 407 87 90. The information contained in this publication constitutes information which Ahlsell AB (publ) is required to disclose under the Swedish Securities Market Act. The information was provided for publication at 08.30 CET on 24 March 2016.

Finnair selected as Best European Airline at TTG China Travel Awards

Finnair has been selected as the Best European Airline at the 10th annual TTG China Travel Awards for the second year in a row. The TTG China Travel Awards recognizes Greater China’s best companies in the travel industry, including airlines, hotels and resorts, serviced residences and travel services. The selection is done by TTG readers and travel industry professionals. Commenced in 2007, TTG China Travel Awards has become one of the most popular and influential travel industry awards in Greater China. “We are honored to receive this prestigious award and I would like to thank all TTG readers and contributors in China,” says Juha Järvinen, Chief Commercial Officer, Finnair. “We want to offer a Unique Nordic experience and the best long-haul business class among European carriers. We will continue to invest in customer service, meals, entertainment, lounges and aircraft cabin to maintain and improve our high customer satisfaction level. We have also recently launched a pilot program on our Beijing and Shanghai routes, where customers can use Alipay mobile payment onboard for easy shopping, and the feedback has been very positive.” Finnair is focused on fast Europe-Asia connections, and currently connects six destinations in Greater China to its network of over 70 European destinations. Finnair has year-round flights to Beijing, Chongqing, Hong Kong and Shanghai, and a summer service to Xi'an and Guangzhou.

Scania switches to fossil free electricity

Scania’s efforts in driving the shift towards sustainable transport systems is about developing smart and energy-efficient transport solutions, but also about streamlining the company’s own energy usage. ”Scania itself must be a forerunner in this shift. We place high demands on our suppliers to adhere to the highest environmental standards and deploy new and innovative technology. Many of our customers also have ambitious environmental targets,” says Anders Williamsson, Executive Vice President and Head of Purchasing, Scania. Switching to fossil free energy leads to a significant reduction of the carbon emissions for a manufacturing company of Scania’s magnitude. Scania’s commitment however, is not limited to its production sites but includes all operations, not the least the hundreds of Scania workshops. In Scandinavia, the energy supplied to Scania is primarily sourced from hydroelectric power plants. In France and Poland, wind and solar power is most common. In countries without deregulated energy markets, Scania is unable to procure fossil free electricity. In these countries Scania will use available alternatives for carbon offsetting. Scania’s goal is to conclude the shift to fossil free electricity by 2020 in all countries where these alternatives exist. At present, 79 percent of the electricity Scania purchases or generates internally derives from fossil free sources. Countries that are next in line to switch to 100% fossil free electricity are, among others, Italy, Netherlands and the UK. For further information, please contact: Karin Hallstan, Public Relations Manager, phone +46768428104, email karin.hallstan@scana.com

NOTICE OF ANNUAL GENERAL MEETING 2017 OF CATENA MEDIA PLC

in accordance with Articles 18 and 19 of the Articles of Association of the Company. NOTICE IS HEREBY GIVEN that the ANNUAL GENERAL MEETING 2017 (the “Meeting”) of Catena Media plc, company registration number C70858 (the “Company” or “Catena”), will be held on Friday, 28 April 2017, at 08:30 a.m. (CET) at the premises “Perrongen”, Spårvagnshallarna, Birger Jarlsgatan 57 A in Stockholm, Sweden. Attendance and voting · To be entitled to attend and vote at the Meeting (and for the Company to be able to determine the number of votes that may be cast), shareholders must be entered in the register of members maintained by Euroclear Sweden AB on 17 April 2017. · Shareholders whose shares are registered in the name of a nominee must temporarily re-register their shares in their own name in the register of members maintained by Euroclear Sweden AB in order to be entitled to attend and vote at the Meeting. Such registration must be effected no later than the 17 April 2017. Shareholders must, therefore, instruct their nominees well in advance thereof. · To be entitled to attend and vote at the Meeting, shareholders must also notify the Company of their intention to participate by mail to Catena Media plc, c/o Euroclear Sweden AB, Box 191, SE-101 23, Stockholm, Sweden, or by phone +46 8 402 91 48 during the office hours of Euroclear Sweden AB, by no later than 12:00 p.m. CET on 10 April 2017. Such notification should include the shareholder’s name, personal identification number/company registration number (or similar), address and daytime telephone number, number of shares in the Company, as well as, if applicable, details of proxies. Proxies · A shareholder, who is entitled to attend and vote at the Meeting, is also entitled to appoint one or more proxies to attend and vote on such shareholder’s behalf. A proxy does not need to be a shareholder. The appointment of a proxy must be in writing and its form must comply with Article 37 of the Articles of Association of the Company and (a) where the shareholder is an individual, be signed by him/her or (b) where the shareholder is a corporation, be signed by a duly authorised officer of the corporation. A proxy form is available on the Company’s website: www.catenamedia.com. · The original signed proxy form and, where the shareholder is a corporation, a certified copy of a certificate of registration or similar evidencing the signatory right of the officer signing the proxy form, must be received at the registered office of the Company not less than 48 hours before the time appointed for the Meeting and in default shall not be treated as valid. Shareholders are, therefore, encouraged to send or deliver their proxy forms (and, if applicable certified copies of certificates of registration or similar) as soon as possible. A copy of the signed proxy form must be received by the Company no later than 10 April 2017 at 12:00 p.m. (CET) and shall be sent by post or courier to Catena Media plc, c/o Euroclear Sweden AB, Box 191, 101 23 Stockholm, Sweden. Agenda General 1                    Opening of the Meeting 2                   Election of Chairman of the Meeting 3                   Drawing up and approval of the voting list 4                   Election of one or two persons to approve the minutes of the Meeting 5                   Approval of the agenda 6                   Determination whether the Meeting has been duly convened 7                   The CEO’s presentation Ordinary business (ordinary resolutions) 8                   To receive and approve the Consolidated Financial Statements (Annual Report) of the Company for the year ended 31 December 2016 and the Directors’ Report for the year ending 31 December 2016 and the Auditors’ Report for the year ending 31 December 2016 9                   Resolution on dividends 10                 Determination of fees for the members of the Board of Directors 11                  Determination of fees for the auditor 12                 Election of the Board of Directors and Chairman of the Board of Directors. In conjunction to this, report on the work of the Nomination Committee 13                 Election of auditor Special business (ordinary resolutions) 14                 Resolution on the Nomination Committee of the Company for the Annual General Meeting of 2018 15                 Resolution regarding guidelines for remuneration to the senior management 16                 Resolution on adoption of an incentive programme for the CEO Special business (extraordinary resolutions) 17                 Resolution on amendments to the Memorandum and Articles of Association of the Company Information on resolution proposals Agenda item 2; Election of Chairman of the Meeting The Nomination Committee, established in accordance with the principles adopted at the annual general meeting of 2016, has declared that it proposes Kathryn Moore Baker to be appointed as chairman of the Meeting. Agenda item 8; Approval of Consolidated Financial Statements, Directors’ Report and Auditors’ Report for the year ending 31 December 2016 The Board of Directors proposes that the Meeting resolves to approve the Consolidated Financial Statements (Annual Report) of the Company for the year ended 31 December 2016 and the Directors’ Report and the Auditors’ Report. Agenda item 9; Resolution on dividends The Board of Directors proposes, in accordance with the Consolidated Financial Statements (Annual Report) of the Company for the year ended 31 December 2016 and in accordance with the directors’ recommendation as set forth in the Directors’ Report, that the Meeting resolves to not declare any dividends. Agenda item 10; Determination of fees for the members of the Board of Directors The Nomination Committee proposes that the aggregate fees for the Directors of the Company shall amount to EUR 220,000, of which EUR 70,000 shall be paid to the Chairman and EUR 30,000 to each of the other Directors; and the Directors of the Company may invoice the fees through a company, if fiscal conditions so permit and provided that such arrangement is cost neutral for the Company. The committees of the Company have received remuneration for their work up until the Meeting in accordance with the following: (i) Audit Committee Chairman: EUR 12,500;(ii) Audit Committee member: EUR 6,250; (iii) M&A Committee Chairman: EUR 12,500; (iv) M&A Committee member: EUR 6,250; (v) Remuneration Committee Chairman: EUR 6,250; and (iv) Remuneration Committee member: EUR 3,125. The Nomination Committee proposes that the remuneration to the Audit Committee, M&A Committee and Remuneration Committee, respectively, for the period until the next Annual General Meeting, shall be unchanged. Agenda item 11; Determination of fees for the auditor The Nomination Committee proposes that the auditor’s fees shall be payable in accordance with approved invoice. Agenda item 12; Election of members of the Board of Directors and Chairman of the Board of Directors The Nomination Committee proposes that Andre Lavold, Anders Brandt,Henrik Persson Ekdahl, Kathryn Moore Baker, Mathias Hermansson and Mats Alders are re-elected as members of the Board of Directors for the period until the end of the next Annual General Meeting. The Nomination Committee proposes that Kathryn Moore Baker is re-elected as Chairman of the Board of Directors. Agenda item 13; Election of auditor The Nomination Committee proposes to re-elect PricewaterhouseCoopers Malta as auditor of the Company for the period until the end of the next annual general meeting. Agenda item 14; Resolution on the Nomination Committee of the Company for the Annual General Meeting of 2018 The Nomination Committee proposes that the Meeting resolves on the following regarding the principles for appointing the Nomination Committee for the next Annual General Meeting. The Nomination Committee shall consist of four members. The three, in terms of votes, largest shareholders/owner groups (the “Largest Shareholders”) as per 31 August the year prior to the next annual general meeting, according to the list of shareholders in the share register maintained by Euroclear Sweden AB or that in another way are proved to be one of the Largest Shareholders, are entitled to appoint one member of the Nomination Committee each. In addition, the Chairman of the Board of Directors shall be appointed as member of the Nomination Committee. The Chairman of the Board of Directors shall no later than 15 October 2017 summon the Largest Shareholders of the Company. If any of these shareholders waive their right to appoint a member of the Nomination Committee, the next shareholder/owner groups in order of size shall be given the opportunity to appoint a member of the Nomination Committee. The CEO or any other person from the senior management shall not be a member of the Nomination Committee. The Chairman of the Board of Directors shall summon the Nomination Committee’s first meeting. The Chairman of the Board of Directors shall not be appointed chairman of the Nomination Committee. The Nomination Committee’s term of office extends until a new Nomination Committee is appointed. The composition of the Nomination Committee shall be made public no later than 6 months before the next Annual General Meeting. If it becomes known that a shareholder that has appointed a member of the Nomination Committee, as a result of changes in the said owner’s shareholdings or due to changes in other owners’ shareholdings, is no longer one of the Largest Shareholders, the committee member who was appointed by said shareholder shall, if the Nomination Committee so decides, resign and be replaced by a new member appointed by the shareholder who at the time is the largest registered shareholder that has not already appointed a member of the Nomination Committee. If the registered ownership structure is otherwise significantly changed prior to the completion of the Nomination Committee’s work, the composition of the Nomination Committee shall, if the Nomination Committee so decides, be changed in accordance with the above stated principles. The tasks of the Nomination Committee shall be to prepare, for the next Annual General Meeting, proposals in respect of number of directors of the Board of Directors, remuneration to the Chairman of the Board of Directors, the other directors of the Board of Directors and the auditors respectively, remuneration, if any, for committee work, the composition of the Board of Directors, the Chairman of the Board of Directors, proposal for the composition of the nomination committee, chairman at the annual general meeting and election of auditors. The Company shall pay for reasonable costs that the nomination committee has considered to be necessary in order for the nomination committee to be able to complete its assignment. Agenda item 15; Resolution on guidelines for remuneration to the senior management The Board of Directors proposes that the Meeting resolves on the following guidelines for remuneration to the senior management for the period until the Annual General Meeting of 2018. Compensation and conditions of employment for the CEO and the other senior management (“Senior Management”) shall be designed to ensure the Company’s access to executives with the right set of skills. The remuneration shall consist of a fixed salary and a possible variable compensation. The remuneration shall be on market terms and competitive, and be related to the executive’s responsibilities and authorities. Any variable remuneration shall be limited to a maximum amount and linked to predetermined and measureable criteria, designed with the aim of promoting the Company’s long-term value creation. Further, in case any variable remuneration in cash has been paid out on the basis of information which later proves to be manifestly misstated, the Company shall be assured possibility to reclaim such remuneration. In case earnings before taxes of the Company are negative, any variable remuneration shall not be paid out. As regards the CEO, the variable remuneration shall be capped at 80 per cent of the annual basic salary. The variable remuneration shall be based on individual goals set by the Board of Directors. Examples of such goals are the results of the business, quality objectives and the development of the business. In respect of other members of the Senior Management than the CEO, the variable remuneration shall be capped at 70 per cent of the annual basic salary and be based on the result within the executive’s responsibility area as well as the outcome of individual goals. From time to time the Board of directors shall have the possibility to propose share-based long-term incentive programs, which then shall be resolved upon by a shareholders’ meeting. Members of the Senior Management may also receive other customary benefits such as occupational health care, housing allowance etc. Upon termination by the Company, the CEO is entitled to six months’ salary as severance pay. Other members of the Senior Management may in addition to their fixed monthly salary during the notice period be entitled to severance pay in a maximum amount of three months’ basic salary. The Board of Directors of the Company is given the possibility to deviate from the above guidelines in individual cases should special reasons justify this. If this is the case, the information and the reasons for the deviation shall be reported at the next annual general meeting. Agenda item 16; Resolution on adoption of an incentive programme for the CEO The Company’s current CEO, Robert Andersson, was allotted 450,000 share options in connection with his appointment as CEO of the Company in February 2015. Each option entitles Robert Andersson to subscribe for one new share in the Company during a period starting 26 February 2018 and ending six months thereafter (the “Existing Programme”). Besides the Existing Programme, Robert Andersson is not included in any other share based incentive programme offered by the Company. In order to continue to incentivize the CEO after the Existing Programme is ended, the Board of Directors proposes that the Meeting resolves to implement a new incentive programme for the CEO in accordance with the following (the “Programme”). The Programme means that the CEO will be allotted a maximum of 300,000 share options free of charge. Provided that the CEO is still employed by the Catena Group at the time of the exercise of the options and that the financial target described below is fulfilled, each option entitles the CEO to subscribe for one share in the Company. 50 per cent of the share options shall have a vesting period of three (3) years from the date when the CEO enters into a share option agreement regarding the Programme (“Tranche 1”) and the remaining 50 per cent of the share options shall have a vesting period of four (4) years from the date when the CEO enters into a share option agreement regarding the Programme (“Tranche 2”). The share options shall, however, not be allotted to the CEO earlier than 1 March 2018. Furthermore, the share options shall be exercised within a period of six months from the end of the vesting period of Tranche 1 and Tranche 2, respectively. Subject to customary recalculation provisions in case of certain corporate actions taken by the Company, the subscription price shall be equal to 130 per cent, for the shares under Tranche 1, and 140 per cent, for the shares under Tranche 2 of the volume-weighted average price of the Company’s share on Nasdaq Stocholm (or the corresponding information on a stock exchange, authorized market place or regulated market on which the shares are listed) during a period of thirty (30) trading days prior to 1 March 2018. Furthermore, the final number of share options the CEO shall be entitled to exercise shall also be dependent on the degree of fulfilment of a financial target defined as average annual percentage growth in earnings per share during the vesting period of Tranche 1 and Tranche 2, respectively, compared with earnings per share for the most recent financial year prior to the allotment date of the share options, whereas earnings per share shall be calculated as net profit divided by the weighted average number of shares during the relevant financial year. The CEO will be entitled to exercise (i) the full amount of share options allotted to the CEO under Tranche 1 (i.e. 150,000) if the annual average growth in earnings per share is at or above 20.0 per cent during the vesting period of Tranche 1, and (ii) the full amount of share options allotted to the CEO under Tranche 2 (i.e. 150,000) if the annual average growth in earnings per share is at or above 20.0 per cent during the vesting period of Tranche 2. The CEO will not be entitled to exercise any share options under Tranche 1 or Tranche 2, respectively, if the annual average growth in earnings per share is below 18.0 per cent during the relevant vesting period. The CEO shall be entitled to exercise 25 per cent of the share options under the respective Tranche if the annual average growth in earnings per share is 18.0 per cent during the relevant vesting period. The right to exercise share options if the annual average growth in earnings per share during the relevant vesting period is between 18.0 and 20.0 per cent shall be linear. When calculating the earnings per share, the Company shall, to a reasonable extent, take into consideration changes in the number of shares due to a split or a bonus issue or similar action. The Board of Directors shall, within the framework of the above stated conditions and guidelines, be responsible for preparing the detailed terms and conditions of the Programme. The Board of Directors shall also be entitled to make adjustments to the Programme if significant changes in the Company, or its markets, result in a situation where the decided terms and conditions for exercising the options are no longer appropriate. Should Robert Andersson’s assignment as CEO be terminated prior to the allotment of the share options, the Board of Directors shall be authorised to offer the Programme to his replacement. In such case, the Board of Directors shall be authorised to allot the share options prior to 1 March 2018 and the subscription price for the shares shall be equal to 130 per cent for the shares under Tranche 1 and 140 per cent for the shares under Tranche 2 of the volume-weighted average price of the Company’s share on Nasdaq First North Premier (or the corresponding information on a stock exchange, authorized market place or regulated market on which the shares are listed) during a period of thirty (30) trading days prior to the allotment date of the share options. Furthermore, in case of special circumstances, the Board of Directors shall be authorised to resolve that share options may be kept and exercised despite the fact that the employment in the Catena Group has ceased, for example due to long-term illness. The share options may not be transferred or pledged and no compensation will be paid for any dividends until the share options have been exercised. The Programme corresponds to not more than approximately 0.6 per cent of the share capital and votes of the Company at the date of this notice (on a fully diluted basis). Furthermore, the Company has allotted a total of 1,675,378 share options and 365,100 warrants under the Company’s existing incentive programmes, corresponding to approximately 3.9 per cent of the share capital and votes of the Company at the date of this notice (on a fully diluted basis). The fair value of the Programme cannot be reliably measured at this point in time. Therefore, the potential cost of the Programme for the Company reflected below is based on an estimated market price of the Company’s shares as at 1 March 2018. The Black & Scholes formula has been used for the valuation of the share options. The cost of the Programme will also be subject to the probability of exercise of the share options granted under the Programme, which is however not taken into consideration in the table below. Estimated market price of the Tranche 1 (EUR) Tranche 2 (EUR) TotalCompany’s shares as at 1 march (EUR)2018SEK 140 365,166 408,457 773,623SEK 160 417,332 466,809 884,141SEK 170 443,415 495,984 939,399 Agenda item 17; Resolution on amendments to the Memorandum and Articles of Association of the Company The Board of Directors proposes that the Meeting resolves to update the Memorandum & Articles of Association (“M&A”). For this purpose, a copy of the Company’s proposed revised M&A with the relevant changes marked up in redline version, are available on the Company’s website www.catenamedia.com. Given the Company’s contemplated listing on Nasdaq Stockholm, the main changes to the M&A are being proposed to reflect the provisions of the Shareholder Rights Directive (Directive 2007/36/EC), as transposed into the Listing Rules published by the Malta Financial Services Authority, which apply to Maltese companies whose shares are admitted to trading on a regulated market situated or operating within an EU Member State or a European Economic Area State. The other changes to the M&A are meant to reflect the current status of involvements in the Company and are meant to address any discrepancies between the contents of the Company’s Memorandum of Association and its Articles of Association and other requirements by the Registry of Companies in Malta. The business of the Meeting will therefore be to consider, and if thought fit, to adopt the following Extraordinary Resolutions: 1. That the proposed updated M&A of the Company, as made available on the Company’s website www.catenamedia.com, is hereby approved and adopted in its entirety; and 2. That any Director or the Company Secretary be and is hereby authorised to sign the updated M&A of the Company and handle its registration with the relevant authorities. Other The Company has 51,885,821 ordinary shares outstanding as at the date of this notice (one vote per ordinary share). The Nomination Committee’s complete proposals and a copy of the Company’s proposed revised M&A are available at the Company’s website www.catenamedia.com. The Consolidated Financial Statements (Annual Report) of the Company for the year ended 31 December 2016 together with the Directors’ Report and the Auditor’s report will be available on the Company’s website: www.catenamedia.com. Such documents will also be (a) sent to shareholders who so request and who inform the Company of their mailing address and (b) made available at the Meeting. * * * Malta in March 2017CATENA MEDIA PLC The Board of Directors For further information, please contact: Anne Rhenman Eklund, Head of IR and Communications, phone: +356 99 36 82 18, e-mail: anne.rhenman@catenamedia.com www.catenamedia.com The information was submitted for publication, through the agency of the contact person set out above on March 24, 2017 at 10.30 CET About Catena Media   Catena Media is a fast-growing online performance marketing and lead generation company within iGaming with portals like AskGamblers  and RightCasino . The Group has established a leading market position through strong organic growth and acquisitions in its core markets. Catena Media was listed on Nasdaq Stockholm First North Premier in February 2016. During 2016, the company’s revenues reached approximately EUR 40 million. The Group was founded in 2012 and has today about 200 employees. The Group Head Office is situated in Malta. The company’s certified advisor is Avanza. 

Farstad Shipping ASA – Signed plans to merge Solstad Offshore ASA, Farstad Shipping ASA and Deep Sea Supply Plc.

Skudeneshavn, Ålesund and Limassol, 24 March, 2017 Reference is made to previous announcements concerning the planned combination of Solstad Offshore ASA ("SOFF" or "Solstad"), Farstad Shipping ASA ("Farstad") and Deep Sea Supply Plc ("DESSC") as first announced on 6 February 2017, and most recently the announcement of 13 March 2017 regarding inter alia the status of the merger plans. The statutory merger plans have today been approved and signed by the boards of Solstad, Farstad, DESSC and Solstad's relevant subsidiaries, into which Farstad and DESSC will be merged. The exchange ratio for Farstad's shares is 0.028 SOFF shares per Farstad share (corresponding to 0.35:12.50). The exchange ratio for DESSC shares is 0.1052631578947368 SOFF shares per DESSC share (corresponding to 1.31578947368421:12.50). Each of Solstad, Farstad and DESSC will immediately after this release also issue a separate release which will contain the relevant technical details on the mergers. Assuming completion of the mergers and transactions ancillary thereto, the issued number of shares in SOFF is expected to be increased to 291,532,299 on the basis that the existing outstanding warrants in DESSC will be continued as warrants in SOFF, in total 1,052,631, instead of being exercised in DESSC. All shares will be of the same class. Aker Capital AS ("Aker"), a subsidiary of Aker ASA, will hold 58,496,302 shares representing 20.1 % of the shares and votes, and Ocean Yield ASA ("Ocean Yield"), a subsidiary of Aker, will hold 8,836,681 shares, representing 3.0 % of the shares and votes. The aggregate holding of Aker and Ocean Yield will be 67,332,983 shares, representing 23.1 % of the shares and votes. Hemen Holding Limited will hold 46,961,289 shares, representing 16.1 % of the shares and votes. The Solstad family will, through its related companies SOFF Invest AS and Ivan II AS, hold 21,066,965 shares, representing approximately 7.2 % of the shares and votes. On a consolidated basis, the Farstad family will hold a total of 4,470,909 shares, representing a consolidated holding of 1.5 % of the shares and votes. Ellen Solstad and Lars Peder Solstad of the Solstad family, who through their related companies hold shares in Solstad Offshore ASA, are a member of the board of directors and the Chief Executive Officer, respectively, of Solstad Offshore ASA. Mr. Frank Ove Reite, CFO of Aker ASA, is a member of the board of directors of Solstad Offshore ASA. Mr. Audun Stensvold, Investment Director of Aker ASA, is a member of the board of directors of Farstad Shipping ASA. *** For further information, please contact: Lars Peder Solstad, Chief Executive Officer of Solstad Offshore ASA at +47 913 18 585 or Sven Stakkestad, Deputy Chief Executive Officer of Solstad Offshore ASA at +47 905 15 802. Karl-Johan Bakken, Chief Executive Officer of Farstad Shipping ASA at +47 901 05 697 or Olav Haugland, Chief Financial Officer of Farstad Shipping ASA at +47 915 41 809 Anders Hall Jomaas, Chief Financial Officer of Deep Sea Supply Plc at +47 400 42 918 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Oncology Venture to evaluate Eisai oncology drug for in-license to 2X Oncology Inc.

“Oncology Venture is thrilled to work with Eisai and develop a Drug Response Predictor (DRP™) for the compound, and if successful, the drug will be in-licensed for further DRP™-guided clinical development as a precision therapy for Women’s Cancers in 2X Oncology Inc. – a co-owned spinout from Oncology Venture,” said Peter Buhl Jensen, M.D., CEO of Oncology Venture.   About the Drug Response Predictor (DRP™) biomarker platform Oncology Venture uses the Medical Prognosis Institute (MPI) multi gene DRP™ to select those patients that by the genetic signature in their cancer is found to have a high likelihood of response to the drug. The goal is to develop the drug for the right patients and by screening patients before treatment the response rate can be significantly increased. This DRP™ method builds on the comparison of sensitive vs. resistant human cancer cell lines including genomic information from cell lines combined with clinical tumor biology and clinical correlates in a systems biology network. The DRP™ is based on messenger RNA from the patients biopsies. The DRP™ platform (i.e. the DRP™ and the PRP™ biomarkers) can be used in all cancer types, and is patented for more than 70 anti-cancer drugs in the US. The PRP™ is used by MPI for Personalized Medicine. The DRP™ is used in Oncology Venture for drug development. For further information, please contact Ulla Hald Buhl, COO and                   Peter Buhl Jensen, CEOChief IR &     Or           Mobile: +45 21 60 89 22Communications    E-mail: pbj@oncologyventure.com Mobile: +45 2170 1049uhb@oncologyventure.com This information is information that Oncology Venture Sweden AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on March 24th 2017. About Oncology Venture Sweden AB Oncology Venture Sweden AB is engaged in the research and development of anti-cancer drugs via its wholly owned Danish subsidiary Oncology Venture ApS. Oncology Venture has an exclusive license to use the Drug Response Predictor (DRP™) technology in order to significantly increase the probability of success in clinical trials. DRP™ has proven its ability to provide a statistically significant prediction of clinical outcomes from drug treatment in cancer patients in 29 of the 37 clinical studies that were examined. The Company uses a model that alters the odds in comparison with traditional pharmaceutical development. Instead of treating all patients with a particular type of cancer, patients’ tumors’ genes are screened first with DRP™ and only those who are most likely to respond to the treatment will be treated. Via a more well-defined patient group, the risk and costs are reduced while the development process becomes more efficient. The current product portfolio: LiPlaCis® for Breast Cancer in collaboration with Cadila Pharmaceuticals, Irofulven developed from a fungus for prostate cancer and APO010 – an immuno-oncology product for Multiple Myeloma. Oncology Venture has spun out two companies in Special Purpose Vehicles: 2X Oncology Inc. a US based company focusing on Precision medicine for women’s cancers with a pipeline of three promising phase 2 product candidates and Danish OV-SPV 2 will test and potentially develop an oral phase 2 Tyrosine Kinase inhibitor.

Addnode Group continues European expansion and acquires Dutch company infostrait

Background and motive · Infostrait matches very well the TechniaTranscat strategy to grow by acquiring highly skilled Value-Added Resellers of Dassault Systèmes software in selected geographies, where the Benelux region (Belgium, The Netherlands and Luxemburg) with a population similar to the Nordics represents a growth opportunity. · As part of TechniaTranscat, Infostrait will have access to even broader competence and a larger number of consultants, making it possible for their customers to realize their PLM vision. · TechniaTranscat will after the transaction have more than 540 employees in Austria, Finland, Germany, India, Norway, Slovakia, Sweden and USA and combined net sales of SEK 804 million (2016). “Infostrait, a partner of us for many years is very customer focused, quality aware and agile in their business approach. It is with great pleasure that I welcome them to TechniaTranscat and I’m really looking forward to grow together in the Benelux area, expanding the 3DEXPERIENCE platform and TechniaTranscat footprint by providing measurable business improvements to our customers”, says Jonas Gejer, CEO of TechniaTranscat. “We are very excited to become part of the European leader in PLM. This gives us the possibility to bring the full capabilities of TechniaTranscat to our customers and to continue our growth journey in the Benelux region”, says Jaap Holweg, founder of infostrait and new Director for the Business Area Benelux within TechniaTranscat. Infostrait, with 18 employees and a revenue of SEK 25 million, will be a part of TechniaTranscat and business area Product Lifecycle Management. The acquisition has no conditions and completion is expected on April 3, 2017.

yA Bank issues NOK 400 million of senior unsecured bonds

Resurs Bank Group, a subsidiary to Resurs Holding AB (Nasdaq Stockholm: RESURS), has issued senior unsecured bonds of NOK 400 million on the Norwegian market. The 2 year bonds, issued by yA Bank AS, pays a coupon of 3m Nibor + 1.33% and will be listed on Nordic ABM. yA Bank is a wholly owned subsidiary to Resurs Bank AB. SEB Markets acted as bookrunners in the transaction. For additional information:  Per Kristian Haug, CFO yA Bank, pkh@ya.no, +47 95 23 87 17Peter Rosén, CFO Resurs Holding, peter.rosen@resurs.se +46 736 564 934Gunilla Wikman, Investor Relations Manager, gunilla.wikman@resurs.se  +46 707 638 125  About Resurs Holding The Resurs Group, which operates through subsidiaries Resurs Bank and Solid Försäkringar, is the leader in retail finance in the Nordic region, offering payment solutions, consumer loans and niche insurance products. Since its start in 1977, Resurs has established collaborations with over 1,200 retail partners with approximately 35,000 stores and built a customer base of approximately 5 million private customers in the Nordics. Resurs Bank has had a bank charter since 2001 and is under the supervision of the Swedish Financial Supervisory Authority. The Resurs Group, with operations in Sweden, Denmark, Norway and Finland, had 728 employees and a loan portfolio of approximately SEK 21,2 billion at the end of 2016. Resurs Group has been listed on Nasdaq Stockholm since 29 April 2016.

UTA biologist quantifying coral species’ disease susceptibility by examining immune traits

A biologist from The University of Texas at Arlington is leading a new study aimed at quantifying how susceptible coral species are to disease by examining their immunity through a series of novel experiments and approaches. Laura Mydlarz, associate professor of biology, is principal investigator of the project, titled “Immunity to Community: Can Quantifying Immune Traits Inform Reef Community Structure?”  and funded by a two-year, $220,331 grant from the National Science Foundation’s Division of Ocean Sciences. Co-principal investigators are Marilyn Brandt, research associate professor of marine and environmental science at the University of the Virgin Islands, and Erinn Muller, staff scientist at the Mote Marine Laboratory and Aquarium in Sarasota, Fla. During the past three decades, environmental changes – including global warming – have likely led to the sharp increase in coral disease in reefs around the world. Unhealthy coral reefs cannot support the fish and other forms of life that make reefs such vibrant and diverse ecosystems. Coral reefs in the Caribbean Sea are disease hotspots and many reefs have experienced population collapses due to outbreaks of disease, Mydlarz explained. Coral species vary in their susceptibility to disease, but the reasons behind this variation are unknown. “Coral diseases don’t affect all coral species in a reef the same,” Mydlarz said. “Some coral are more susceptible to certain diseases. A reef is made up of many different species of coral. If a disease kills off one species of coral in a reef, that’s going to greatly affect the reef community as a whole. We want to learn why some coral species are more tolerant of certain diseases.” The project will focus on coral reefs in the Caribbean off the U.S. Virgin Islands. The site was chosen due to the high diversity of coral found there and the presence of “white plague” disease, which can cause rapid tissue loss in corals, affects many coral species and can cause partial or total colony mortality. The project will use immune-challenge experiments that will quantify novel components of the innate immune system of corals, coupled with the application of a trait-based model, to fulfill three goals, Mydlarz said. The first is to determine variability of coral immune traits in seven common coral species found on Caribbean reefs; the second is to determine the variability in resistance to white plague disease transmission in the same coral species; and the third is to develop a predictive model of coral community assemblage that incorporates immune traits. The coral species which will be examined differ in disease susceptibility, growth rates and reproductive strategies. Susceptibility to white plague disease will be measured by exposing the corals to active white plague and calculating disease transmission rates in a laboratory setting. The immune responses of each species will be measured by exposing samples to bacterial immune stimulators. Samples will be collected and injected with lipopolysaccharides, which are molecules that elicit strong immune responses in some organisms. “We want to see the coral in its natural state and in an immune-stimulated state,” Mydlarz said. The immune response and disease transmission data for each coral species will be used to develop a predictive model to determine how different coral communities will respond to disease threats under climate change scenarios, she said. Mydlarz traveled to the Virgin Islands in October to visit the site where the research will be done and to meet with Brandt. She plans to return in June along with some of the graduate students from her laboratory to collect samples and conduct experiments. Clay Clark, professor and chair of the UTA Department of Biology, said the project is an example of the important work Mydlarz is doing to shed more light on the ties between climate change and the delicate ecosystems which have been adversely affected by that change. He noted that her research is a prime example of global environmental impact, which is one of the four pillars of the University’s Strategic Plan 2020 Bold Solutions|Global Impact.  “Dr. Mydlarz has been studying how environmental changes are affecting the ability of coral to fight disease for years and has contributed a great deal to our knowledge of coral immunity,” Clark said. “This research will add to that knowledge and help us to better inform and encourage conservation.” The research will be highlighted at outreach events in Texas, Florida and the Virgin Islands, including Earth Day Texas 2017, scheduled for April 22 at Fair Park in Dallas; the Living Reef Exhibit and Aquarium at Mote Marine Laboratory; and Reef Fest and agricultural fairs at Coral World Ocean Park in St. Thomas, U.S. Virgin Islands. Mydlarz earned bachelor’s and master’s of science degrees in Marine Biology from Florida Atlantic University in 1996 and 1998, respectively, and received her doctorate in Marine Science from the University of California at Santa Barbara in 2004. She did postdoctoral work in ecology at Cornell University from 2004-06 before joining UTA in 2006. Much of the research in her lab focuses on coral immunity and disease. About the College of Science The UTA College of Science is addressing the nation’s pressing need for a larger and better-prepared STEM workforce. The College has 42 undergraduate and graduate degree offerings in six departments and is equipping future leaders in science through award-winning classroom teaching and lab training. The College’s internationally acclaimed faculty is leading the way in innovative research and is finding solutions to some of the world’s most challenging problems. Visit www.uta.edu/cos to learn more about how the College of Science is changing the world through education and research. About The University of Texas at Arlington The University of Texas at Arlington is a Carnegie Research-1 “highest research activity” institution. With a projected global enrollment of close to 57,000, UTA is one of the largest institutions in the state of Texas. Guided by its Strategic Plan 2020 Bold Solutions|Global Impact , UTA fosters interdisciplinary research and education within four broad themes: health and the human condition, sustainable urban communities, global environmental impact, and data-driven discovery. UTA was recently cited by U.S. News & World Report as having the second lowest average student debt among U.S. universities. U.S. News & World Report lists UTA as having the fifth highest undergraduate diversity index among national universities. The University is a Hispanic-Serving Institution and is ranked as the top four-year college in Texas for veterans on Military Times’ 2017 Best for Vets list.          

ALLIANZ GLOBAL ASSISTANCE LAUNCHES INNOVATION INITIATIVES TO MAKE CLAIM PAYMENTS FASTER AND MORE FLEXIBLE

One of the most frequent complaints that insurance companies hear from customers involves the claims process.  Customers often feel that the process is too cumbersome, rigid and time consuming and doesn’t meet the needs of today’s on-the-go consumer.  In order to improve the claims filing process, Allianz Global Assistance USA , a leading travel insurance provider, has rolled out a suite of innovations and improvements to make filing a travel insurance claim and receiving payment faster and easier.  Among the innovations the company has launched are redesigned claim forms that are easier to understand and use, the option of selecting a direct deposit payment to the customer’s checking account, and the ability to use the company’s TravelSmart mobile app to file and track claims. Now when a customer files a claim, they can select their preferred payment method including direct deposit or receiving a check by mail.  A debit card deposit option will be available in May.  Selecting the direct deposit option reduces the time it takes to receive payment to as little as 1 or 2 days.  Currently about one-third of Allianz customers are choosing the direct deposit payment option when they file their claim. The company has made the claims forms more intuitive with an easier to understand look and feel.  The redesign should help customers complete the requested information faster, more accurately and with fewer questions.  The redesign should also help consumers avoid payment delays caused by incomplete claim forms. Consumers also now have the option to file travel insurance claims a number of ways, including on the company’s AllianzTravelInsurance.com website using any device, through paper forms or now through the company’s TravelSmart mobile app.  The TravelSmart app now includes a “Claims” button that can be used to file and track claims. The ability to file claims on mobile devices using easier to understand forms and selecting direct deposit should significantly reduce the time spent filing a claim and waiting for payment.  Some customers may receive payment within 48 hours of filing a claim. “We’re proud to roll out innovations that will reinvent the Travel Protection industry,” said Joe Mason, Chief Marketing Officer at Allianz Worldwide Partners USA.  “Now consumers can file travel insurance claims faster and easier and may be reimbursed almost immediately.  These improvements to the customer experience are just the beginning of the exciting innovations we have planned.” Allianz Global Assistance offers travel insurance through most major U.S. airlines, leading travel agents, online travel agencies, other travel suppliers and directly to consumers. For more information on Allianz Global Assistance and the policies offered for travelers, please visit: http://www.allianztravelinsurance.com.  # # # Allianz Global Assistance USA  Allianz Global Assistance USA (AGA Service Company) is a leading consumer specialty insurance and assistance company.  We provide insurance to over 25 million customers annually and are best known for our Allianz Travel Insurance plans. In addition to travel insurance, Allianz Global Assistance USA offers tuition insurance, event ticket protection, registration protection for endurance events and unique travel assistance services such as international medical assistance and concierge services. The company also serves as an outsource provider for in-bound call center services and claims administration for property and casualty insurers and credit card companies.  To learn more about Allianz Travel Insurance, please visit allianztravelinsurance.com or Like us on Facebook at Facebook.com/AllianzTravelInsuranceUS.  ** - Terms, conditions, and exclusions apply to all plans.  Plans are available only to U.S. residents.  Not all plans are available in all jurisdictions.  For a complete description of the coverage and benefit limits offered under your plan, carefully review your plan’s Letter of Confirmation/Declarations and Certificate of Insurance/Policy.  Insurance coverage is underwritten by BCS Insurance Company (OH, Administrative Office: Oakbrook Terrace, IL), rated "A-" (Excellent) by A.M. Best Co., under BCS Form No. 52.201 series or 52.401 series, or Jefferson Insurance Company (NY, Administrative Office: Richmond, VA), rated "A+" (Superior) by A.M. Best Co., under Jefferson Form No. 101-C series or 101-P series, depending on state of residence.  Allianz Global Assistance and Allianz Travel Insurance are brands of AGA Service Company.  AGA Service Company is the licensed producer and administrator of these plans and an affiliate of Jefferson Insurance Company.  The insured shall not receive any special benefit or advantage due to the affiliation between AGA Service Company and Jefferson Insurance Company.  Non-insurance benefits/products are provided and serviced by AGA Service Company.

Rovio Entertainment and Mikael Hed recognized with Hulda Award

The Angry Birds Movie is the most internationally successful Finnish film of all time – circling nearly $300 million in worldwide box office. It is also the second highest-grossing movie based on a game of all time. “Last year a delightfully high number of Finnish projects became international successes but there was never any deliberation as to who the winner was. The Angry Birds Movie’s stratospheric success set a new bar for what was possible for us Finns. It’s also a fantastic example of a best-case scenario of where an unwavering, well thought-out brand architecture can take you,” says Johanna Karppinen, CEO, Audiovisual Finland.“In addition to its financial success, the jury was impressed with how the film moved forward under Mikael Hed’s leadership. Its development process reflected determination and an ambitious vision, as well as courage to take large financial risks. The team had the foresight to gather the top international talents in the business whilst also making sure the knowledge capital was amassed and utilized in Finland,” Karppinen summarizes jury’s argumentation. The award will be presented by Finland’s Minister of Economic Affairs Mika Lintilä at the annual Finnish film industry event, Jussi Gaala, taking place on Friday, March 24. “We are extremely grateful for the recognition. The Angry Birds Movie production, led by Mikael Hed, and its worldwide success has been a remarkable and unique achievement for our company. The Angry Birds brand awareness is higher than ever,“ says Kati Levoranta, CEO, Rovio Entertainment, who will be accepting the award on behalf of Rovio Entertainment.

DNB has sold its part of Dakota Access Pipeline loan

“By selling our stake, we wish to signal how important it is that the affected indigenous population is involved and that their opinions are heard in these types of projects. Although there have been attempts at consultation by the project parties, the outcome of the process suggests that these have been inadequate," says Harald Serck-Hanssen, group executive vice president and head of Large Corporates and International in DNB.   DNB Asset Management chose to sell their mutual fund investments in the companies behind the pipeline in November 2016. Several other Norwegian financial institutions followed suit and have since also sold their investments. At that time, DNB communicated that a sale of the project financing was one of the options under review, but that such a sale would take longer than the sale of shareholdings. In the meantime, DNB has used its position as a lender to try to influence the process, call for a lower level of conflict and took the initiative to carry out an independent investigation of how indigenous people's rights are being safeguarded.  “During the process, we have met several interest groups and listened to their suggestions. We have met, among others, representatives from the Standing Rock Sioux Tribe. We have also engaged in an ongoing dialogue with the company building the pipeline. Many of our customers have contacted us and expressed what they expect from us as a Norwegian bank. In our evaluations, we have taken account of all the input we have received,” says Serck-Hanssen.  Following the sale of the loan, DNB no longer has any direct financial exposure to the Dakota Access Pipeline.  Press contacts:Even Westerveld, EVP, Corporate Communications tel. no. (+47) 400 16 744Pictures: https://dnbfeed.no/bildebank/harald-serck-hanssen/

Vattenfall Heat in major deal with GE Healthcare in Uppsala

GE Healthcare employs some 1,200 people in Uppsala and is investing MSEK 900 there to increase its production capacity. This expansion increases energy needs, and Vattenfall can now supplement the current deals with the supply of district cooling. The agreement runs for 10 years with volumes increasing every year up to 22 GWh. As the volume of energy supplied by Vattenfall increases, GE Healthcare will gradually reduce its own cooling production, leading for instance to a reduction in groundwater use in Uppsala. The deal is one of the biggest ever in Vattenfall Heat's history, and means closer collaboration with one of the most important customers in Uppsala. It is also a significant part of Vattenfall's endeavors to establish climate-smart solutions.   "The agreement shows that we have an in-demand, competitive product and that we are continuing our expansion of district cooling in Uppsala. There has been a high rate of expansion in recent years, and all the indications are that this growth is set to continue. It's positive to be able to offer solutions like this, with reduced environmental impact and increased resource efficiency, and this is in line with Vattenfall's overall objectives," says Jenny Larsson, Head of Vattenfall Heat in Sweden. District cooling is a cost-effective and eco-friendly option for integrating cooling in the manufacturing process. District cooling gives high levels of operational security and security of supply, and good comfort, with low maintenance requirements and without any need to handle refrigerants. Vattenfall is constructing a new cooling accumulator tank with a capacity of 40 MW to ensure it can supply GE Healthcare with this large volume of district cooling and continue the expansion of district cooling in Uppsala. The business deal also includes the construction of a new culvert to supply GE Healthcare. The project construction period is expected to be between six and eight months, but Vattenfall will begin supplying district cooling from 1 July 2017 using an interim solution. For GE Healthcare, the deal means ensuring a stable process, and having a single supplier of district heating, steam and district cooling facilitates an effective energy partnership.  "We are happy with this solution for our operations in Uppsala. Our production facility requires large energy resources and the collaboration with Vattenfall provides a safe, reliable, eco-friendly and sustainable supply solution," says Bo Lundström, Site Manager at GE Healthcare Life Sciences in Uppsala. For further information, please contact: Lars-Åke Linander, Press Officer Vattenfall, +46 (0)70 982 67 69 Adrian Berg von Linde, Head of Business Development Vattenfall Heat, +46 (0)70 246 71 49 Saara Nordenström, Press Officer GE Healthcare Life Sciences, +46 (0)73 868 12 86 From Vattenfall’s Press Office, telephone: +46 (0)8 739 50 10, email: press@vattenfall.com

TMG’s major stakeholders commit to an 'orderly market agreement' and four step growth plan for 2017 at Winter Summit

Stockholm, 27th March, 2017 – The Marketing Group (“TMG” or the “Group”) (ST: TMG, FRANKFURT: 2MG), a global network of creative agencies, agreed to enter into an orderly market agreement during its Winter Summit 2017, held 16-18 March. Under the agreement, agency management and Unity Group of Companies’ shareholders must first approach TMG before directly selling shares in the open market. In addition, summit attendees developed a four-point plan for greater collaboration and communications in order to fully leverage cross-agency opportunities for organic growth and develop new business streams and activities. Orderly market agreement An agreement was reached that sees all agency-level management and Unity Group of Companies personnel who received shares as part of their original acquisition arrangements to enter into an orderly market agreement that will last for three years from the point that their respective lock-ups expire. This means that all trades subject to the agreement will be considered in aggregate at any given time and, with the assistance of a reputable broker, TMG will help conduct divestments in a manner that will be least disruptive to the market. Four-point plan TMG’s 2017 Winter Summit focused on building on the core strategy, which is to bring together the best in global marketing expertise to develop a culture of creativity and entrepreneurialism. With a shared understanding that communications and collaboration are key drivers in underpinning agency-level organic growth, TMG agency management has devised a four-point plan to leverage the size and collective might of the network. This collaboration will see the Group: (1)     Refine the new business process. The new business teams from each agency around the world will be connected via a database and instant messaging tools to facilitate real-time communication about opportunities to work together. Regular new business meetings will also be held regionally to encourage more collaboration on a local level. As the Group grows, the agencies are learning more about one another and how they can work with their colleagues in the network to provide more value to clients. (2)   Unlocking economies of scale. Several opportunities around consolidated cost centres and Group purchasing have been identified. Combining the media purchasing power of the Group is a quick win and aligns to the ambition to develop a more comprehensive offering around media, data and insight. (3)   Improving internal communications. At the heart of collaboration is communication and the Group will be deploying a task force to drive this collaboration and implement the sharing of not only detailed credentials but also successes, and case studies, creating a shared resource that can be filtered by sector and by geography.  (4)   Sharing the Group, and subsidiaries’ achievements. Recognising the need for the market to fully understand the strengths of both the Group and its individual subsidiary agencies, improved internal communications (outlined above) will lead to greater external communications of successes with the market in the very near future. 2017 Winter Summit The three-day summit served primarily as a platform for key management of the Group’s direct agency-level subsidiaries to foster a greater understanding of Group-wide expertise and to deepen relationships with their peers and uncover areas of collaboration. It also provided an excellent opportunity for the new management team to get to know everyone and work with agency principals to develop the strategy for the Group and agree to the longer-term vision for building an agile, progressive marketing network.  -END- The information was submitted for publication, through the agency of the contact person set out above, at 07:00am CEST on 27th March 2017.  For more information, please contact Stella TanDirector of CommunicationsE-mail: ir@marketinggroupplc.comSwedenClaes Delin / Mikael WidellPhone: +46 703 11 9960E-mail: claes.delin@cordcom.se  SingaporeMalcolm Robertson / Tom EvrardPhone: +65 6831 7829 / 9850 1998E-mail: ftiunitygroup@fticonsulting.com  The Marketing Group in brief The Marketing Group plc is a global marketing network that comprises a portfolio of successful and independent subsidiary businesses brought together under a central, publicly-listed operating platform. Each company within the Group provides specialist marketing services and together form a global network of companies offering clients a full suite of services. The central operating platform supports its subsidiary companies with management and coordinating activities as well as a common publicly-listed investment vehicle. The Marketing Group is listed on Nasdaq First North Stockholm. www.marketinggroupplc.com. Mangold Fondkommission AB, +46 8-5030 15 50, is the company’s Certified Adviser and liquidity provider. 

Tieto introduces Forest Hub – the new ecosystem platform for digitalized wood and fibre supply

Tieto is introducing a new Forest Hub ecosystem platform that helps wood supply business partners in their operational data transfer regarding wood logistics and mill reception processes. Tieto Forest Hub seeks to improve daily operational planning and follow-up, management of the inventories, and information quality, while also decreasing the amount of manual work required and reducing errors. Tieto Forest Hub is open to all actors in the industry, from large forest industry companies to medium size and small businesses, including bioenergy producers. Two major forest products companies Metsä Group and UPM are implementing the Forest Hub this year. ”Efficient and modern two-way data transfer between us and our industrial partners and customers helps us serve them even better and also improves our own operational steering. System open to all actors is cost-efficient and enables predicted growth in data transfer”, says Olli Laitinen, SVP, Development, Metsä Group Wood Supply and Forest Services. “Tieto Forest Hub improves the forest industry logistics data transfer capabilities by connecting different wood supply business partners into a modern ecosystem. By implementing the Forest Hub we are able to improve the wood supply chain together with our partners,” says Tomi Simola, Director, Business Development, UPM Wood Sourcing and Forestry. Tieto sees, also beyond wood sourcing, great potential for similar hubs in the distribution of forest products, as well as in other industries relying on trading partners and logistics ecosystems. ”We are excited to help our customers to boost their business efficiency and provide an environment for new growth opportunities. Tieto Forest Hub offers service packages for actors of all sizes, from small entrepreneurs to large international companies. Because of this, we believe it will grow into an ecosystem platform on which future solutions and applications are developed and applied in wood and fibre sourcing”, says Jaakko Kuusisaari, Director, Wood & Fibre, Tieto. Tieto’s Forest Hub innovation is based on Business Information Exchange (BIX), which is a cloud service for B2B integration. Tieto BIX currently covers 1,500 direct customers, 26 sales partners, and exchanges close to 500 million transactions annually. By using this large scale B2B integration service as its core, Tieto Forest Hub can provide cost efficient and reliable services that meet the business continuity requirements of mission critical processes. For more information, please contact: Jaakko Kuusisaari, Director, Wood and Fibre Solutions, TietoTel.: +358 (0)40 501 5197 e-mail: jaakko.kuusisaari[at]tieto.com (jaakko.kuusisaari@tieto.com)  Kimmo Hannus, Director, Value Networks, TietoTel: +358 (0)40 524 5203 e-mail: kimmo.hannus[at]tieto.com (hannus@tieto.com) Tieto aims to capture the significant opportunities of the data-driven world and turn them into lifelong value for people, business and society. We aim to be customers’ first choice for business renewal by combining our software and services capabilities with a strong drive for co-innovation and ecosystems. www.tieto.com  

Eltel’s communication business wins new frame agreements for fibre deployment in Germany

The new agreements cover southern, western and southwestern operator regions of Germany. The scope of Eltel’s delivery is to build fibre networks with a variety of access points within these regions in the urban as well in the rural areas. The new agreements will support Eltel’s Communication business in Germany and are expected to provide new opportunities for further expansion in this market. Access to broadband for all citizens Fibre penetration in Germany is relatively low compared with most other European countries. The current technology is based on deploying fibre to the curb, i.e. to the street cabinet or pole, and utilizing high bandwidth copper technologies up to buildings and homes. The national digital agenda in Germany has ambitious targets for operators to invest in fibre. All citizens should get access to a minimum of 50Mbit/s data transfer speed. A recent study shows that approximately 80% of urban households have access to 50Mbit/s, while this applies to less than 20% of rural households. In addition to German operators’ own investment plans, a programme, called “Rural Initiatives” which is subsidized by the German government, has been initiated to boost this development. New ways of deploying larger broadband rollouts Measured by penetration of fibre, Sweden and Norway are the leading countries in Europe. Eltel is well positioned in the Nordic telecommunication sector and has achieved a leading position also in deploying larger fibre rollouts. Eltel has developed a rollout concept based on a unified process from planning and design, to fibre rollout and related services assurance and aims to offer this expertise also in the German market. Eltel’s concept is called Fibre Force. Eltel’s international footprint and experience in cross-border workforce management supports project resourcing with skilled and sufficient amount of technicians in the German market. Peter Uddfors – President Eltel Communication comments:“We are proud of this recognition of our competence and capacity to deploy fibre in Germany. With the vast experience, our industrialised concept and best practices developed during the fiberisation in the Nordics, we are now able to grow in Germany and aiming at a market leadership position also in this market”. For further information:Ingela UlfvesVP – Investor Relations and Group CommunicationsTel: +358 40 311 3009, ingela.ulfves@eltelnetworks.com Hannu TynkkynenDirector – External Communications and SustainabilityTel: +358 40 311 4503, hannu.tynkkynen@eltelnetworks.com This information is information that Eltel AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication through the agency of the contact persons set out above, at 8.00 CET on 27 March 2017. About EltelEltel is a leading European provider of technical services for critical infrastructure networks – Infranets – in the segments of Power, Communication and Transport & Security, with operations throughout the Nordic and Baltic regions, Poland, Germany, the United Kingdom and Africa. Eltel provides a broad and integrated range of services, spanning from maintenance and upgrade services to project deliveries. Eltel has a diverse contract portfolio and a loyal and growing customer base of large network owners. In 2016, Eltel net sales amounted to EUR 1.4 billion. The current number of employees is approximately 9,500. Since February 2015, Eltel AB is listed on Nasdaq Stockholm.

Ms. Saila Miettinen-Lähde appointed as CEO of Endomines AB

Endomines is pleased to announce the appointment of Ms. Saila Miettinen-Lähde, born 1962, as the new Chief Executive Officer of Endomines AB. Saila is an experienced leader with extensive experience including posts as Deputy CEO and CFO of Talvivaara Mining Company Plc during the period 2005 - 2015 and Board Membership in Outokumpu Oyj since 2015. Recently she has been working as the CFO for F-Secure, a cyber security company listed at Nasdaq Helsinki. Saila holds a Master of Science degree in engineering from the Tampere University of Technology. Saila will assume her position at Endomines AB on 1st of May 2017. “I am looking forward to contributing to the development and execution of a new strategy for the Company. We anticipate advancing our activities along the Karelian Gold Line and building significant value to our shareholders,” comments Ms. Saila Miettinen-Lähde. “I would like to congratulate Saila on her appointment. Saila is a proven leader and very capable of heading the Endomines team during the foreseeable necessary strategical changes,” Chairman of the Board Staffan Simberg comments. The CEO of Endomines AB Mr. Markus Ekberg, born 1957, will leave the company not later than on August 18, 2017. During the transition period Markus Ekberg will be available as a senior advisor for the Company.Mr. Markus Ekberg was appointed as CEO of Endomines in August 2009. “We would like to thank Markus for his considerable contribution to the Company during his time at the helm, particularly progressing the company from an exploration company to a gold mining company. We wish Markus well with his future endeavours,” comments Staffan Simberg, Chairman of the Board. In her role as CFO and Board member of Talvivaara Mining Company Plc, Saila Miettinen-Lähde has been prosecuted under Finnish law in two cases relating to security markets information offence and insider trading respectively during 2012 and 2013. The cases are still ongoing. The Board of Endomines has been duly informed of the prosecutions and the background by Saila Miettinen-Lähde and her lawyers and has full confidence in Saila Miettinen-Lähde and her ability to act as CEO of Endomines. The Board will follow the prosecutions closely and will ensure that any relevant updates are communicated to Endomines’ shareholders and the market For more information Staffan SimbergChairman of the Board of Endomines AB+358 50 020 92 16 Contact personsMarkus Ekberg, CEO of Endomines AB, tel. +358 40 706 48 50 and Börje Lindén, CFO of Endomines AB, tel. +46 8 611 66 45 This information is information that Endomines AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08:45 CEST on MARCH 27, 2017. -----------------------------------------------------------------------------------------------------------------------------------  About EndominesEndomines is a gold concentrate producer with mining, development and exploration operations in Eastern Finland along the 40 kilometer long Karelian Gold Line. Through various regulatory approvals, Endomines controls the exploration rights to this entire area. Endomines vision is to participate in the future structural transformation and consolidation of the Nordic mining industry. The Company may therefore be involved in acquisitions of interesting deposits or companies, should such opportunities arise. The shares trade on Nasdaq Stockholm (ENDO) and Nasdaq Helsinki (ENDOM). Company´s website www.endomines.com 

Albin Rännar will become the new Vice President and CFO of the subsidiary Seamless Distribution Systems (SDS)

Albin Rännar will become the new Vice President and CFO of the subsidiary Seamless Distribution Systems (SDS). His task will be to strengthen the work of preparing the company for the proposed spin-off and continued profitable growth as a stand-alone company. About Albin Rännar: Albin Rännar is 42 years old and until recently held the position as Head of Market Surveillance at the Swedish Shareholders’ Association, where he has been since 2013. Amongst his responsibilities was monitoring the listed companies from a quality perspective. Prior to that, Albin was an entrepreneur since the year 2002. He was co-founder and CEO of Nordic Investor Services, which offers advice to institutional shareholders on corporate governance. Albin is a Master of Science in Economics and Business from the Stockholm School of Economics, specialising in accounting and finance. He has also worked in the areas of venture capital, corporate finance and as a management consultant, both in Sweden and internationally. “I’m looking forward to be able to contribute with my experience and knowledge of orderliness and transparency in publicly listed companies. SDS is a stable, profitable company that processes electronic transactions in emerging markets and contributes to the creation of effective financial markets. This is FinTech that works, for the benefit of ordinary people. We have 675,000 resellers in 28 markets who have an opportunity to earn an income. This is profitable sustainability in emerging markets. It will be an exciting journey, piloting SDS to become a spinned-off, independent company that is valued on its own merits.” “We’re delighted to be able to complete the management team with the arrival of Albin as new Vice President and CFO ahead of the proposed departure from the Seamless Group and Seqr. Albin enjoys a high level of confidence among investors as an incorruptible scrutinizer of listed companies, so his engagement with us represents a hallmark of quality”, says Tommy Eriksson, CEO of SDS. A proposal will be put forward to the general meeting of the parent company on April 20 to authorise the board to decide on the sale of the subsidiary, either through a separate listing on Nasdaq First North or to a third party. Albin will assume the position of Vice President and CFO on April 5.  About Seamless Seamless is one of the world’s largest suppliers of payment systems for mobile phones. Founded in 2001 and active in 35 countries, Seamless handles more than 5.3 billion transactions annually through 675 000 active sales outlets. Seamless has three main business areas including the transaction switch, the technology provider for the distribution of e-products and the mobile payment platform Seqr. www.seamless.se Seamless Distribution AB, Box 6234, 102 34 Stockholm | Visiting address: St Eriksgatan 121 D | Org. no: 556610-2660 Phone: 08-564 878 00 | Fax: 08-564 878 23 | www.seamless.se

Kreditbörsen (the credit exchange) launches public peer-to-peer lending service for investors and borrowers

Kreditbörsen  now launches its service for investors and borrowers online focusing on P2P-lending. Kreditbörsen has been built out of the group of companies which are called LendyTech , which has been operating since 2011 to create better loan products for borrowers and better returns for investors. Kreditbörsen is unique in the way that it manages the complete lifecycle of a credit. To do that Kreditbörsen has created very efficient systems to manage the collection process which creates a whole experience for its customers. For the borrowers of Kreditbörsen the company offers responsible and simple processes from submitting applications to getting loans approved with risk adjusted interest rates and durations. The offering for investors is very advantageous since interest and amortization is paid out daily and then automatically lent out which creates an unbeatable compounding interest effect. This is the main factor that contributes to investors that use Kreditbörsen can achieve a higher return on capital than what otherwise has been possible.   Kreditbörsen does not obtain any income unless its investors make money. The borrower does not have to pay any fees for loans to be set up. The main income for Kreditbörsen is obtained from the interest that the borrowers are paying. This ensures that Kreditbörsen has an incentive to approve loans that does not fail during the full duration of the credit. The interests of Kreditbörsen is hereby harmonized with the interests of the investor and borrower. ”As in all our projects we want to build a stable base for the long term before we make any projects public in order to assume the main part of the risk ourselves. Kreditbörsen is no exception, we have built the whole operation from the ground with our own capital since 2011 with a very strong team. We started our lending business because of two things. We have for ourselves seen both sides of the coin. Throughout the years, we have been frustrated borrowers and unhappy investors, with Kreditbörsen we wanted to build a service that we could use ourselves to generate good and fair returns on our capital. All underwriting is associated with a certain level of risk where the interest levels are set in a responsible manner while considering the soft variables for the borrowers. My own background has mattered quite a bit in the creation of Kreditbörsen where I started my career as an entrepreneur in 1998 as a financial analyst, operated my own hedge fund in the US and an online broker in England. The result is an ecosystem within Fintech with Willebrand Invest  as a public investment company since 2010, Bricknode  as a developer of a financial platform since 2010 and the LendyTech  group within financial services since 2011. The launch of Kreditbörsen enables new ways of financing within the ecosystem where we can offer entrepreneurs and FinTech-companies that use the Bricknode Platform various types of capital.” says Stefan Willebrand, Founder & Chairman.

NORDIC NANOVECTOR ASA - FINANCIAL CALENDAR

Oslo, Norway, 27 March 2017 FINANCIAL YEAR 2017 Quarterly Report - Q1 - 24.05.2017Quarterly Report - Q2 - 23.08.2017Quarterly Report - Q3 - 22.11.2017 Annual General Meeting - 24.05.2017Capital Markets Day - 27.09.2017 The dates are subject to change. The time and location of the presentations will be announced in due time. For further information, please contact: IR enquiries:Tone Kvåle, Chief Financial OfficerCell: +47 91 51 95 76Email: ir@nordicnanovector.com About Nordic Nanovector:Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The company aspires to become a leader in the development of targeted therapies for haematological cancers. Nordic Nanovector’s lead clinical-stage candidate is Betalutin®, a novel CD37-targeting Antibody-Radionuclide-Conjugates (ARC) designed to improve upon and complement current options for the treatment of non-Hodgkin Lymphoma (NHL). NHL is an indication with substantial unmet medical need and orphan drug opportunities, representing a growing market forecast to be worth nearly USD 20 billion by 2024. The Company aims to rapidly develop Betalutin®, alone and in combination with other cancer therapies, for the treatment of major types of NHL, targeting first regulatory submission in relapsed/refractory follicular lymphoma in 1H 2019. Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets. The Company is also advancing a pipeline of ARCs and other immunotherapies for multiple cancer indications.Further information about the Company can be found at www.nordicnanovector.com Forward-looking statementsThis announcement may contain certain forward-looking statements and forecasts based on uncertainty, since they relate to events and depend on circumstances that will occur in the future and which, by their nature, will have an impact on Nordic Nanovector’s business, financial condition and results of operations. The terms “anticipates”, “assumes”, “believes”, “can”, “could”, “estimates”, “expects”, “forecasts”, “intends”, “may”, “might”, “plans”, “should”, “projects”, “will”, “would” or, in each case, their negative, or other variations or comparable terminology are used to identify forward-looking statement. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied in a forward-looking statement or affect the extent to which a particular projection is realised. Factors that could cause these differences include, but are not limited to, implementation of Nordic Nanovector’s strategy and its ability to further grow, risks associated with the development and/or approval of Nordic Nanovector’s products candidates, ongoing clinical trials and expected trial results, the ability to commercialise Betalutin®, technology changes and new products in Nordic Nanovector’s potential market and industry, the ability to develop new products and enhance existing products, the impact of competition, changes in general economy and industry conditions and legislative, regulatory and political factors. No assurance can be given that such expectations will prove to have been correct. Nordic Nanovector disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. This information is subject to a duty of disclosure pursuant to Section 5-12 of the Securities Trading Act.

ASETEK – New Datacenter Customer in South Korea

Asetek today announced confirmation of an initial order from Intech & Company, Inc., based in Seoul, South Korea, a new customer for our datacenter business. “I am delighted to have Intech & Company come onboard as a new customer. As we continue to expand our datacenter business, I am particularly pleased to have a partner with such strong potential for growing our business in South Korea,” said André Sloth Eriksen, CEO and founder of Asetek. "In Asetek we have found a partner with strong potential for future growth. We are excited to be able to bring Asetek's pioneering liquid cooling technology to our customers and strengthening the datacenter business together," said Jum Sik Kim, CEO of Intech & Company, Inc. This initial order is for sealed loops and therefore comes without Asetek’s standard RackCDU infrastructure. Asetek expects the business with Intech & Company to grow to include both sealed loops and RackCDU/D2C products going forward. This order will result in revenue to Asetek in the range of USD 25,000 with delivery in Q2 2017. About Intech & Company, Inc.Intech & Company, Inc. distributes PC and server components, EMC storage products, and APC power supplies in South Korea. It also provides IT solutions and services for customers. The company was founded in 1981 and is based in Seoul, South Korea. For more information, visit www.intechn.com About AsetekAsetek (ASETEK.OL) is the global leader in liquid cooling solutions for data centers, servers and PCs. Founded in 2000, Asetek is headquartered in Denmark and has operations in California, Texas, China and Taiwan. Asetek is listed on the Oslo Stock Exchange. For more information, visit www.asetek.com For further information, please contact:      André S. Eriksen, Chief Executive OfficerMobile: +45 2125 7076, e-mail: ceo@asetek.com

Notice of Annual General Meeting in Transcom WorldWide AB (publ)

Stockholm, 27 March 2017 The shareholders of Transcom WorldWide AB (publ), reg. no. 556880-1277, (the “Company” or “Transcom”) are hereby invited to the annual general meeting on Wednesday 26 April 2017 at 10.00 at Gjörwellsgatan 30, 2nd floor in Stockholm. Right to attend the annual general meeting and notification Shareholders who wish to attend the annual general meeting must: i) be registered in the share ledger maintained by Euroclear Sweden AB on the record day, which is on Thursday 20 April 2017. Shareholders whose shares are registered in the name of a nominee must no later than on Thursday 20 April 2017 temporarily register the shares in their own name in order to be entitled to participate at the general meeting; ii) notify the Company of their intention to attend the general meeting no later than on Thursday 20 April 2017. Notice of participation shall be sent by e-mail to agm@transcom.com or by regular mail to Transcom WorldWide AB, Box 34220, 100 26 Stockholm (kindly mark the envelope “AGM”). Upon notification, the shareholders should state their full name, personal identification number or registration number, address and telephone number, and, where applicable, details of representatives, proxy holders and advisors. In order to facilitate the registration at the general meeting, a shareholder who wishes to be represented by proxy should, well before the meeting, provide the Company with a written and dated proxy. If the proxy is issued by a legal entity, a certified copy of the registration certificate or corresponding document shall be enclosed. Forms of power of attorney are available at the Company’s website, www.transcom.com. Proposed agenda 1.  Election of chairman of the general meeting.  2.  Preparation and approval of voting list.  3.  Approval of the agenda.  4.  Election of one or two persons who shall approve the minutes of the meeting.  5.  Determination of whether the general meeting was duly convened.  6.  Submission of the annual report and the auditors’ report as well as the consolidated financial statements and the auditors’ report for the group.  7. Resolutions regarding the adoption of the income statement and the balance sheet as well as the consolidated income statement and the consolidated balance sheet.  8. Resolutions regarding allocation of the Company’s profits or losses in accordance with the adopted balance sheet.  9. Resolutions regarding discharge of the members of the board of directors and the managing director from liability. 10. Determination of the number of members of the board of directors. 11. Determination of fees for members of the board of directors. 12.  Election of the members and the chairman of the board of directors. 13.  Adoption of guidelines for remuneration to senior executives. 14. Closing of the meeting. Proposals for resolutions Item 1: Election of chairman of the general meeting Altor AB which, following its public offer to the shareholders of Transcom, holds more than 90 percent of the shares and votes in the Company, proposes that Carl Svernlöv, attorney at law, at Baker & McKenzie Advokatbyrå KB is appointed as chairman of the general meeting. Item 8: Resolutions regarding allocation of the Company’s profits or losses in accordance with the adopted balance sheet The board of directors proposes that all funds available for the annual general meeting shall be carried forward. Items 10-12: Determination of the number and election of members of the board of directors as well as determination of fees for members of the board of directors The Company has been informed that Altor AB intends to provide the Company with proposals in respect of items 10-12 well in advance of the annual general meeting. The Company will announce these proposals as soon as they have been provided to the Company.. Item 13: Adoption of guidelines for remuneration to senior executives The board of directors proposes that the annual general meeting resolves to adopt guidelines for remuneration to senior executives in accordance with the following: The remuneration to the senior executives shall consist of a well-balanced combination of fixed salary, variable cash remuneration and/or long term incentive programs, pension benefits and other benefits. Performance targets for variable remuneration may be quantitative and/or qualitative and shall aim to fulfill Transcom’s long term strategy. Variable cash remuneration shall not exceed the fixed salary. Pension benefits shall as far as possible be defined contribution. The managing director’s and the other senior executives’ notice period shall be a maximum 18 months. Fixed salary during notice periods and severance pay are together not to exceed an amount equivalent to the individual’s fixed salary for two years. In special circumstances and in a certain case, the board of directors may deviate from these guidelines. The total amount of remuneration granted directly or indirectly by Transcom to the senior executives is fully described in the Notes to the consolidated financial statements of Transcom, as disclosed in its Annual Report for 2016 which is available at Transcom’s website, www.transcom.com. Number of shares and votes The total numbers of shares and votes in the Company on the date of this notice are 26,916,584, of which 26,322,212 are ordinary shares and 594,372 are shares of series C. Each share (regardless of series) represents one vote. The Company does today own 108,594 ordinary shares and all 594,372 issued shares of series C. The Company will not exercise voting rights connected to the shares held in the Company’s custody. Miscellaneous Accounts, audit report and auditor statement regarding the guidelines for remuneration to senior executives,  will be available at the Company at Gjörwellsgatan 30 in Stockholm and at the Company’s website www.transcom.com, at least three (3) weeks in advance of the annual general meeting and will be sent to shareholders who request it and provide their e-mail or postal address. The shareholders are reminded of their right to request information at the annual general meeting from the board of directors and the managing director in accordance with Ch. 7 § 32 of the Swedish Companies Act. Stockholm in March 2017 Transcom WorldWide AB (publ) The board of directors -------------------- For further information, please contact: Johan Eriksson, President and CEOTelephone +46 70 776 80 22 Ulrik Englund, CFOTelephone +46 70 286 85 92 Stefan Pettersson, Head of Group CommunicationsTelephone +46 70 776 80 88

Ripasso Energy publishes annual report for 2016

In 2016, Ripasso Energy saw major progress. A framework agreement with our Italian-based partner and customer Horizon was entered, allowing us to develop a clear strategic path for the commercialization of our product. The agreement itself stipulates a maximum of 600 engines annually and during the last six months of 2017, we are expecting an order of the first 100 units for delivery in 2018. Moreover, in the first half of 2017, a facility will be constructed at the university of Palermo for demonstration purposes. The past year has further brought significant technological development, in particular with regard to our hybridization technology. We have successfully demonstrated that our Stirling engine can be powered with alternative fuels, complementing the sun when it is not available. This puts us in a unique position as the sole supplier of a renewable-based solution that can reliably provide electricity at any time of day or year. The development in this department has been so substantial that in March 9, 2017, we filed a total of three patent applications to the European Patent Office (EPO). The protection offered by these patents will serve to reinforce our leading position in our business field. Last year was also the year Ripasso Energy became a public company. Following an over-subscribed stock emission, the company was listed at NGM Nordic MTF in Stockholm and traded for the first time on November 28, 2016. The listing has resulted in over 3000 new shareholders and provided us with sufficient funds to now have the capitalization requirements covered well in to 2018. As the company was made public, an agreement with Finwire Media was entered in late 2016. Together with them, we will produce a number of videos detailing the progress of the company. The purpose of this is to provide shareholders with periodic updates of the current matters in Ripasso Energy and as of today, two such movies have been made available. They can be viewed at: https://ripassoenergy.com/en/media/. In addition to these videos, the company is also participates in a number of shareholders’ meetings and fairs, most recently InvestorDagen in Copenhagen with an estimated 1500 visitors. In March of 2017, the first shareholder visit to our production facility in Sibbhult, Sweden was arranged, with approximately 20 attendees. Since the year-end report was published February 14, 2017, the annual report has been adjusted in order to be in line with the rules for large companies in the K3 regulations. Consequently, the expenses of the company are gross reported in the income statement and the capitalized expenditures for development work is a separate item of revenue. An equivalent adjustment has been made to the comparative figures of 2015. Gross reporting in this way does not affect the previously reported operating profits. The annual and audit report are available either as an attachment to this release or under Financial reports on the webpage of Ripasso Energy, https://ripassoenergy.com/en/financial-reports/. For additional information with respect to this press release, please contact Ripasso Energy’s CEO and founder Gunnar Larsson, e-mail: ir@ripassoenergy.com. For more information about the company, visit: https://ripassoenergy.com/. This information is information that Ripasso Energy is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out above, at 10:00 on March 27, 2017.

Annual General Meeting in Capio AB (publ)

1. RIGHT TO PARTICIPATE IN THE ANNUAL GENERAL MEETING Shareholders who wish to participate in the AGM must: firstly, be registered in the share register maintained by Euroclear Sweden AB no later than Wednesday 26 April 2017, and secondly, notify the company of their intention to attend the AGM under the address Capio AB, c/o Euroclear Sweden, “Annual General Meeting”, P.O. Box 191, SE-101 23 Stockholm, by calling +46 8 402 91 36, weekdays between 9:00 a.m. and 4:00 p.m., or at the website www.capio.com no later than Wednesday 26 April 2017. In connection with notification, shareholders must state their name, address, telephone number (daytime), personal or corporate identity number and information concerning their shareholding. Shareholders or proxies for shareholders at the AGM may take a maximum of two representatives with them to the AGM. Representatives may be brought to the Meeting only if the shareholder gives notice of their attendance as described above for notification of participation of shareholders. For shareholders who will be represented by proxy at the AGM, the original version of a signed and dated power of attorney must be enclosed with the notification. A form for the power of attorney is available on the company’s website, www.capio.com and will be sent by mail on request to shareholders who state their address. For those representing a legal entity, a verified copy of the registration certificate or corresponding document showing the company’s signatories must also be submitted. In order to be entitled to participate in the AGM, shareholders whose shareholding is registered in the name of a trustee must re-register their shares in their own name at Euroclear Sweden AB. Shareholders who require such re-registration should notify their trustee well in advance of Wednesday 26 April 2017, when such re-registration must have been completed. 1. AGENDA OF THE ANNUAL GENERAL MEETING Proposal for agenda 1. Opening of the Meeting. 2. Election of Chairman of the Meeting. 3. Preparation and approval of the list of shareholders entitled to vote at the Meeting. 4. Approval of the agenda. 5. Election of one or two persons to approve the minutes of the Meeting. 6. Determination of whether the Meeting has been duly convened. 7. The Managing Director’s report.  8. Report on the work of the Board of Directors and the Committees of theBoard of Directors. 9. Presentation ofa)   the annual report and the auditors’ report, as well as the consolidated financial report and auditors’ report on the consolidated financial report for the financial year 2016, b)  statement from the company’s auditor confirming compliance with the remuneration guidelines for the CEO and other senior managers that have applied since the preceding AGM, andc)   the Board’s proposal for appropriation of the company’s profit and the Board’s motivated statement thereon.10. Resolutions regardinga)   adoption of the income statement and the balance sheet, and of the consolidated income statement and the consolidated balance sheet, all as per 31 December 2016,b)  appropriation of the Company’s profit as set forth in the balance sheet adopted by the Meeting and the record date for dividend distribution, andc)   discharge of the Board of Directors and the Managing Director from personal liability for the financial year 2016.11. Determination of the number of members and deputy members of the Board.12. Determination of the fees to be paid to the Board members and auditor.13. Election of members of the Board.14. Election of auditor.15. Proposal for remuneration guidelines for the CEO and other senior managers.16. Proposal for a resolution regarding amendment of the Articles of Association. 17. Closing of the Meeting. Proposals Election of Chairman of the Meeting (Item 2) The Nomination Committee appointed in anticipation of the 2017 AGM, comprising Robert Furuhjelm (Nordic Capital Fund VI), Chairman, Joakim Rubin (Zeres Capital), Per Hesselmark (R12 Kapital), Per Colleen (Fjärde AP-fonden), Bo Lundgren (Swedbank Robur fonder) and Anders Narvinger (Chairman of the Board) has proposed that the Chairman of the Board, Anders Narvinger, be elected Chairman of the 2017 AGM. Proposed appropriation of the Company’s profit (Item 10 b) The Board proposes that a dividend of SEK 0.9 per share be declared and that the record date for the dividend shall be 5 May 2017. If the AGM so resolves, the dividend is expected to be distributed by Euroclear Sweden AB on 10 May 2017. Proposals regarding election of Board members, auditor and fees (Items 11-14) The Nomination Committee proposes the following: -         The number of Board Members shall be eight, without deputies.-         Directors’ fees shall be paid as follows: SEK 1,100,000 to the Chairman of the Board, SEK 400,000 to each of the other Board Members elected by the AGM who are not employed by the company. As remuneration for committee work, the chairman of the Finance and Audit Committee shall receive SEK 150,000 and each member of the Finance and Audit Committee SEK 50,000, the chairman of the Remuneration Committee shall receive SEK 50,000 and member of the Remuneration Committee SEK 50,000 and the chairman of the Medical Quality Committee shall receive SEK 150,000 and member of the Medical Quality Committee SEK 75,000. An additional compensation of SEK 20,000 per meeting in person for travelling time will be offered to Pascale Richetta and Michael Flemming.-         Re-election of Board Members Gunnar Németh, Fredrik Näslund, Birgitta Stymne Göransson, Pascale Richetta and Michael Flemming and new election of Michael Wolf, Gunilla Rudebjer and Karl Åberg as ordinary members of the Board. Anders Narvinger and Gun Nilsson have declined reelection.-         Election of Michael Wolf as the Chairman of the Board. Michael Wolf (born 1963) was previously President & CEO of the Swedish/Baltic banking group Swedbank AB (publ). Prior to joining Swedbank, Michael was President & CEO of Intrum Justitia AB and before that he held several different leading positions at the insurance company Skandia, including the positions CEO of Skandia Group Germany, CIO of Skandia Group and Executive Vice President, Head of Division Europe & Latin America. Michael is currently Chairman of the Stockholm Chamber of Commerce and the Anna Lindh Academy. Michael holds a Degree in Business Administration from Stockholm University. Gunilla Rudebjer (born 1959) is currently Partner at Blomqvist & Rudebjer HB. Gunilla has extensive experience from the service industry and has held several positions as Chief Financial Officer in both public and private companies, such as Scandic Hotels, Cision, Parks & Resorts Scandinavia, Mandator and TUI Nordic (Fritidsresor). Gunilla is currently a board member and Chairman of the audit committee in Ambea AB. Gunilla holds a M.Sc. in Business Administration and Economics from Stockholm School of Economics. Karl Åberg (born 1979) is currently Partner at Zeres Capital, based in Stockholm. Prior to establishing Zeres Capital, Karl was a Partner at CapMan and before that he worked in the Investment Banking department of Handelsbanken Capital Markets. Karl is currently a board member of Eltel. Karl holds a M.Sc. in Business Administration and Economics from Stockholm School of Economics. The Finance and Audit Committee has proposed the re-election of the registered auditing firm EY as the company’s auditor for a period of one year and that the fees to the auditors shall be payable according to contract. The Nomination Committee proposes election of auditor in accordance with the recommendation of the Finance and Audit Committee, whereby it is noted that the auditing firm has notified that, if the auditing firm is re-elected, the authorised public accountant Mikael Sjölander will be appointed principally responsible auditor. Proposal for remuneration guidelines for the CEO and other senior managers 2017(Item 15) The Board of Directors proposes that the AGM 2017 adopts guidelines for remuneration to the CEO and other senior managers in accordance with the following. These guidelines concern the remuneration and other terms of employment for the CEO and other senior managers. Senior managers include Group Management. The guidelines are valid for employment agreements entered into after the approval of the guidelines by the AGM, and for changes made to existing employment agreements thereafter. Remuneration to the CEO and other senior managers will include fixed salary (base salary), possible variable remuneration, other benefits and pension. The variable compensation comprises (i) an individual annual variable compensation, and may also, as a supplement, include (ii) a long-term incentive program. The total remuneration should correspond to market conditions and be competitive in the senior manager’s relevant labor market. Fixed salary and variable remuneration is to be linked to the manager’s responsibility and authority. The annual variable salary for the CEO and the other members of the management may not amount to more than 60 percent of the fixed annual gross salary. The variable remuneration is to be based on the outcome of predetermined objectives and, as far as possible, be linked to the growth in value of the Capio share, from which the shareholders benefit. Programs for variable remuneration shall be designed in such a way as to enable the Board of Directors, if exceptional economic conditions prevail, to restrict or omit payment of the variable remuneration if such action is deemed reasonable and consistent with the company’s responsibility towards shareholders, employees and other stakeholders. In order to establish a long-term perspective in the decision-making and to ensure long-term achievement of goals, the Board of Directors may propose the general meeting to resolve on long-term incentive programs. The program participants shall be nominated based on, i. a. competence and performance. The outcome shall be dependent on the fulfillment of certain predetermined performance requirements. The aim of the Group’s long-term incentive programs shall be to create a long-term commitment to Capio, to offer the participants to take part in Capio’s long-term success and value creation and to create possibilities to attract and retain members of the management and key employees. In the event of termination of employment, the notice period should not exceed 12 months. The right to severance payment, which shall only be payable if the termination is initiated by the company, should not exceed 12 months, and include a reduction of other income during the period. Consequently, the combined notice period and period during which the employee is entitled to severance payment should not exceed in aggregate 24 months. Pension benefits should if possible be defined by contribution but may also be defined by benefit, or by a combination thereof, and should entitle the senior manager to pension payments from the age of 65 at the earliest, unless local regulations provide otherwise. Variable remuneration shall not be included in the base when calculating pension unless local regulations provide otherwise. Matters of remuneration for the CEO shall be prepared by the Remuneration Committee and be resolved by the Board of Directors. The remuneration for senior managers who report directly to the CEO shall be prepared by the Remuneration Committee and can also be resolved by the Remuneration Committee. The Board of Directors may derogate from the guidelines in certain cases if there are special reasons for doing so. Special reasons may include, for example, offering to members of the senior management who reside outside Sweden terms that are competitive in their country of residence. Proposal for a resolution regarding amendment of the Articles of Association (Item 16) The Board of Directors proposes that the object of the company’s business is clarified. The Board of Directors thus proposes that the Annual General Meeting resolves to amend § 3 in the Articles of Association in accordance with the following: Current Proposed wording § 3wording § 3The objects The company shall, directly or through subsidiaries,   conductof the work within healthcare and medical care, provide subsidiariescompany’s with   services mainly regarding administration and governance,business and conduct other   activities compatible therewith.are to,directly orindirectly,  own andmanage realand movablepropertysuch asreal estateandsecurities,  and anyotheractivitiescompatibletherewith. The validity of a resolution in accordance with the aforementioned is conditional upon the support of shareholders representing at least two-thirds of both the votes cast and the shares represented at the Meeting. C.         NUMBER OF SHARES AND VOTES IN THE COMPANY The total number of shares and voting rights in the company is 141,159,661. D.         AVAILABLE DOCUMENTATION The Annual Report and the auditor’s statement, including the Board’s proposal for remuneration guidelines for the CEO and other senior managers, as well as the auditors’ statement regarding whether the guidelines have been complied with and the Board’s complete proposal concerning Items 15 and 16, as well as the Board’s motivated statement to the proposal for dividend distribution according to Item 10 b) will be available for the shareholders at the company’s office in Gothenburg no later than Wednesday, 12 April 2017. Copies of the documents will be sent to those shareholders who request to receive such information and who have provided their address. They will also be available on the company’s website www.capio.com and at the AGM. E.         INFORMATION AT THE ANNUAL GENERAL MEETING At the AGM, the Board and the Managing Director shall, if requested by a shareholder and the Board considers that it can be done without material damage to the company, provide information regarding issues that may (i) affect the assessment of an item on the agenda, (ii) affect the assessment of the company’s or a subsidiary’s financial situation or (iii) concern the company’s relation to another group company. A shareholder may send questions in advance by mail to Capio AB, ”AGM 2017”, P.O. Box 1064, SE-405 22 Gothenburg, Sweden, or by email to agm@capio.com. Gothenburg in March 2017 CAPIO AB (publ) Board of Directors

Saab and Loomis Group sign Global Framework Agreement for a Secure Transport Logistic System

The framework agreement consolidates already existing agreements between Saab and Loomis Group and includes the use of the TRACK and TRACE system in four new markets. “We are excited about this new agreement and look forward to continuing our successful partnership with Loomis to jointly develop and deliver their key operational system across their global operation. Our solution will support them in consolidating their systems portfolio and standardising their operational procedures and support. The agreement also supports expansion into new markets,” says Jonas Hjelm, head of Saab business area Support and Services. Saabs offers a system called TRACK and TRACE that provides customers with a secure logistic solution for different kinds of transportation. With this solution a user can gain full control over their logistic services through a work-order based system that manages, monitors and measures all services provided for the end customer. The system also creates an operational audit trail from commitment start to final execution, which facilitates having full control throughout the entire transport logistics chain. The system can also be used on mobile platforms. For further information, please contact:Saab Press Centre,+46 (0)734 180 018presscentre@saabgroup.com www.saabgroup.com www.saabgroup.com/YouTube Follow us on twitter: @saab  Saab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers’ changing needs.

Altor initiates compulsory redemption and Transcom will be delisted

Stockholm, 27 March 2017 On 13 March 2017, Altor AB (“Altor”), announced that they will complete the public takeover offer to the shareholders of Transcom WorldWide AB (publ), (”Transcom” or the ”Company”). After completion of the offer, Altor holds more than 90 percent of the shares and votes in Transcom and has notified Transcom’s board of directors that Altor has resolved to call for compulsory redemption of the remaining shares in the Company.  In light of the above, Transcom’s board of directors no longer finds it motivated for the Company to remain listed and has therefore applied for delisting of the Company’s shares from Nasdaq Stockholm. Nasdaq Stockholm has approved the application and resolved that the last day of trading in the Transcom share will be Monday 10 April, 2017.    The change in ownership has triggered a change of control clause in the Company’s long-term incentive programs (LTIP 2014, 2015 and 2016), and Transcom’s board of directors has therefore, in accordance with the terms of the programs, resolved to replace the estimated number of shares to be vested by a cash payment to the participants amounting to approximately EUR 1.3 million in total. --------------- The information was submitted for publication at 3:30 PM CET on March 27, 2017. For further information, please contact: Johan Eriksson, President and CEOTelephone +46 70 776 80 22 Ulrik Englund, CFOTelephone +46 70 286 85 92 Stefan Pettersson, Head of Group CommunicationsTelephone +46 70 776 80 88

Holmen AGM - Dividend of SEK 12.00 per share

The AGM re-elected Fredrik Lundberg, Carl Bennet, Lars Josefsson, Lars G. Josefsson, Carl Kempe, Louise Lindh, Ulf Lundahl, Henrik Sjölund and Henriette Zeuchner. Fredrik Lundberg was re-elected Chairman of the Board. KPMG AB was re-elected as company auditors. Joakim Thilstedt, authorised public accountant, has been appointed principal auditor. The AGM resolved in favour of mandating the Board for the period until the next AGM to make decisions to buy back the company’s own shares via the stock market. Acquisitions may be made of up to so many Class B shares that the company’s own shareholding does not exceed 10 per cent of all shares in the company at any time. The Board was also mandated to make decisions to use bought-back shares as settlement for acquisitions or to finance such acquisitions. The 2016 AGM gave the Board a corresponding mandate. Excerpt from President and CEO Henrik Sjölund's speech to the AGM: “Holmen is a company with its own forest and profitable industries, with forest and hydro power accounting for two-thirds of its assets. Together with large-scale production of paperboard, paper and wood products in well invested plants, this provides stable profitability that will increase over time. At the same time, our business brings substantial climate benefits, as it reduces the amount of carbon dioxide in the atmosphere by over two million tonnes per year.” The address to the AGM by Henrik Sjölund, President and CEO, is available on our website www.holmen.com For more information, please contact:Ingela Carlsson, Communications Director, Holmen, tel. 46 702 12 97 12 This information is information that Holmen AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 27 March 2017 at 17.20 CET.

Study proves wood’s positive impact on human beings

We spend, on average, 90 per cent of our lives indoors. This means that the air quality and indoor temperature not only affects our health, but also our quality of life. But exactly in what way and how much has previously not been mapped out. In order to fill this gap in existing research, an international research project was initiated in 2014 in which a number of wood industry companies and universities participate. The final report was presented at a seminar at Linköping University at the beginning of March 2017. Scientists engaged in the project state in the report that wood has superior strength in proportion to its weight, is easy to work with, renewable and widely accessible. It is quick to work with, promotes good conditions at the building site, is flexible and provides designers with a great scope of freedom. Furthermore, wood binds and stores carbon dioxide, evens out indoor humidity and can be recycled. When we, for example, have a shower or cook food on our stoves, it contributes to increased indoor humidity. Wood absorbs this - and later, when it becomes drier, emits humidity – a process that has been studied with a thermocamera.  ”Apart from the purely technical properties, we have also measured the emotional aspects of using wood in health care institutions, for example, through using focus groups in different countries. It’s interesting to note that wood is perceived in the same way – regardless of culture – i.e. natural, warm and cosy. It has a calming effect, as well as good acoustic and air properties,” says Mark Hughes, Professor at the Aalto University in Finland and project coordinator of Wood2New. The overall goal of the project was to contribute to creating competitive and sustainable wood based interior products and systems for modern wood constructions through: · Identifying opportunities and limitations for using wood interior elements · Examining if, and how wood may affect human health · Developing, designing and evaluating concepts for sustainability, value-adding, multifunctional wood based interior products and systems · Developing business models based on the acquired facts of how wood affects health The research project has been conducted, apart from the Aalto University, also at the Linköping University, Holzforschung Austria, Norsk TreTeknisk Institutt (Norway), Building Research Establishment Ltd (UK) and Technisches Büro für Chemie - Dr. Karl Dobianer (Austria). ”We were lucky to be able to engage such committed partners in Europe, including Kährs Group,” says Mark Hughes. The project is part of the international program WoodWisdom-Net+ Research, aimed at strengthening the competitiveness and sustainability of Europe’s forest and wood industry by developing long-term cooperation between different players. Read more about the project on www.wood2new.org For more information, please contact:  Bruce Uhler, Environmental Ambassador, Kährs Group, tel: +46 70 253 04 76 Helén Johansson, Corporate Communication, Kährs Group, tel: +46 70 364 60 30 Mark Hughes, Professor, Aalto University in Finland, tel: +358 50 512 2615 About Kährs GroupKährs Group is a world-leading flooring manufacturer in hardwood and resilient flooring with a number of strong brands in its product portfolio, including Kährs, Karelia and Upofloor. The Company's innovations have shaped the industry throughout history and Kährs Group is dedicated to providing the market with innovative new flooring solutions. Kährs Group, which delivers products to more than 70 countries, is the market leader in Sweden, Finland, Norway and Russia and holds a strong position in other key markets, such as the UK and Germany. The Group has approximately 1,600 employees and annual sales of EUR 300 million. www.kahrsgroup.com

Nordea Economic Outlook: Optimism in uncertain times

In a new forecast Nordea expects the global economy to grow by 3.5 per cent this year and 3.7 per cent in 2018 after 3.1 per cent in 2016. This is slightly higher than the winter forecast from December. The more benign forecast stems from an upgrade of the outlook for the advanced economies amid the increasing political uncertainties surrounding the business environment including the upcoming French elections, the Brexit negotiations and doubts about Donald Trump’s economic policy, says Nordea’s Group Chief Economist, Helge J. Pedersen. The outlook for the Nordic countries has also improved over the past months. 2017 seems to be yet another year with growth of about 3 per cent for the Swedish economy. Growth is rather broad-based with increasing domestic demand and exports. The benign financial conditions for households should largely persist. However, we expect house prices to level out later this year. Bottlenecks are an increasing problem, but still wages are not rising at the usual pace in a tight labour market. Growth in the mainland economy is gaining momentum in Norway. Oil investments continue to fall, but at a slower pace. Meanwhile, low interest rates, NOK weakness and an expansionary fiscal policy should boost both private and public demand and mainland exports in 2017. Growth in employment should pick up in the coming years, but so will labour supply. Thus, it will take time before unemployment drops significantly. Wage growth will remain low and inflation will be well below the 2.5 per cent target. The crisis is over and the Danish economy is now in a phase where available resources in the labour market are gradually being depleted. Still, growth is not high enough to suggest overheating. Capacity shortage could, however, limit the future growth potential. Growth will mainly be driven by private consumption and gradually rising investment activity. Also, higher global growth should improve conditions for Danish exporters. The Finnish economy is finally enjoying a tailwind. GDP growth in 2016 continually exceeded expectations and the economy recorded the highest growth rate in five years. Economic sentiment has improved a lot, consumer confidence is close to a record high, and risks appear significantly more balanced. Employment will improve moderately and unemployment continues to fall. More robust global growth suggests realistic chances for positive surprises in foreign trade. Read Economic Outlook http://ndea.mk/EO1702DLeng For further information:Helge J. Pedersen, Group Chief Economist, Tel: +45 55 47 15 32 | Mob: +45 22 69 79 12E-mail: helge.pedersen@nordea.com

Listing of Actic on Nasdaq Stockholm

Not for disclosure, distribution or publication, directly or indirectly, in or into the US, Australia, Canada, Hong Kong, Japan, New Zealand, South Africa or Singapore. · The price per share in the Offering is SEK 50.50, corresponding to a value of the total number of outstanding shares in Actic upon completion of the listing of approximately SEK 803 million. · The Offering comprises 8,613,860 shares, of which 5,346,534 are newly issued shares offered by the Company and 3,267,326 are shares offered by Actic International S.à.r.l. (the “Principal Owner”) which is owned by the IK 2007 Fund. · The newly issued shares are expected to provide the Company with gross proceeds of approximately SEK 270 million before deduction of costs related to the Offering. The Company intends to use the proceeds to repay certain outstanding loans and thereby decrease the Company’s indebtedness, which creates a financial flexibility and enables continued acquisitions. · In order to cover possible overallotments, the Principal Owner has further undertaken to sell additional shares corresponding to a maximum of 15 percent of the number of shares comprised by the Offering (the “Over-Allotment Option”), entailing a maximum of 1,287,128 shares. · Given full exercise of the Over-Allotment Option, the Offering will comprise 9,900,988 shares, corresponding to approximately 62 percent of the total number of shares outstanding in the Company after completion of the Offering. · Athanase Industrial Partner, Swedbank Robur and Fjärde AP-fonden (the “Cornerstone Investors”) have committed, subject to certain conditions, to acquire shares corresponding in total to approximately 31 percent of the total number of shares in the Offering (given full exercise of the Over-Allotment Option), which corresponds to approximately 19 percent of the total number of shares in the Company after completion of the Offering. · A prospectus will be published today on Actic’s website and SEB’s website for prospectuses, as well as on Nordnet’s website on 29 March 2017. · The first day of trading is expected to be around 7 April 2017. Christer Zaar, President and Chief Executive Officer, comments: “I would like to convey my sincerest gratitude to all the employees who have contributed to the company’s success over the past few years. The stock exchange listing, which will result in increased recognition of our brand and offering, among other benefits, comprises a key milestone in the company’s development. Actic’s management anticipates further strengthening of market positions through new establishments and acquisitions, in parallel with the continuous development of our offering to our members.” Erik Lautmann, Chairman of the Board, comments: “Actic has a track record of growth, good profitability and ability to generate cash flow. The company has every possibility of continuing on its established path. The Board believes the time has come for a stock exchange listing and looks forward to continuing to develop and expand the company as a listed entity.” Kristian Carlsson Kemppinen, Partner at IK Investment Partners and advisor to the IK 2007 Fund, comments: “Under the ownership of the IK 2007 Fund, Actic has grown, both organically and through strategic acquisitions, into one of the leading companies in the Nordic gym market. We believe that Actic has reached the appropriate time to diversify ownership with the aim of promoting the company’s future development and expansion.” Stefan Charette, Chief Executive Officer of Athanase Industrial Partner, comments: "Actic is a well-managed company with a strong focus on a high quality customer proposition, strategic partnerships and growth. The company has expanded in a consistent way and Athanase Industrial Partner is looking forward to becoming one of the larger shareholders in the planned IPO. Athanase will actively support the company, also through board representation, in its future development and expansion." Financial targets and dividend policy Actic has adopted the following medium-term financial targets: · Growth: Average yearly organic growth of at least 5 percent, with additional growth from acquisitions. · Profitability: Adjusted EBITDA margin of more than 20 percent in the medium term. · Capital structure: Net debt/adjusted EBITDA ratio below 3.0x in the medium term. · Dividend policy: A dividend rate of 30 to 50 percent of annual net income. However, decisions pertaining to future dividends must take into consideration the Company’s financial position, cash flows and future prospects. Cornerstone Investors The Cornerstone Investors have, subject to certain conditions, undertaken to acquire shares corresponding in total to approximately 31 percent of the total number of shares in the Offering (given full exercise of the Over-Allotment Option), which corresponds to 19 percent of the total number of outstanding shares in the Company after completion of the Offering. The Cornerstone investors are Athanase Industrial Partner (7.5 percent of the total number of outstanding shares in the Company after completion of the Offering), Swedbank Robur (6.0 percent) and Fjärde AP-fonden (5.8 percent). As part of the agreement with Athanase Industrial Partner, the Principal Owner has undertaken to vote in favour of Stefan Charette, representative of Athanase Industrial Partner, being elected as board member of the Company at the annual shareholders’ meeting of the Company to be held on 11 May 2017. Background and reasons for the Offering Since 2012, Actic has been owned by the IK 2007 Fund through Actic International S.à.r.l. In order to facilitate Actic’s continued growth and development, Actic and the Principal Owner believe the next natural step to promote Actic’s continued development and expansion is a stock exchange listing. Actic is expected to benefit from the listing in terms of more diverse ownership in the Company, which will provide access to Swedish and international capital markets. The listing is expected to increase recognition of the Company’s brand and offering, and thereby strengthen its market position and continued growth. Prospectus A prospectus, containing the Offering’s complete terms and conditions, will be published today on Actic’s website (www.acticgroup.com ) and SEB’s website for prospectuses (www.sebgroup.com/prospectuses) as well as on Nordnet’s website (www.nordnet.se) on 29 March 2017. Applications can be made through SEB’s internet banking service and Nordnet’s internet service. The first day of trading in the Company’s shares is expected to be around 7 April 2017. Preliminary timetable Application period for the general 29 March-5 AprilpublicApplication period for institutional 201729 March-6 Aprilinvestors 2017First day of trading on Nasdaq Stockholm 7 April 2017Settlement date 11 April 2017 Advisors SEB is acting as Global Coordinator and Joint Bookrunner. Carnegie and DNB Markets are acting as Joint Bookrunners. Vinge is legal adviser to Actic. White & Case is legal adviser to the Global Coordinator and Joint Bookrunners. For more information, please contact: Niklas Alm, Head of Investor Relations, Actic Telephone: + 46 708 24 40 88 Email: niklas.alm@actic.se Mikaela Hedborg, Communications Manager, IK Investment Partners Telephone: +44 77 87 573 566 Email: mikaela.hedborg@ikinvest.com About Actic Actic (formerly Nautilus Gym) was founded in 1981 and launched the Gym & Swim club concept. The company began its international expansion in 1995 and as per 31 December 2016, Actic had 166 facilities and about 211,000 members in five countries. Actic’s main markets are Sweden, Norway, Finland as well as Germany and Austria. Actic is one of Sweden’s leading operators and operated 118 clubs in Sweden as of 31 December 2016. In Actic’s business model the majority of Actic’s facilities are located at a public swimming hall with access to swimming included in the Actic membership. Actic operates four types of facilities. Full-service clubs, with gym and swimming facilities operated by Actic’s own personnel; Gym & Swim clubs, where the fitness facilities are operated by Actic and the swimming facility is operated by an external partner; Stand-alone clubs, where Actic’s personnel exclusively operate fitness facilities and In-house clubs, where the fitness and pool facilities are operated by external personnel. Actic offers a well-established exercise method known as high-intensity training (HIT) and offers its members personal training programmes including follow-up sessions with trained instructors. Together with swimming, this forms the core of Actic’s offering and differentiates the Company in the market. The range of exercise options is extensive and includes strength training, group classes and personal training (PT), which attracts a broad target group that builds up successful clusters of Gym & Swim clubs as well as Stand-alone clubs in the Nordics and Germany. Actic’s vision is to create a healthier society by attracting a broad target group and thereby expanding the market. The facilities engage in the local community to contribute to a healthier society. Actic, which has its head office in Solna, Stockholm, has approximately 700 full-time equivalent employees and had net sales of SEK 802 million in 2016. Actic is led by its President and CEO Christer Zaar. Strengths and competitive advantages · Distinct Gym & Swim club concept · An added-value offering that appeals to a wider target group · Strong position in small to mid-sized towns · Strong local positions attained through cluster strategy · Partnerships with municipalities · Flexible operational model with low risk profile About IK Investment Partners IK Investment Partners (“IK”) is a Pan-European private equity firm focused on investments in the Nordics, DACH region, France, and Benelux. Since 1989, IK has raised more than EUR 9 billion of capital and invested in over 100 European companies. IK funds support companies with strong underlying potential, partnering with management teams and investors to create robust, well positioned businesses with excellent long-term prospects. For more information, visit www.ikinvest.com. Athanase Industrial Partner Athanase Industrial Partner (“Athanase”) is a value investor that adds an ownership focus to its investments through board representation. The Athanase Industrial Partner team have a long tradition as active owners in listed companies. Athanase was founded in 2014 by Stefan Charette, former chief executive officer of, for example, Creades, Öresund and Custos. Athanase’s investors include Swedish and international institutions. Swedbank Robur Swedbank Robur is one of Scandinavia’s largest fund managers and a wholly owned subsidiary of Swedbank. Swedbank Robur offers savings alternatives for retail and institutional clients through mutual funds and discretionary asset management. Fjärde AP-fonden Fjärde AP-fonden (the Fourth Swedish National Pension Fund) is a Swedish government authority with the mission of contribution to the stability of the retirement pension system through the management of the fund capital to the highest possible return with low risk. The fund is focused on creating long-term returns through active management and at the end of 2016 the fund had SEK 334 billion under management. Important information This announcement does not contain or constitute an offer to sell or a solicitation of any offer to buy or subscribe for any shares or securities in the Company. This announcement has not been distributed, and will not be distributed or by other means released in the United States, Australia, Canada, Japan or any other jurisdiction in which such distribution would be unlawful or would require registration or other measures. This material does not comprise an offer for sale of securities in the United States. Securities may not be offered for sale or sold in the United States absent registration with the United States Securities and Exchange Commission or an exemption from registration under the U.S. Securities Act of 1933, as amended (the “Securities Act”). The Company does not intend to register any part of the Offering in the United States or to conduct a public offering of the securities in the United States. Any securities sold in the United States will be sold only to qualified investors (as defined in Rule 144A under the Securities Act) pursuant to Rule 144A. This announcement is an advertisement and is not a prospectus for the purposes of Directive 2003/71/EC (this directive, together with any amendments therein and any applicable implementing measures in any Member State under this directive, is hereinafter referred to as the “Prospectus Directive”). A prospectus prepared pursuant to the Prospectus Directive will be published, which, when published, can be obtained from the Company. Investors should not subscribe for any securities referred to in this announcement except on the basis of information contained in the prospectus. In any EEA Member State other than Sweden that has implemented the Prospectus Directive, this communication is only intended for and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive, i.e., only to investors who can participate in the Offering without an approved prospectus in such EEA Member State. This announcement is only being distributed to and is only directed at (i) persons who are outside the United Kingdom; (ii) investment professionals falling within Article 19(5) of the UK Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons in (i), (ii) and (iii) above together being referred to as “relevant persons”). The securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in, only with relevant persons. Any person who is not a relevant person should not act or rely on this announcement or any of its content. Matters discussed in this announcement may constitute forward-looking statements. Forward-looking statements are all statements that do not pertain to historical facts and events, and statements that are attributable to the future and may be identified by words such as “deem”, “assess”, “expect”, “await”, “wait”, “judge”, “assume”, “predict”, “can”, “will”, “shall”, “should or ought to”, “according to estimates”, “consider”, “may”, “plan”, “potential”, “calculate”, “as far as is known” or similar expressions suitable for identifying information that refers to future events. This applies in particular to statements referring to future results, financial position, cash flow, plans and expectations for the company’s operations and management, future growth and profitability, general economic and regulatory environment, and other circumstances which affect the company. Forward-looking statements are based on current estimates and assumptions, which are based on the company’s current intelligence. Such forward-looking statements are subject to risks, uncertainties and other factors which may result in actual results, including the company’s financial position, cash flow and profits, deviating considerably from the results which expressly or indirectly form the basis of, or are described in, the statements, or may result in expectations which, expressly or indirectly, form the basis of or are described in the statements not being met or turning out to be less advantageous compared to the results which, expressly or indirectly, formed the basis of or were described in the statements. The Company’s business is exposed to a number of risks and uncertainties which may result in forward-looking statements being inaccurate or an estimate or calculation being incorrect. Therefore, potential investors should not place undue reliance on the forward-looking statements herein and are strongly advised to read the sections of the prospectus that include a more detailed description of factors which have an effect on the company’s business and the market in which the company operates. The information, opinions and forward-looking statements contained in this announcement speak only as at its date, and are subject to change without notice.

Notice of the Annual General Meeting of Coor Service Management Holding AB

The shareholders of Coor Service Management Holding AB are invited to participate in the annual general meeting to be held on Thursday, May 4, 2017 at 3 p.m. at Kista Entré, Knarrarnäsgatan 7, Kista, Stockholm, Sweden. Registration commences at 2.15 p.m. and refreshments will be served. Registration and notification Shareholders who wish to participate in the annual general meeting must · be recorded in the share register kept by Euroclear Sweden AB on Thursday, April 27, 2017, and · give notice of intent to participate to the company not later than on Thursday, April 27, 2017. Shareholders who are private individuals may register on the Company’s website www.coor.com, by phone +46 (0) 771-24 64 00, or in writing to the following address: Computershare AB, "Coor Service Management Holding AB:s Annual General Meeting", P.O. Box 610, SE-182 16 Danderyd, Sweden. Representatives for legal entities shall give notice to attend by phone at +46 (0) 771-24 64 00, or in writing to the following address: Computershare AB, "Coor Service Management Holding AB:s Annual General Meeting", P.O. Box 610, SE-182 16 Danderyd, Sweden. The notice of attendance should state the shareholder’s name, personal or organization identification number, address, telephone number and the number of assistants attending (if any). Shareholders represented by proxy should submit a copy of the proxy and other documents of authority to the company prior to the annual general meeting. The proxy shall be presented in the original at the meeting. Proxy forms in Swedish and English are available on the group’s website, www.coor.com. Shareholders that have their shares registered in the name of a nominee must, in addition to giving notice of participation in the meeting, temporarily be recorded in the share register in their own names (so called voting-rights registration) to be able to participate in the annual general meeting. In order for such registration to be effectuated on Thursday, April 27, 2017, shareholders should contact their bank or trustee well in advance of that date. Proposed agenda 1. Opening of the meeting. 2. Election of a chairman of the meeting. 3. Preparation and approval of the voting list. 4. Approval of the agenda. 5. Election of one or two persons who shall approve the minutes. 6. Determination as to whether the meeting has been duly convened. 7. Presentation of the annual report and the audit report as well as the consolidated accounts and the audit report for the group. 8. Speech by the president and CEO, Mikael Stöhr. 9. Presentation of the work of the board of directors and the work within the remu-neration, audit and project committees.10. Resolutions regarding:a.  the adoption of the income statement and the balance sheet and the consoli-dated income statement and the consolidated balance sheet,b.  allocation of the company’s profits in accordance with the adopted balance sheet,c.  discharge from liability for the members of the board of directors and the president and CEO,11. Presentation by the chairman of the nomination committee.12. Determination of fees for members of the board of directors and auditors.13. Determination of the number of members of the board of directors and the number of auditors and deputy auditors.14. Election of the members of the board of directors, chairman of the board of direc-tors as well as auditors and deputy auditors.15. Resolution on remuneration guidelines for group executive management.16. Closing of the meeting Proposals by the nomination committee (items 2 and 12-14) The nomination committee in respect of the 2017 annual general meeting has consisted of Jan Andersson (Swedbank Robur Funds), Ulrika Danielson (the Second AP Fund), Jan Särlvik (Nordea Funds), Malin Björkmo (Handelsbanken Funds) and the chairman of the board Anders Narvinger. The nomination committee has proposed the following. Item 2           Anders Narvinger as chairman of the annual general meeting. Item 12         Fees to the board of directors elected by the annual general meeting and not employed by the company as well as fees for committee work in accordance with the following: · Board member: SEK 250,000 · Chairman of the board of directors: SEK 700,000 · Board member who is a member of the audit committee: SEK 100,000 · Chairman of the audit committee: SEK 150,000 · Board member who is a member of the remuneration committee: SEK 50,000 · Chairman of the remuneration committee: SEK 50,000 · Board member who is a member of the project committee: SEK 75,000 · Chairman of the project committee: SEK 100,000 It is proposed that the fee for board members who are members of the project committee be increased from SEK 50,000 to SEK 75,000 and that the fee for the chairman of the project committee be increased from SEK 50,000 to SEK 100,000. The remaining proposed fees are unchanged in comparison with the fees decided at the previous annual general meeting. Fees to the auditor shall be paid in accordance with approved invoices. Item 13         Seven board directors and no deputies. One auditor and no deputies. Item 14         Election of Anders Ehrling as board member (new election). Re-election of Mats Granryd, Mats Jönsson, Monica Lindstedt, Kristina Schauman, Heidi Skaaret and Mikael Stöhr as board members. New election of Mats Granryd as chairman of the board of directors. Anders Narvinger and Sören Christensen, who have been chairman of the board of directors since 2008 and member of the board of directors since 2011, respectively, have declined re-election. In accordance with the recommendation by the audit committee, re-election of Öhrlings PricewaterhouseCoopers AB as auditor. Anders Ehrling, born 1959, has recent previous experience as CEO and President of Braathens Regional Airlines (BRA). Previous positions include CEO and President of Scandic Hotels and several senior positions within SAS, including President of SAS Sverige. Anders Ehrling is chairman of the board of directors of Nordic Cinema Group and board member of Parks & Resorts Scandinavia AB. Information regarding the proposed board members is available at the company’s website, www.coor.com. The board’s proposal on dividend and record date (item 10b) The board of directors proposes a dividend for 2016 of SEK 3.00 (whereof SEK 1.55 is ordinary and SEK 1.45 extra dividend) per share and Monday, May 8, 2017, as record date for the dividend. Subject to resolution by the annual general meeting in accordance with this proposal, the dividend is expected to be distributed by Euroclear Sweden AB on Thursday, May 11, 2017. The board’s proposal on remuneration guidelines for the Coor group executive management (item 15) The board of directors proposes that the annual general meeting resolves to adopt the following guidelines for the remuneration of senior executives for the period until the 2018 annual general meeting. The remuneration of group executive management is to comprise fixed salary, possible variable salary, pension and other benefits. The total remuneration package should be based on market terms, be competitive and reflect the individual’s performance and responsibilities, and as regards a possible long-term variable remuneration, the value growth of the Coor share benefitting the shareholders. The variable salary may comprise yearly incentives in cash and long-term incentives in cash, shares and/or share-based instruments in Coor. Variable salary in cash is conditional upon the fulfillment of defined and measurable goals and should be maximized to 50 per cent of the annual fixed salary. Terms and conditions for variable salary should be designed so that the board, if exceptional economic circumstances prevail, has the option of limiting or refraining from payment of variable salary if such a measure is considered reasonable. In specific cases, agreements may be reached regarding one-off remuneration amounts provided that such remuneration does not exceed an amount corresponding to three months of the individual’s fixed salary, and is not paid more than once per year and individual. Pension benefits should be defined contribution. Normally, severance payment is made when employment is terminated by the company. Members of group executive management may have a period of notice of not more than six (6) months, in combination with severance pay corresponding to at maximum eighteen (18) months fixed salary. No severance payment will be made when employment is terminated by the employee. The board is entitled to depart from the guidelines resolved on by the annual general meeting if, in an individual case, there are special reasons for this. The group of senior executives encompassed by the guidelines comprises the President and CEO and other members of group executive management. Shares and votes There are in total 95,812,022 shares in the company. The company has only one series of shares and the total number of votes in the company thus amounts to 95,812,022. The company does not hold any treasury shares. Information at the AGM The board of directors and the President and CEO shall, if any shareholder so requests and the board of directors believes that it may be done without material harm to the company, provide information regarding circumstances that may affect the assessment of an item on the agenda, circumstances that can affect the assessment of the company’s or its subsidiaries’ financial situation and the company’s relation to other companies within the group. Shareholders wishing to submit questions in advance may send them to Coor Service Management Holding AB, Attn: General Counsel Erik Strümpel, Knarrarnäsgatan 7, SE-164 99 Kista, Sweden. Documents The annual report, the auditor’s report, the board of directors’ statement pursuant to Chapter 18, Section 4 of the Swedish Companies Act relating to the proposal under item 10b above, and the auditor’s statement pursuant to Chapter 8, Section 54 of the Swedish Companies Act regarding the remuneration guidelines for the group management will be available at the company, Coor Service Management Holding AB, Knarrarnäsgatan 7, SE-164 99 Kista, Sweden and on the website www.coor.com, as from April 11, 2017. The documents will also be sent to shareholders who so request and state their address.    Stockholm in March 2017Coor Service Management Holding AB (publ)The board of directors

Vattenfall’s Annual and Sustainability Report 2016: “Power Climate Smarter Living”

This can be read in Vattenfall’s 2016 Annual and Sustainability Report (corporate.vattenfall.se), which was published today. “A more sustainable energy system is currently being created as the electricity market continues its shift towards fossil-free generation. This system is closer to customers and combines efficient, large-scale production with decentralised solutions. Today we are exceptionally well positioned to develop Vattenfall’s business in line with these trends,” comments Magnus Hall, President and CEO of Vattenfall. Vattenfall’s new investment plan for the period 2017–2018 reflects a distinct strategic shift, where most growth investments will be made in wind power, solar energy and electricity distribution. Total investments for the period will amount to SEK 50 billion, of which SEK 28 billion pertain to growth investments. Of this total, planned investments in onshore and offshore wind power will amount to SEK 17 billion, with a tangible increase in investments in solar energy. Reduce climate footprintVattenfall’s strategy is also based on the premise that increased electrification can help reduce the climate footprint of the transport sector, industry, and heat production. “In collaboration with cities, industries and other parties we are developing smart solutions and services that are making it possible for our customers to reduce their climate impact,” says Magnus Hall. “Examples are charging infrastructure for e-vehicles and electric hybrid buses, new solutions for production of heat, biofuels that can replace oil and gas, new technology that will enable fossil-free steel and concrete production, and Europe’s first web-based service for sharing locally produced renewable energy.” A large step in the strategy to create a sustainable energy portfolio was taken with the divestment in 2016 of the lignite operations in Germany. Through this sale Vattenfall’s fossil-based production decreased from approximately 50% of total in 2015 to 25% in 2016. Parallel with this, the company’s CO2emissions decreased from 83.8 million tonnes to 23.7 million tonnes. Vattenfall discloses this information pursuant to the Swedish Securities Market Act.  For further information, please contact:Johan Sahlqvist, Head of Investor Relations, tel.: +46 8 739 72 51Markus Friberg, Director Media Relations Nordic, tel. +46 70 2613084 Issued by Vattenfall’s Press Office, telephone: +46-8-739 50 10, e-mail: press@vattenfall.com Facebook: facebook.com/vattenfallpressrum ; Twitter: twitter.com/Vattenfall_Se   Vattenfall is a Swedish, state owned energy company with around 20,000 employees with operations in Sweden, Germany, the Netherlands, Denmark, UK and Finland. Vattenfall focuses on growth in business areas that drive the transition to a renewable energy system and has the objective to become leading in sustainable energy production and thereby secure a reliable and cost effective energy supply.

Scania reports a 40% increase in sales of vehicles that run on alternative fuels and hybrids

The number of vehicles that Scania sold that run on alternative fuels and hybrids increased by 40 percent in 2016, a proof point of the company’s efforts to lead the shift towards a sustainable transport system. In total, close to 5,000 such vehicles were sold in 2016. “The demand for vehicles that support the shift to sustainable transport is growing and so is the demand for services that support fleet owners in reducing fuel consumption, and consequently also both carbon emissions and cost. This proves that sustainability and profitability go hand-in-hand,” says Henrik Henriksson, President and CEO of Scania. Almost 40,000 of Scania’s customers’ drivers were trained in fuel-efficient driving in 2016. This is a year-on-year increase of 30 percent. Ecolution by Scania is another area that has shown significant growth. A consultancy service that on average saves 12 percent in fuel and CO2 emissions for customers, the number of Ecolution by Scania contracts signed in 2016 increased by 37 percent from 2015, to more than 2,700. For more than 25 years, Scania has produced commercial biofuel solutions, and today the company provides the largest variety of engines for alternative fuels on the market. For more information on the key performance indicators through which Scania measures its work within sustainability, read the Annual and Sustainability Report , pages 128-129. For further information, please contact: Karin Hallstan, Public Relations Manager, email karin.hallstan@scania.com, phone +46768428104

Pressrelease: Mobile spirometry company, Pond Healthcare Innovation AB, raises capital from Investment AB Spiltan

Stockholm, March 28th, 2017 Pond Healthcare Innovation AB, the company behind the Air Smart Spirometer, announced today capital for an undisclosed amount from Investment AB Spiltan. Håkan Sjunnesson, Spiltan’s Investment Manager will join the Company’s Board of Directors, alongside Dan Mangell and Lorenzo Consoli. The financing will be used to strengthen the team, the product development and commercial efforts. The Air Smart Spirometer is the first ultra-portable spirometer connected to a smartphone. Launched in Europe in 2016, Air Smart has very quickly reached strong success in the market, with thousands of units sold among physicians and patients in over 20 countries. The device won numerous design awards including the Red Dot Award and the design S award in 2016. Air Smart could measure all the parameters that a professional spirometer can measure, but at a fraction of the cost, just 69 Euro. Spirometers have been traditionally bulky and complex devices used in hospital settings by trained personnel. Air Smart has demystified spirometry bringing it directly to the hands of patients and physicians worldwide. "Due to the compelling design, affordable price and ease of use, Air Smart has rapidly gained a leadership position in the fast-growing market of portable spirometers," says Håkan Sjunnesson. "We are very excited to work with Lorenzo and his talented team to build a global company with the vision to improve the life of people with lung problems.” “Spiltan is a perfect match for us, because they are a long-term investor who really understood and married our vision” says Lorenzo Consoli, CEO of Pond Healthcare Innovation. “We want to empower respiratory patients to live a more active life, and the development of Air Smart is the first step to achieve our vision. Whether you have cystic fibrosis, Asthma or COPD, understanding how and why your lung health changes over time is extremely relevant. With Air Smart patients can check their lung health anytime and adjust their medication and lifestyle if needed.  More importantly” continues Lorenzo Consoli “Air Smart bridges the communication gap between patients and physicians, thus improving the quality of care. Patients can share their lung health history with their physicians in advance of their visits enabling much better clinical decisions”. Respiratory diseases cause an immense worldwide health burden and the cost to society is worth billions of dollars. It is estimated that over 300 million people suffer from asthma, more than 200 million people have chronic obstructive pulmonary disease (COPD).  COPD alone, each year, kills 4 million people prematurely and is the fourth leading cause of death worldwide and the numbers are growing. Air Smart can make a real difference to the millions people suffering from respiratory diseases. Air Smart Spirometer is a CE-certified, class IIa medical device and developed according to ISO 26782:2009. 

Precise Biometrics and NXP Sign License Agreement for Fingerprint Software

The first business agreement under the framework agreement covers licensing of fingerprint software for embedding into NXP´s fingerprint reader products. The business agreement includes a per unit license fee, a fee for support and maintenance and a fee for non-recurring engineering efforts. Precise Biometrics is currently projecting that some initial revenues generated under the agreement will be recognized starting from the first quarter of 2017. The per unit license fee is volume dependent and cannot be forecasted by Precise Biometrics at this point. “NXP Semiconductors is a leader in secure connectivity solutions for embedded applications and we are pleased to enter this framework agreement. The agreement presents opportunities for further cooperation in a wide range of secure identification areas and strengthens our position as the leader in fingerprint software” said Håkan Persson, CEO of Precise Biometrics. This information is information that Precise Biometrics AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 15.00 CEST on March 28, 2017.   FOR FURTHER INFORMATION, PLEASE CONTACTHåkan Persson, CEO, Precise Biometrics ABPhone; +46 46 31 11 05 or +46 734 35 11 05E-mail; hakan.persson@precisebiometrics.comABOUT PRECISE BIOMETRICSPrecise Biometrics is a market leading supplier of solutions for convenient and secure authentication of people’s identity. We develop and sell fingerprint software and mobile smart card readers that provide the market’s best user experience and security. Our solutions are used hundreds of millions of times every day by people all over the world and are marketed together with strong business partners. For more information, please visit; http://precisebiometrics.com  Follow us on LinkedIn  and Twitter .

Resolutions of Lemminkäinen Corporation's Annual General Meeting

LEMMINKÄINEN CORPORATION  STOCK EXCHANGE RELEASE  28 MARCH 2017 AT  5:20 P.M. RESOLUTIONS OF LEMMINKÄINEN CORPORATION'S ANNUAL GENERAL MEETING On 28 March 2017, Lemminkäinen Corporation's Annual General Meeting adopted the company's annual accounts and consolidated financial statements for 2016 and granted the members of the Board of Directors and the President and CEO discharge from liability. Payment of dividend The General Meeting resolved, in accordance with the Board of Directors' proposal, to pay a dividend of EUR 0.66 per share, i.e. EUR 15,325,134.00 in total. The dividend will be paid to shareholders who are registered on the record date for payment of dividend, i.e. on 30 March 2017, in the shareholders' register of the company held by Euroclear Finland Ltd. The dividend will be paid on 6 April 2017. Board membership and remuneration The General Meeting confirmed the number of members of the Board of Directors as eight. Berndt Brunow, Noora Forstén, Finn Johnsson, Juhani Mäkinen, Kristina Pentti-von Walzel, Heikki Räty and Heppu Pentti were re-elected as members of the Board and Harri-Pekka Kaukonen as new member of the Board. The General Meeting confirmed that a fixed annual fee of EUR 120,000 be paid to the Chairman of the Board, EUR 54,000 to the Vice Chairman of the Board and the Chairman of the Audit Committee and EUR 42,000 to the members of the Board of Directors. In addition, the Board members shall be paid an attendance fee of EUR 500 per Board meeting and the Audit Committee members shall be paid an attendance fee of EUR 500 per Audit Committee meeting. Members residing abroad are to be paid the attendance fee increased by EUR 1,000. Travel expenses will be reimbursed as invoiced. Election of the auditor and audit fee Authorised Public Accountants PricewaterhouseCoopers Oy was re-elected to serve as the company's auditor. The audit fee will be paid as invoiced and approved by the company. Authorisation to repurchase the company's own shares The General Meeting resolved, in accordance with the Board of Directors' proposal, to authorise the Board of Directors to resolve on the repurchase of the company’s own shares, in one or several instalments, using the unrestricted shareholders’ equity of the company. The authorisation covers a maximum of 2,321,990 own shares, which corresponds to 10 per cent of all the current shares of the company, however taking into account the provisions of the Finnish Limited Liability Companies Act on the maximum amount of own shares in the possession of the company or its subsidiaries. The Board of Directors may resolve to repurchase shares in another proportion than that of existing shareholdings of the shareholders. The shares shall be purchased in public trading at the prevailing market price. The purchases shall be carried out on Nasdaq Helsinki Ltd in accordance with its rules and regulations. The authorisation also includes the right of the Board of Directors to resolve on all other terms and conditions of the repurchase of the shares. The authorisation remains effective for a period of 18 months from the resolution of the General Meeting. The previous authorisation granted to the Board of Directors regarding repurchase of own shares expired simultaneously.  Authorisation of the Board of Directors to resolve on a share issue and an issue of special rights The General Meeting resolved, in accordance with the Board of Directors' proposal, to authorise the Board of Directors to resolve on a share issue and/or an issue of special rights entitling to shares referred to in Chapter 10, Section 1 of the Finnish Limited Liability Companies Act in one or several instalments, either against payment or without payment. The number of shares to be issued, including the shares to be received based on special rights, shall not exceed 4,643,980 shares. The maximum number corresponds to 20 per cent of all the current shares of the company. The Board of Directors may resolve to issue either new shares or own shares possibly held by the company. The authorisation entitles the Board of Directors to resolve on all terms and conditions of the share issue and the issue of special rights entitling to shares, including the right to derogate from the pre-emptive right of the shareholders. The authorisation may be used for the financing or execution of any acquisitions or other business arrangements, to strengthen the balance sheet and financial position of the company or for other purposes as determined by the Board of Directors. The authorisation remains effective for a period of 18 months from the resolution of General Meeting. The previous authorisation regarding a share issue and an issue of special rights expired simultaneously. Minutes of the meeting The minutes of the General Meeting of shareholders will be available on Lemminkäinen's website as from 11 April 2017 at the latest. LEMMINKÄINEN CORPORATIONCorporate Communications ADDITIONAL INFORMATION:General CounselJohan NyberghTel. +358 2071 54811johan.nybergh@lemminkainen.com DISTRIBUTION:Nasdaq Helsinki LtdKey mediawww.lemminkainen.com  Lemminkäinen is an expert in complex infrastructure construction and building construction in Northern Europe and one of the largest paving companies in its market. Together with our customers and 4,700 professionals we employ, we build a sustainable society. In 2016, our net sales were EUR 1.7 billion. Lemminkäinen Corporation’s share is quoted on Nasdaq Helsinki Ltd. www.lemminkainen.com

Eva Halldén acting managing director of SKB

Eva has been the managing director for both Ringhals and Forsmark nuclear power plants and since then Eva has led the Ringfors program as well as Vattenfall’s Business Area Generation’s improvement work. Christopher Eckerberg, presently managing director for SKB, will instead lead the Ringfors program as well as the improvement work. In this new role, Christopher Eckerberg will report directly to Torbjörn Wahlborg, chairman of the SKB Board and Head of BA Generation. Over the past years SKB has evolved from a research and site investigation organization to become more of an operations and project organization. Eva Halldén brings her extensive experience from the management of nuclear operations as well as major projects to SKB leadership. “Under Christopher’s leadership SKB moved to become a successful operations organization. In June 2016, the regulator SSM approved SKB’s application concerning a final repository for spent nuclear fuel in Forsmark. This was a historic milestone. I am very pleased that Eva Halldén now will take SKB into the future with its nuclear operations and the coming large final-repository project. At the same time I look forward to welcoming Christopher in his important mission to restore profitability in nuclear,” says Torbjörn Wahlborg. In 2017 SKB moves towards yet another important milestone in connection with the final repository program with the beginning in September of the main proceeding in the Land and environmental court. “SKB is very important for the Swedish nuclear industry and an exciting company with a broad range of activities. SKB has a world-leading role in its field. I very much look forward to take on my new role and to work with SKB’s employees in so many areas”, says Eva Halldén. The next step involves codetermination in order to permanent Eva Halldén’s role as managing director of SKB For further information, please contact:Vattenfall’s Press Office, telephone: +46 8 739 50 10

Seqr™ integrates Masterpass to create the first digital wallet for shopping in all channels across multiple markets

PRESS RELEASE Seqr™, the innovative and easy mobile payment solution developed by Seamless, has joined forces with Mastercard to provide a contemporary and secure way to pay. Seqr continues to innovate by integrating Masterpass by Mastercard into its mobile payment app to provide even greater convenience to its consumers, by enabling them to make secure digital payments online, in-app and in-store. During the second quarter of 2017, Seqr customers will benefit from being able to shop and pay at hundreds of thousands of online stores, wherever Masterpass is accepted, globally. Masterpass and Seqr Masterpass is a digital payment service from Mastercard that empowers consumers to make fast and secure digital payments. It allows them to pay with any enrolled payment card, anywhere, using any device. Consumers securely store Mastercard and other branded credit, debit and prepaid card information, as well as certain private label and loyalty cards, along with shipping addresses, all in one place, so that they can be easily accessed during checkout. Masterpass eliminates the need to enter detailed payment and shipping information with every purchase, and simplifies the process of completing a transaction from any connected device.  Masterpass has the added advantage of an online acceptance network that has merchants in over 34 countries. These trusted advantages combined with the power and innovation of Seqr will help to enable even greater growth within the mobile payments and e-commerce world. Peter Fredell, CEO of Seamless, sees the great benefits of the cooperation between Mastercard and Seqr concerning Masterpass: “To integrate with Masterpass gives us an online acceptance network consisting of 340,000 online retailers where you can pay with Seqr. This is obviously a great leap for Seqr and visualizes the strength both of Seqr and the Mastercard network. Furthermore, we have created a digital wallet for shopping in all channels in multiple markets where you now will be able to pay within Mastercard’s network both in the online market and physical stores globally.” Mats Taraldsson, Head of Digital Development, Mastercard Nordics and Baltics: “We are delighted to partner with such an innovative company as Seqr that will support the roll-out of Masterpass for shopping in all channels, not only in Sweden, but across multiple markets.” A digital wallet for shopping in all channels to launch across multiple markets Seqr, together with Mastercard, has created an international digital wallet for shopping in all channels, which will launch across multiple markets. The wallet will support not only contactless payments through Host Card Emulation (HCE), but also in-app payments and e-commerce payments. This omni-channel wallet will make it possible for all Seqr users to now pay in over hundreds of thousands of online stores where Masterpass is accepted. The additional benefits of Masterpass and its acceptance network will only help strengthen the position of Seqr’s digital positioning within the mobile payments market. About Seqr Seqr is the standard way to pay. Developed by Seamless, Seqr is the safe, fast and easy way to pay by mobile. The only thing the user needs is the Seqr app to scan a QR code or tap on the NFC terminal. Globally, over 30 million contactless card terminals now accept Seqr. The low investment and transaction fees for merchants and among others ensure that Seqr is the most widely used mobile payment solution in Europe. www.seqr.com  About Seamless Seamless is one of the world’s largest suppliers of payment systems for mobile phones. Founded in 2001 and active in 35 countries, Seamless handles more than 5.3 billion transactions annually through 675,000 active sales outlets. Seamless has three main business areas including the transaction switch, the technology provider for the distribution of e-products and the mobile payment platform Seqr. www.seamless.se  For more information, please contact: Annika Blomé - COO.                                                     +46 856 48 78 00 Dominique Tilleman - Head of Communications            +32 473 27 04 90 This information is information that Seamless Distribution AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. This information was submitted for publication, through the agency of the contact person set out above, at 08.50 a.m. CET on March 29, 2017. Seamless Distribution AB, Box 6234, 102 34 Stockholm | Visiting address: St Eriksgatan 121 D | Org. no: 556610-2660 Phone: 08-564 878 00 | Fax: 08-564 878 23 | www.seamless.se 

RaySearch enters collaboration with premier US cancer center regarding RayCare

The University of Texas MD Anderson Cancer Center in Houston, Texas, will collaborate with RaySearch on the development of RayCare®*, the next-generation oncology information system designed for the clinical workflow needs of today and tomorrow. The agreement covers all of MD Anderson’s sites in the Greater Houston area, including five regional cancer centers. One goal of the collaboration is to enable clinical implementation of RayCare in a complex and large-scale environment.   MD Anderson is one of the world’s largest cancer centers and a global leader in clinical research. The center treats around 130,000 patients per year and has over 20,000 employees. The scale of its operations make efficiency and safety key priorities, and these will be significant strengths of the RayCare system. RayCare is designed to unify and consolidate the different software systems that are commonly in operation, including systems for medical oncology, radiation oncology and surgical oncology.  Integrating the varied activities in these workflows saves time, reduces complication and minimizes the risk of errors that can occur when transferring information between systems. Potential benefits for patients include a smoother treatment experience and better continuity of care. This is the next step in a strong strategic collaboration that combines the research and development strengths of MD Anderson and RaySearch, with the aim of converting research findings into practical solutions that can be brought to market quickly for the benefit of cancer clinics everywhere. MD Anderson has also started using RayStation® to generate clinical treatment plans. This is the first phase of a planned clinical rollout that follows extensive training of the clinical teams. RayStation and RayCare are designed to integrate seamlessly, paving the way for even greater gains. Johan Löf, CEO of RaySearch, says: “I am proud that MD Anderson Cancer Center has joined us in the RayCare project. Solving the coordination, safety and efficiency needs of one of the world’s largest cancer care providers is one of our most exciting challenges to date. This collaboration has a strong foundation for success, building on the vast clinical knowledge and resources of MD Anderson and the innovative development capabilities of RaySearch.”

Annual General Meeting of AB SKF

Gothenburg, 29 March 2017: The Annual General Meeting of Aktiebolaget SKF, parent company of the SKF Group, was held in Gothenburg on Wednesday, 29 March 2017, under the chairmanship of Mr Leif Östling. The income statements and the balance sheets were adopted, together with the Board’s proposal for distribution of dividend. A dividend of SEK 5.50 per share was approved. To be entitled to receive the dividend, shareholders must be recorded in the share register on 31 March 2017. The Meeting resolved that the Board’s fee for 2017 is to be in accordance with the following: a) a firm allotment of SEK 7,512,000 to be distributed with SEK 2,008,000 to the Chairman of the Board, and with SEK 688,000 to each other Board member elected by the General Meeting and not employed by the company; and b) an allotment for committee work of SEK 1,182,000 to be distributed with SEK 233,000 to the chairman of the Audit Committee, with SEK 166,000 to each of the other members of the Audit Committee, with SEK 133,000 to the chairman of the Remuneration Committee and with SEK 106,000 to each of the other members of the Remuneration Committee. A prerequisite for obtaining an allotment is that the Board member is elected by the General Meeting and is not employed by the company. The following Board members were re-elected: Mr Leif Östling, Mr Peter Grafoner, Mr Lars Wedenborn, Mr Baba Kalyani, Mr Hock Goh, Ms Marie Bredberg, Ms Nancy Gougarty and Mr Alrik Danielson. The following Board members were newly elected: Mr Ronnie Leten and Ms Barb Samardzich. Mr Leif Östling was elected Chairman of the Board. PWC was elected auditor for the time up to the closing of the Annual General Meeting 2021. The Meeting approved the Board’s proposal regarding principles of remuneration for Group Management and the Board’s proposal for a resolution on SKF’s Performance Share Programme 2017. The programme covers not more than 225 senior managers and key employees in the SKF Group with an opportunity to be allotted, free of charge, SKF B shares. Under the programme, not more than 1,000,000 shares, corresponding to around 0.2% of the total number of outstanding shares, may be allotted. The number of shares that may be allotted must be related to the average TVA development during 2017-2019 compared to the actual TVA in 2016. The Meeting approved the proposal presented regarding the Nomination Committee. Aktiebolaget SKF      (publ)